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Abstract 
Tumor necrosis factor-alpha (TNF) is one of the pleiotropic cytokines that is 
primarily produced by activated macrophages and lymphocytes. It elicits a wide range of 
immunological events such as fever, inflammation and tumor kiUing. Recently, it was 
found that TNF increased the release of reactive oxygen species (ROS) such as superoxide 
radical (02*") and hydrogen peroxide (H2O2) inside the cells. Moreover, some findings 
indicate that TNF produces the increase in the intraceUular free calcium concentration 
([Ca2+]i). 
High concentration of ROS induces Upid peroxidation and DNA damage. High 
[Ca2+] inside the cell activates phosphoUpases, proteases and/or endonucleases. In this 
connection, ROS and Ca^^ have been suggested to be the messengers that lead to a form 
of ceU death known as apoptosis. However, the relationship between ROS and Ca?+ is stiU 
unknown. Therefore, the objective of my research project is to investigate the role and the 
relationship between the ROS and Ca^^ in the TNF-mediated cytotoxicity in a TNF-
sensitive ceU Une, L929 ceUs. Techniques such as agarose gel electrophoresis, confocal 
laser scanning microscopy, flow cytometry and cytotoxicity assay were applied. 
Results from my experiments indicate that TNF induces D N A fragmentation, a 
haUmark of apoptosis, as observed by agarose gel electrophoresis. Moreover, in the cell 
cycle study with flow cytometry, TNF produced a hypodiploid peak next to the G0/G1 
phase suggesting the presence of apoptotic cells and apoptotic bodies. On the other hand, 
Abstract Page viii 
TNP caused a slow rise in ROS and [Ca^^i in L929 cells. The release ofROS could be 
suppressed by enzymatic antioxidants such as catalase or manganese dependent 
superoxide dismutase (MnSOD), and the non-enzymatic antioxidants such as N-
acetylcysteine or 4-hydroxy-TEMPO. Application of mitochondrial electron transport 
chain inhibitors such as rotenone and antimycin A indicates that TNF caused the release of 
ROS from the mitochondria mainly at the ubiquinone site (complex ffl). The use of 
dinitrophenol indicates that the TNF-mediated ceU death was an energy dependent 
process. Application of antioxidants and mitochondrial electron transport chain inhibitors 
could suppress or enhance the TNF-mediated cytotoxicity. 
Similar to the ROS formation, TNF did not produce an immediate increase but a 
slow rise of [Ca2+]i in L929 cells. This was confirmed by the use of thapsigargin, an 
ATPase inhibitor. In the presence of thapsigargin, the [Ca^^]i was significant increased by 
TNF. Addition of calcium-inducing agent such as thimerosal produced a higher TNF-
mediated cytotoxicity. L i contrast, application of calcium chelator such as BAPTAy'AM 
suppressed both the redox rate and the cytotoxicity in TNF-treated cells. L i the 
experiments with the use of mitochondrial Ca^^ cycling inhibitors such as ruthenium red 
and diltiazem, the possible source of Ca!+ for the TNF-effect was found to be 
mitochondria. These results suggest that [Ca^^]i might induce the release ofROS in TNF-
treated L929 cells. 
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In addition, TNF did not change the intraceUular pH in the early phase of 
treatment. Moreover, there was no change in the mitochondrial membrane potential (A^m) 
in TNF-treated L929 ceUs. 
The differences between TNF-sensitive cell Une L929 and TNF-resistant cell lines, 
rL929, rL929- l lE and rL929-4F were also examined. It was found that (1) TNF induced 
cytotoxicity in the sensitive cell line but not in the resistant cell lines; (2) TNF induced 
apoptosis in L929 cells but not in rL929; (3) TNF induced the release ofROS and Ca^^ in 
the sensitive cell line while no similar response was observed in resistant cell lines. These 
observations thus suggest that both ROS and [Ca^^i play an important role in the TNF-
mediated cell killing. 












species) ’包括過氧化物自由基(3叩6^乂丨46位(1化&1)和過氧化氫0^ (^^ 08611 peroxide) 
等。再者，它亦能夠令細胞釋放出銘離子(031(：丨 1^1丨00)。 
高濃度的過氧化物能弓丨致脂肪的過氧化①丨？记pe^oxidation)反應及去氧核糖 





Abstract in Chinese Page xi 
將焦點集中在過氧化物及躬離子的相互關係。癌細胞壞死因子敏感的細胞L929 
會作爲硏究的對象0本研究利用瓊脂糖凝膠電泳法(Agarose gel electrophoresis) ’ 





在細胞內慢慢地釋放。過氧化氫 ^ ( C a t a l a s e ) 、锰離子 -竭氧化物歧化晦 




Q) ’並引致更多過氧化物的釋放o利用二硝基苯i&(2,4-Dinitrophenol) ’我們發 
現癌細胞壞死因子所導致的細胞死亡是需要能量的。抗氧化劑和電子傳遞鏈抑制 
物的應用能增加或降低癌細胞壞死因子所弓丨致的細胞死亡。 




物的釋出。利用粒線體的®離子循環(Mitochondrial calcium cycUng)的抑制物如 
姥紅(Ruthenium Red)和地爾硫草(Diltiazem)證明癌細胞壞死因子弓丨致的躬離子釋 
Abstract in Chinese Page xii 
物的釋出°利用粒線體的躬離子循環(^^00&0^(^丨&1 calcium 07(：1]^目)的抑制物如 
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Chapter 1. General Introduction 
1.1 Tumor Necrosis Factor 
1.1.1 History of Tumor Necrosis Factor 
The tumor necrotic effects of bacterial endotoxins have been known for a long 
time and are mediated by tumor necrosis factor (TNF). The story of the discovery o fTNF 
properly begins with Willam B. Coley. In the late 19^ century, he and a few other 
physicians had some successes in treating cancer patients by infecting them with vaccines 
of killed bacteria, and the mixture of Streptococcus pyogenes and Serratia marcescens 
which came to be known as Coley's toxins (Coley, 1891). Gratia and Linz in 1931 (Gratia 
and Linz, 1931) and Shear and colleagues in 1943 (Shear et al., 1943) demonstrated that 
endotoxins can induce hemorrhagic necrosis of certain transplanted tumors in mice. 
However, endotoxins are not directly cytotoxic to tumor cells in vitro. L i 1975 Carswell 
and colleagues showed that serum from mice infected with Bacillus Caknette-Guerin 
(BCG) and subsequently treated with endotoxin contained a substance capable of inducing 
tumor necrosis in certain transplantable tumors in mice (CarsweU et al., 1975). They called 
this substance ' ^ m o r necrosis factor". They developed a hypothesis that endotoxin-
induced tumor necrosis was mediated by the release o fTNF from activated macrophages. 
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1.1.2 TNF Subtypes and Their Purification 
There are two types ofTNP, TNF-a (generaUy caHed TNF or cachectin) and TNF_ 
p (previously known as lymphotoxin (LT)). 
Cachexia is a profound loss of weight and wasting of muscle which sometimes 
occurs in patients with chronic bacterial infection or parasitic infestation. Cachectin is a 
molecule which was first isolated from the culture supernatants of endotoxin-treated 
mouse macrophages, that caused cachexia when injected into normal mice (Beutler et al., 
1985a; Beutler etal., 1985b). Extensive biochemical analysis of this molecule has revealed 
its identity as TNF-a (Beutler and Cerami, 1986). 
Actually, the initiation of the TNF field can be assigned back to 1967 when Ruddle 
and his coUeagues ORiiddle and Waksman, 1967) studied delayed-type hypersensitivity. 
They found that lymphocytes from immunized rats, when cultured in the presence of 
specific antigen, killed syngeneic fibroblasts. This kiUing was due to a "cytotoxic factor" 
released from lymphocytes. Later, Granger and his coUeagues showed that mitogen-
activated spleen cells could produce such a soluble cytotoxic factor that they called 
"lymphotoxin" (Granger and WiUiams, 1968). 
In summary, TNF>a can be obtained from endotoxin-treated macrophage cell lines 
whereas TNF-P can be obtained from lectin-stimulated T-lymphocytes. Moreover, some 
researchers demonstrated that TNF-a is produced not only by macrophages but by several 
other ceU types, including monocytes, natural kiUer cells, T-lymphocytes and glial cells. 
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The production of TNF-3, however, seems to be restricted to lymphocytes. A report 
indicates that myeloma cells may also be a source ofTNF-P (Garrett et cd., 1987). 
Adherent ceUs isolated from human peripheral blood mononuclear ceUs stimulated 
with BCG and endotoxin produced a factor with tumor necrosis activity (pennica et al., 
1984). This factor named human TNF-a ^ IuTNF-a) showed in vivo activities similar to 
those of murine TNP originally discovered in the sera of mice injected with BCG and 
subsequently treated with endotoxin (Carswell etal., 1975). Measurable levels o fHuTNF-
a were detectable after 4-P-phorbol-l, 2P-myristate- 13a-acetate (PMA) stimulation of 
HL-60 cells. Therefore this cell Une was used for both the protein purification and the 
cDNA isolation OPennica et al., 1984). The mature polypeptide consists of 157 amino 
acids. The NH2-terminal amino acid sequence of natural HuTNF-a, however, consists of 
233 amino acids. A segment of 76 residues preceded in natural HuTNF-a is probably 
involved in TNF secretion as it is not observed on mature HuTNF~a (Pennica et al., 
1984). From the cDNA sequence, a relative molecular weight of 17,000 was calculated for 
the mature protein. 
The accessibility of a cDNA probe for recombinant H u T N F ^ (rHuTNF-a) 
permitted the isolation of the cDNA for Murine TNP-a (MuTNF-a). It was found that 
PU5-1.8 cell line with PMA stimulation secreted the highest levels o f MuTNF activity 
(Pennica et a/.，1985). The isolated MuTNF-a cDNA encoded a polypeptide consisting of 
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a 79-amino-acid presequence region foUowed by a sequence for mature MuTNF-a of 156 
amino acids and with a relative molecular weight o f approximately 16,000 to 18,000. 
The human TNF-P (HuTNF-P) was successMy purified from supematants of 
PMA-stimuhted RPMI-1788 B-lymphobkstoid ceUs grown in serum-free RPMI-1640 
medium (Aggarwal et al., 1984). Recombinant TNF-p was determined to be a 
glycoprotein with 171 amino acid residues in length with a rehtive molecukr weight of 
approximately 25,000. An N-Unked glycosylation probably accounted for the increased 
size. 
The gene for murine TNF-P (MuTNF-p) was cloned in 1987 (Ruddle et al, 1987). 
The number of amino acids in mature protein is 169 with a molecular weight of 
approximately 18,000. There are 33 residues in the signal peptide. 
The characteristics ofTNFs isokted from human and murine is shown in Table 1.1 
(review: Aggarwal and Vilcek, 1992; Pennica et al., 1987; Ruddle et al., 1987). Figure 1.1 
shows the comparison of rHuTNF-a, rMuTNF-a and rHuTNF-P sequences (Pennica et 
aL, 1987). Table 1.2 shows the summary o f discovery o fTNF (modified from PaUadino et 
aL, 1987). 
In this thesis, the actions o fTNF-a wiU be focused in more detail and TNF-a wiU 
be abbreviated as “TNF ’ in the foUowing sections. 
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Table 1.1 
Characteristics ofTNFs isolated from human and murine. 
Human TNF-a Murine TNF-a Human TNF-P Murine TNF-p 
Source HL-60 PU5-1.8 RPMI-1788 T lymphocyte 
Molecular 17 16-18 B fg 
weight (kDa) 
Glycoslation No Yes Y ^ y ^ 
Cysteine 2 2 None~~~“ 1 
residues 
Amino acid 1^7 1^ Wx i^ 
length 
Signal peptide 76 79 ^ ^ 
Chromosome 6 17 6 f / 
assignment 
Homology 79 % 72 % 
(Modified from Aggarwal and Vilcek, 1992; Pennica et al” 1987; Ruddle et al” 1987) 
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Human TNF-P NHj-Leu Pro Gly Val Gfy Leu Thr Pro Ser Ala A1& Qn Thr Ak Arg Ghi His Pro Lys Met 
Human T N F ^ NHj-VallArg Ser 
Murine TNT^x NHj-Le^^Lsa 
Human TNF-P His Leu Ala His Ser Thr Leij Lys Pro| A^ Ala His| Leu He Gly A s p [ ^ Ser Lys Gk 
Human T N F ^ Ker Ser|Arg Thr Pro|J>erAsp Lys ProS^i AIa H^ Val Val ^ a Asn P r c S ^ a n o n T 
Murine TNFni Ker SerlGto Asn Sej Ser Asp Lvs Pro Val Ala His Val Val Ala Asn _ Gin |vaj G1ii 
Human TNF-p Asn Ser Leu Leu Trp Arg Ala Asn Thr Asp Arg M p y Leu| Gh Asp 5 y 
Human TNpKx GtyHjETeQ Ghi TrpLeu]Asn Arg Arg Ala Asn - AlaTeu Leu Ala Asn Gly 
Murine T N F ^ Glij Gfai Le^ l Glu HTrp Leu CSer Ghi Wrg Ala Asn — — - - kla Leu Leu Ala Asn Glv 
Human TNF-P PheSer .eu Ser \snAsn Ser Lei Leu Val Pro frhr Serf f l jkf fy i j Phe Val |TyrSei 
Human TNTF^ a Val Glu .eu Arg Asp Asn^aEXeuVaTVal Pro 5er d u Gfy Leu TyrLeu| He Tyr Sei 
Murine TNF>ct Met Asp[L^ Lvd Aso Asa Ghi Leu Val Val ProUla Asploh Leu Tvr Led Val rvrSer 
Human TNF-P |Gto Val |V^ al Phe Ser | Gly ^ys Ala Tyr S e i j ^ Lys Ala Thr Ser Ser Pro Leu Tylheu 
HumanTNF^ Gln Val Leu Phe Lys Gfy Gbi Gfy Cyd …Pro — _— SerThr 一 His| v J u u L e u 
Murine TNF^x bto Val Leu Phe Lvs Gh Gba Glv Cvj - P r o | - — AspTyr lvalLeuLeu 
Human TNF-P Ak jfi^ Glu Val Ghi Leu Phe Ser Ser Gln ^ ^ ^ e ffis[^ Pro| Leu Leu Sei| Ser 
Human TNF*KX ¢ ^ His Thrpe |SerArg| De p i | V a l BCTTyrGlnprp^ ValAsn Leu Leu SerAla 
Murme T N F ^ [fhr His Thrkall Ser Arg PheUlj De Ser Tyr filn hhi|l,ys Val Asn T.eii T,en Ser Ala 
Human TNF-p Ghi Lys Met Val Tyr So - - "^^ Leu ^ Glu — |Pro Trp |Leu His 
Human T N F ^ He Lys SerPro Cysphi Arg G h T T B m o W Gfy^aTHu Ala Eys Pro Trp l'yr Glu 
MurineTNF^ VajLvs Ser Pro Cvs Pro Lvs AsplThr Pro Glu Glv Ala Glu| LeuLvs Pro Trp Tvr Glu 
Human TNF-p Ser Met | f^His 网 Ala Ala|Phe Gto Leu |Thr Gto jSly Asp |Gh^  Leu Ser| Thr His Thr 
Human TNF>a p > Ue lyrLeTOly Vjly Val Phe Gh Leu Glu Lys Ufy Asp Arg Leu Ser Ala Uu|ne 
MurineTNF^ Pro fle Tvr Leu GW Glv Val Phe Ghi Leu Glu Lvs Gk Asp b l3 Leu SCT Ala Glulval 
Human TNF-p Asp Gly Ile Pro His peu| Val Leu Ser Pro[s^ Thr - j v 3 ^ P h e Gly|Ala Phe|XIj 
Human T N F ^ p ^ Argp^ A s p p ^ e u Asp Phe Aia Glu Ser Gfy Gh Val Tyr Phe Gfy fle p^Ala 
Murine T N F ^ ] ^ Leubd LvshTvr Leu Asp Phe Ala Glu Ser Glv Ghi Val Tvr Phe Gtvl Val Ee Ala 
Human TNF-P Q - C O O H 
HumanTNFKx Lei -COOH 
MurineTNF^ OLeJ-COOH 
Figure 1.1 
Comparison of rHuTNF-a, rMuTNF^ and rHuTNF-p sequences. Identical amino 
acids are boxed. Broken lines indicate amino acid deletions in the sequences QVIodified 
from GilUs, 1987). 
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Table 1.2 
Summary of discovery of tumor necrosis factor. 
Date Event Reference 
1891 Coley treated human cancer patients with Coley, 1891 
mixtures ofkiUed Streptococcus pyrogenes and 
Serratia marcescens preparations 
1931 Demonstration ofhemorrhagic necrosis of Gratia and Linz, 1931 
animal tumors after injection ofbacterial filtrates 
1943 Bacterial agent that induces hemorrhagic Shear etal., 1943 
necrosis identified as a polysaccharide 
1968 Lymphotoxin (TNF-p) produced by antigen- or Ruddle and Waksman 1987 
mitogen-stimulated lymphocytes shown to cause Granger and Williams 1968 
target cell lysis 
1975 Factor capable of inducing tumor necrosis and Carswell etal., 1975 
distinct from endotoxin characterized from 
mouse serum 
1984 Human tumor necrosis factor-P (lymphotoxin) Aggarwal et al., 1984 
cDNA cloned 
1984 Human tumor necrosis factor-a (cachectin) Pennica etal., 1984 
cDNA cloned 
(Modified from PaUadino et aL, 1987) 
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1.1.3 Release ofTNF 
The release o fTNF is divided into two stages, priming and triggering. Figure 1.2 
shows the possible mechanism of priming and triggering of TNF-a production in 
macrophage (Kitahara-Tanabe et al., 1991; Kriegler et al., 1988). The primers such as 
BCG and Corynebacterium parvum can prime on TNF production in macrophages. The 
inducers such as lipopolysaccharide (LPS), phorbol esters and cytokines can trigger the 
release of TNF from activated macrophage. Proteolysis of membrane-associated TNF 
produces soluble TNF. The proteolysis is mediated by a membrane enzyme, 
metaUoproteinase (Gearing et al., 1994). 
1.1.4 Biological Actions ofTNF 
The native TNF is a trimer. Results from X-ray smaU-angle scattering spectra 
indicated that the TNF trimer has a molecular weight between 50,000 and 53,000 (Lewit-
Bentley et al., 1988). In another study, Smith and his coUeagues showed that treating TNF 
with a nonionic detergent such as triton X-100 and by gel filtration produced, in addition 
to the trimer peak, another peak which is believed to be contributed by monomeric TNF. 
Monomeric TNF had a lower specific biological activitiy (Smith and Baglioni, 1987). 
TNF is ahnost not species specific. Human TNF is capable ofproducing biological 
effects on murine cells, and vice versa (Kramer et al., 1988).However, when measured the 
cytotoxicity of murine L929 cells, the specific activity o fMuTNF is about threefold higher 
than that mediated by HuTNF. 
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Primed stage 
jv^ H[^  Transcription and translation 
I of precursor TNF as membrane 
p _ . 
Membrane ^ 
Extracellular ^C1 i V ^ 
space ^ Z J 
COOH 
Triggered stage 
1 ^ Processing of precursor TNF and 
. 2 release of mature TNF to extracellular 
- l - ~ -
Membrane ^ 
^ ' - - ^ ^ ^ 
Extracellular Metalloproteinase 




Possible mechanism of priming and triggering on TNF production in macrophage. 
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TNF is a pleiotropic cytokine that elicits a wide range ofbiological events. It gives 
effect on hematopoietic system (review; Trinchieri, 1992) and immunomodulation (review: 
Bonavida, 1992). Table 1.3 shows the biological activities o fTNF. Sugarman et al. have 
conducted an extensive in vitro screen on a panel of 23 human tumors and 12 murine 
tumor cell lines and some of the results are shown in Table 1.4 (Sugarman et a/.，1985). 
Their results suggest that not all tumor cells are susceptible to TNF. 
1.2 Tumor Necrosis Factor Receptor 
1.2.1 Purification ofTNF Receptor 
To exerts its biological actions, TNF must first bind to cell surface receptors. TNF 
receptors appear on virtually all somatic cells OBeutler and Cerami, 1989). TNF receptors 
channel signals to the cytoplasm and nucleus. There are two types of surface receptors, 
TNF receptor 1 (TNFR1) and TNF receptor 2 (TNFR2). TNFR1 and TNFR2 have a 
molecular weight of 55 kDa and 75 kDa, respectively. L i 1990, the TNF receptor was 
cloned by Leotscher et al. from a human placental lambda g t l l cDNA Ubrary using a PCR 
probe derived from the N-terminus of the 55 kDa TNF receptor (Leotscher et aL, 1990). 
The sequence is identical to that cloned by SchaU et al. (from both plancental and 
premyelocytic HL-60 cDNA Ubraries) using probes derived from TNF-binding protein 
sequences (SchaU et al., 1990). 
TNFR1 is composed of 455 amino acids that can be subdivided into four domains: 
(1) a signal sequence; (2) a 182 residues extracellular cysteine-rich domain; (3) a 20-22 
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Table 1.3 
Biological activities o f T N F . 
Activity Reference 
Induces hemorrhagic necrosis of tumors Pennica etal., 1984 
Induces EL-1 production Torti etal., 1985 
Activates neutrophil functions Gamble etal., 1985 
Growth-stimulatory action (e.g. murine thymocytes) Ranges et al, 1988 “ 
Antiviral ac t iv i ty~~ “ Wong and Goeddel, 1986 
Antiparasitic ef fect~~ “ Review: P ^ I ^ ^ 
Taveme，1987 
Gene expression (e.g. c-fos, c-myc) Lin and Vilcek, 1987 
Chapter 1. General Introduction Page 13 
Table 1.4 
Summary of responses of human and murine cell lines to rHuTNF-a in vitro. 
Human cell line Origin In vitro sensitivity 
A549 Lung carcinoma -
BT-20 Breast carcinoma + 
Calu-3 Lung carcinoma -
G-361 Melanoma -
HeLa Cervical carcinoma -
ra Oral epidermoid carcinoma -
LS174T Colon carcinoma -
MCF-7 Breast carcinoma + 
Saos-2 Osteogenic sarcoma -
SD-MEL-109 Melanoma + 
T2A Bladder carcinoma -
WK)R Colon carcinoma + 
Murine cell line Origin In vitro sensitivity 
B16F10 Melanoma -
CMS4 Chemically induced sarcoma + 
L929 — Fibroblast + 一 
Meth A ChemicaUy induced sarcoma + 
S ^ Lymphoma -
— WEHI164 Sarcoma + 
(-)Represents < 25 % cytostasis/cytotoxicity. 
(+) Represents > 25 % cytostasis/cytotoxicity. 
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residues transmembrane helical segment; and (4) a 221-223 residues intracellular domain. 
Smith et al. discovered a very different breed of TNF receptor by expression screening a 
human lung fibroblast cDNA library and classified as TNFR2. This receptor is composed 
of 461 amino acids. It comprises signal, cysteine-rich, transmembrane and cytoplasmic 
domains. TNFR1 and TNFR2 show 40 % homology in their extraceUular domains, but 
virtually none in their intraceUular domains (Smith et al., 1990a; TartagHa and Goeddel, 
1992). 
1.2.2 Regulation ofTNF Receptor 
A large number of examples of receptor regulation by homologous or 
heterologous Ugands have been reported (review: Tsujimoto and Oku, 1992). These 
reports suggested that the regulation of receptor number or affinity might be a prevalent 
mechanism of cellular regulation. The biological significance of receptor regulation might 
be related to synergistic or inhibitory effects. 
Up-regulation of TNF receptors 
In some tumor cell lines, TNF and ffNs were shown to exert a synergistic 
cytotoxic action OVilliamson et al., 1983). Pretreatment of various tumor ceUs with mS[-y 
resulted in an increase o f T N F binding (Tsujimoto et aL, 1986a). Resting T cells do not 
express surface receptors for TNF. However, treatment of lymphocytes with JL-2 resulted 
in specific TNF binding to the surface of lympocytes (Owen-Schaub et al., 1989). 
Moreover, exposure of human cervical carcinoma cell line ME-180 to some lectins, such 
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as concanavalin A and wheat germ agglutinin, caused an increase in TNF receptors 
without significant change in their affinity constant (Aggarwal et al., 1986). 
Down-regulation of TNF receptors 
Aggarwal and Eessalu reported that phorbol esters such as PMA, that are known 
to bind and activate protein kinase C (PKC), reduced the total receptor number without 
any significant change in the affinity constant of the receptors in U937 cells (Aggarwal and 
Eessalu, 1987). Treatment ofSV80 cells or FS-11 cells with TL-l resulted in a decrease of 
TNF binding to ceU surface receptors (Holtmann and WaUach, 1987). Recently, it was 
found that blockade of mitochondrial respiration down-regulated tumor necrosis receptors 
(Sanchez-Alcazar et al., 1995). This down-regulation could be simply a side effect of 
mitochondrial dysfiinction, secondary to the loss of ceUular energy. Moreover, LPS and 
glucocorticoids as weU as TNF may down-regulate TNF receptors (Ding et aL, 1989; 
Kull, 1988, Tsujimoto and Vilcek, 1987). 
參 
1.2.3 Functions ofTNFReceptor 1，Receptor 2 and Soluble TNF Receptors 
TNF interacts with its specific receptor and is then intemaUzed. The internalization 
of the receptor-Ugand complex, through receptor-mediated endocytosis, and the eventual 
degradation of the Ugand by lysosomal hydrolases (Tsujimoto et al., 1985). 
TNFR1 
The cross-Unking o fTNFR l is an important component of the activation process. 
TNFR1 was shown to be responsible for inducing nuclear factor KB (NFKB)， 
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accumulation of c-fos, EL-6, and manganous superoxide dismutase mRNA, prostaglandin 
E2，\L-2 receptor, H L A class I and I I cell surface antigen expression, growth inhibition 
and cytotoxicity (Brakebusch et al, 1992; Engelmann et al., 1990b; Espevik et al‘, 1990; 
Hohmann et al., 1990，Kmppa et al., 1992; Naume et al., 1991; Shalaby et al., 1990; 
TartagUa et al, 1991; Thoma et al., 1990). The actions of TNFRl-mediated signaHng 
transduction and cytotoxicity wil l be discussed later. 
TNFR2 
Proliferation of mouse thymocytes and the murine cytotoxic T-cell Une CT-6 is 
stimulated by murine TNF (Tartaglia et al.，1991). Polyclonal antibodies directed against 
TNFR2 induced proliferation in both of these cell types, whereas polyclonal antibodies 
directed against TNFR1 had no effect. In contrast，cytotoxicity in murine L - M ceUs was 
induced by antibodies against TNFR1 but not by antibodies against TNFR2. These results 
suggest that TNFR2 initiates signals for the proliferation of thymocytes and cytotoxic T 
cells, whereas TNFR1 stimulates signals for cytotoxicity. However, TNF-induced 
proliferation may not be mediated by TNFR2 in aU cell types. Engehnann et al. have 
shown that polyclonal antibodies against human TNFR1 can stimulate proliferation of 
human FS11 fibroblasts (Engeknann et al.，1990a). 
Soluble TNFR 
The soluble forms of TNF receptors (sTNFR) have been identified in the serum, 
urine, ascites, and synovial and cerebrospinal fluids of humans. The urinary sTNFR are 
structurally related to the cell surface TNF receptors. Comparison of their amino acid 
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sequences with those of the TNFR1 and TNFR2 revealed that they are in fact the shed 
form of the extraceUular part of the TNFR1 ^Sfophar et al., 1990). The mechanism of the 
release of these receptors is not understood. It has been shown that treatment of U937 
ceUs with PMA could induce the shedding ofTNFRs O^^ ohno et cd., 1990)，suggesting a 
role for PKC. The possible physiological roles of the sTNFR may serve as: (1) TNF 
buffers by inhibiting the acute and potentially harmful effects of high TNF concentrations; 
(2) a slow release pool for TNF, (3) TNF carrier proteins between body compartments; 
and (4) stabiHzers of TNF bioactivity. It was observed that, at physiological 
concentrations, the trimeric bioactive TNF molecule dissociates irreversibly into inactive 
monomers which subsequently form inactive high molecular weight TNF multimers. 
Therefore, sTNFR may prevent trimeric TNF from dissociating into monomers and then to 
form multimers (Aderka et al., 1992). 
1.3 Possible Signal Transductions of Tumor Necrosis Factor-Alpha 
The feature of TNF action is the striking diversity of many cellular responses. 
Nowadays, no specific biological activity o fTNF could be defined that is in common to all 
TNF-responsive ceUs. Based on the limited structural heterogeneity of specific TNF 
receptors, the multitude of biological activities inducible by TNF must depend on a 
diversification of postreceptor signaling mechanisms. In general, the first event in 
triggering a cellular response is specific high-affinity interaction of TNF with membrane 
receptor molecules, thereby initiating a cascade of signal transfer reaction inside the cell. 
The most direct way of the signaling mechanism is found with receptors that themselves 
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possess intrinsic tyrosine kinase activity in their intraceUular domains. However, there is 
no induction for tyrosine kinase activity o fTNF receptors (Waterman and Sha'afi, 1995). 
A report from Smith et al. shows that cytotoxic activity of microinjected TNF was a 
receptor-independent intracellular function of the ligand itself (Smith et al., 1990b). 
According to this report, TNF membrane receptors would serve as a Ugand transporter 
and a signal transmitter in the membrane. 
TNF induces the activation of five possible cascades inside the ceUs: (1) 
phospholipase A2; (2) phospholipase C; (3) sphingomyeUn; (4) protein kinase; and (5) 
death domain. 
1.3.1 Activation of Phospholipase A2 Cascade 
TNF induces the activation of phosphoHpase A2 (PLA2) in human neutrophils 
OBauldry et al., 1991) and can be inhibited by glucocorticoids in human epithelial 
carcinoma ceU Une Hep-2 (Goppelt-Stniebe and Rehfeldt, 1992). Recently, it was found 
that TNF induces the 85 kDa cytosolic PLA2 (cPLA2) gene expression in human bronchial 
epithelial ceUs, BEAS 2B (Wu et al., 1996). PLA2 has been demonstrated to be coupled 
by G-proteins to membrane receptors (SiUc et al., 1989). The PLA2 activation mediated by 
TNF in different cell types induces the production of arachidonic acid (Gustafson-Svard et 
al., 1993). The arachidonic acid metaboUtes such as prostaglandins and leukotrienes 
exhibit gene regulatory activity such as the induction of c-fos gene (Haliday, et aI., 1991) 
and are important mediators of cytotoxicity (Hayakawa et al., 1993; Neale et al., 1988). 
Ln fact, the TNF-induced cytotoxicity can be reduced by inhibitors of PLA2, such as 
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quinacrine (Suffys et al., 1987). However，Robaye and Dumont found that PLA2 activity 
is not involved in the TNF-triggered cell death in bovine aortic endotheUal ceUs (Robaye 
and Dumont，1992). Recently, it was found that TNF-induced apoptosis (programmed ceU 
death that wiU be discussed later) is mediated by caspases, the cysteine proteases related 
to interleukin lp-converting enzyme, that results in the cleavage and activation of cPLA2, 
which in tum elicits to apoptosis O^issing et al., 1997). 
1.3.2 Activation ofPhospholipase C Pathway 
The second major signaling pathway of TNF-mediated ceU responses involves 
specific phospholipases. However, release of Ca^+ from intemal stores and increase in 
intraceUular inositol trisphosphate (P3) levels have not been detectable in U937 ceU Une 
(Schutze et al., 1992a). TNF stimulates the production of 1,2-diacylglycerol (1,2-DAG) 
by activation o f phosphatidylchoUne-specific phosphoUpase C (PC-PLC) in the absence of 
changes in intraceUular calcium concentration ([Ca^^i). The 1,2-DAG formation in 
response to TNF is a very rapid and transient event (Schutze et al., 1992a). L i contrast, 
Beyaert et al. found that Uthium chloride (LiCl), an inhibitor of phosphoinositide 
metaboUsm and cycUng, increases the cytotoxic activity o f TNF towards some 
transformed ceU Unes such as L929. Treatment o f these ceU Unes wi th the combination of 
TNF and LiCl leads to the prolonged accumulation of inositol monophosphate (H*), 
inositol bisphosphate (0*2)，and inositol trisphosphate (EP3), whereas treatment with TNF 
or L iCl alone did not 03eyaert et a/.，1993). Both TNF-mediated cytotoxicity and -
induced accumulation o f inositol phosphates were blocked by neomycin, a phospholipase 
inhibitor. The increase in n*3 after treating ceUs wi th TNF and L iCl suggests a role of 
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[Ca2+]i in TNF action. Moreover, several agents that lower the [Ca^^]i inhibited TNF 
cytotoxicity (Beyaert et al., 1993). In conclusion, TNF-induced production of ff3 or 
[Ca2+]iis still controversial. 
1.3.3 Activation of Sphingomyelin Pathway 
TNF signaling may involve sphingomyelin (SM) hydrolysis to ceramide by 
sphingomyelinase (SMase) fFigure 1.3). In a cell-free system, TNF induced a rapid 
reduction in membrane sphingomyeHn content and a quantitative elevation in ceramide 
concentration p>essler et al., 1992). There are two types of SMase, the acidic and the 
neutral forms, that exert different functions. The SMases belong to a family of C type 
phospholipases that hydrolyze SM to produce phosphorylcholine and ceramide. The latter 
is viewed as a second messenger-Uke molecule, SMases are widely distributed in various 
tissues and exhibit characteristic cellular compartmentation. Acidic SMase is an 
intraceUular, compartmentalized glycoprotein with an optimal pH of 4.5 and a molecular 
size of 72 kDa (Quintera et al., 1987). Activation of the acidic SMase has been shown to 
require 1,2-DAG (Kolesnick，1987). Schutze et al. found that TNF-responsive PC-PLC 
via 1,2-DAG couples to an acidic SMase, resulting in the generation o f ceramide, with 
eventually triggers rapid induction ofnuclear NFKB activity that controls the expression of 
a variety of cellular genes (Schutze et al., 1992b; review: Kolesnick and Golde, 1994). 
The finding indicates that 1,2-DAG activates an acidic SMase that hydrolyzes SM to 
produce ceramide in U937 and Jurkat cells. The second messenger-like molecule ceramide 
is found to display a potent, NFKB-inducing capacity (Schutze et al., 1992b). In contrast, 
neutral SMase has been implicated in mediating TNF-induced differentiation of HL-60 
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Sphingomyelin hydrolysis to ceramide mediated by sphingomyelinase. Sphingomyelin 
is comprised of a phosphocholine headgroup, a long chain or very long chain saturated or 
monounsaturated fatty acid and a sphingoid base backbone, predominantly sphingosine. 
Chapter 1. General Introduction Page 22 
cells (Kim et al., 1991). Neutral SMase was shown to activate a protein kinase but did not 
require PLC (Mathias et aL, 1991). . 
In addition, the generation of ceramide in response to TNF may play a role in 
stimulation of the transcription of cPLA2 and cyclooxygenase 2 in L929 cell (Hayakawa et 
al., 1996). Ceramide-related signaling processes in the induction of apoptosis by TNF was 
found in U937 cell (Jarvis et al., 1994). 
1.3.4 Activation of Protein Kinase 
Activation ofprotein kinase A 
TNF has been noted to rapidly increase the production of cyclic AMP (cAMP) that 
potentially results in activation of protein kinase A (PKA) in human diploid fibroblast FS-4 
(Zhang et al., 1988). TNF may either directly activate adenylate cyclase via G-proteins or 
inhibit phosphodiesterase activity. Scheurich et al. found that activation of PKA results in 
an enhancement of TNFR expression. Addition of the membrane-permeable cAMP 
derivative dibutyric-cAMP resulted in a drastic enhancement of TNF binding capacities in 
HL-60 ceU (Scheurich et al., 1989). 
Activation of protein kinase C 
The involvement o fPKC in TNF signaling pathways was monitored by the effects 
of TNF on the PKC activity in U937 and K562 cell lines (Schutze et al., 1990). TNF 
treatment resulted in activation ofPKC associated with a translocation from the cytosol to 
the cell membrane. The molecular mechanism of TNF-induced PKC activation is likely 
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related to 1,2-DAG that generated by PC-specific PLC. Moreover, it has been shown that 
unsaturated fatty acids, such as arachidonic acid, can activate PKC independently of Ca^^ 
and phospholipids (Murakami and Routtenberg, 1985). Therefore, TNF activation o fPKC 
may occur through stimulation of either phospholipase C, leading to increased levels of 
1,2-DAG, or phospholipase A2, elevating arachidonic acid. As mentioned before, 
activation of PKC may down-regulate TNPR expression ceUs (Aggarwal and Eessalu, 
1987). 
Activation of serine/threonine protein kinases 
Treatment of Swiss 3T3 and L929 ceUs with TNF leads to the rapid stimulation of 
several cytosoUc serine/threonine kinases active toward a number of peptide and protein 
substrates, such as myelin basic protein (Van Lint et al., 1992). This confirms the 
hypothesis that kinases other than PKA and PKC may be involved in the TNF signal 
transduction. 
1.3.5 Activation of the Cascade ofDeath Domain 
The cytoplasmic regions of TNFR1 is responsible for transducing the death signal. 
Subsequent mutational analyses in TNFR1 indicated that this domain has been designated 
a death domain OFigure 1.4) (Tartaglia et al.’ 1993，review: Nagata，1997). The death 
domain contains protein TRADD (TNFRl-associated death domain protein) that binds to 
TNFR1 OHsu et al.’ 1995). TRADD binds to FADD (Fas-associating protein with death 
domain) or M 0 R T 1 OFADDMORT1) via interactions between their death domains OHsu 
et al., 1996b). F A D D M 0 R T 1 then activates caspase-8, that carries two death effector 
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Figure 1.4 
TNF induced a cascade of death domain. TNF binds to TNFR1, and the trimerized 
receptor recruits TRADD via interactions between death domains. The death domain o f 
TRADD then recruits F A D D M 0 R T 1 in one pathway to activate caspase-8. In another 
pathway, RIP binds to TRADD and transduces an apoptotic signal through the death 
domain. In addition, RIP together with TRAF2 activates NF-KB, which may induce the 
expression o f survival genes. 
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domain (DED) or M0RT1 (DED/M0RT1) domains at the N-terminal region, through 
which it binds FADDMORT l . The C-terminal region of caspase-8 is related to caspase-1 
family that transduces an apoptotic signal. In addition to this pathway, TNFR1 has another 
pathway leading to apoptosis. REP (receptor interacting protein) is a serine/threonine 
kinase containing a death domain and binds to TRADD Qisu et al., 1996a) and transduces 
an apoptotic signal. On the other hand, RJP together with TRAF2 (TNF receptor-
associated factor 2) activates NF-KB, that may induce the expression of survival genes. 
The role of the kinase activity ofRJP is currently unknown (Liu et al., 1996b). 
1.4 Induction of Both Apoptosis and Necrosis by Tumor Necrosis Factor-
Alpha 
1.4.1 Apoptosis Versus Necrosis 
Two forms of cell death have been recognized by Wyllie et al. (WyUie et al., 
1980), necrosis and apoptosis (or programmed cell death) that are distinguished by 
morphological characteristics (review: Kerr et al., 1995). 
Cellular necrosis is defined by electron-lucent cytoplasm, mitochondrial swelling, 
loss of plasma membrane integrity without drastic morphological changes in nuclei. 
Necrosis has been considered as a passive degenerative phenomenon induced by direct 
toxic or physical injuries, which most often occurs accidentally (Hawkins et ai., 1972). 
Nuclear DNA is randomly cleaved as a consequence of ceUular degeneration. Leakage of 
Chapter 1. General Introduction Page 26 
the cytoplasm through plasma membrane disruption induces ceMar inflammatory 
responses. Necrotic ceUs in tissues tend to retain their shape until removed by 
mononuclear phagocytes. In cultures, on the other hand, disintegration results in the 
production of amorphous debris CJCerr et al., 1995). 
Apoptosis was originaUy distinguished from necrosis on the basis of its 
ultrasturcture (Kerr et aL, 1972). Apoptosis is characterized by chromatin condensation, 
nuclear fragmentation and formation of apoptotic bodies (WyUie et al., 1980). Apoptosis 
is tightly regulated by molecular mechanisms. In most but not aU forms of apoptosis, 
nuclear DNA is cleaved at intemucleosomal sites that produces 180 base pairs fragments. 
In tissues, apoptotic bodies are often found in clusters, but scattered single bodies are also 
common (Kerr et aL, 1995). Apoptosis can be induced by various stimuU such as ceramide 
(Obeid et al., 1993), cytochrome c (Liu et aL, 1996a), Ca】+ (Park et a!., 1996) and 
hydrogen peroxide (Gardner et al., 1997a). On the other hand, apoptosis can be 
suppressed by Bcl-2 (B-ceU leukemia/lymphoma-2 gene, is a proto-oncogene &st 
identified by its association with B ceU malignancies (Reed, 1994)) (Hockenbery et al., 
1990). Apoptosis is important in animal development such as sculpting, deleting unwanted 
structures, controUing ceU numbers and eUminating nonfunctional, harmfiil, abnormal, or 
misplaced ceUs (review: Jacobson et aL, 1997). 
Recently, the intraceUular ATP leveb have been impUcated both in vitro and in 
vivo as a determinant of the ceU's decision to die by apoptosis or necrosis (review: 
• Tsujimoto 1997). I t was found that necrosis did not require intraceUular ATP. In contrast, 
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depletion of intraceUular ATP by incubating ceUs in glucose-free medium to halt 
glycolysis, in the presence of the mitochondrial Fo-Fi-ATPase inhibitor oHgomycin, 
completely blocked apoptosis induced by Ca:+ ionophore and ATP suppHed through either 
glycolysis or mitochondrial oxidative phosphorylation restored the apoptotic ceU death 
pathway. These results indicate that apoptosis is ATP-dependent (review: Nicotera and 
Leist, 1997). 
1.4.2 TNF Can Induce Both Apoptosis and Necrosis 
Laster et al. found that TNF can induce both apoptotic and necrotic forms of ceU 
lysis that depends on ceU type (Laster et al, 1988). In TNF-sensitive target, an adenovirus 
E l transformant F17 undergoes DNA fragmentation when it dies. This suggested that in 
F17 ceUs, TNF triggers apoptosis. However, L - M ceUs die in a completely different 
manner. UnUke F17 ceUs, L - M ceUs undergo necrotic form of ceU death after TNF 
treatment. 
1.5 Possible Mechanisms of Tumor Necrosis Factor-Alpha-Mediated 
Cytotoxicity 
TNF is cytotoxic to some ceU Unes, but not aU tumor ceUs (Table 1.4). The exact 
mechanism for TNF cytotoxicity is still unknown. In this section, several possible 
mechanisms wil l be introduced. 
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1.5.1 Release of Reactive Oxygen Species 
Review of reactive oxygen species 
Reactive Oxygen Species (UOS), a reduced form of oxygen, are unstable. For 
examples，superoxide radical (02*"), hydrogen peroxide (H2O2), hydroxyl radical (OH*), 
nitric oxide OSK>)，semiquinone (SQ*), peroxyl and alkoxyl radicals 0^00« and R0* ) 
(review: Dawson and Dawson, 1996) are the ROS found in the cytosol. The normal 
background level for H2O2 is about micromolar range (^iM) and there is about nanomolar 
(nM) range for 02*~, OH* and NO*. Mitochondria are considered to be the major site of 
ROS production whereas the primary source is from the electron transport chain. 
Therefore, ROS are generated continuously in respiring cells. Figure 1.5 shows the 
metabolic pathways for the generation of 02*", H2O2 and OH*. N A D H that come from 
glycolysis or TCA cycle, donates electron to ubiquinone QJQ) and then pass through a 
cascade, finally to the electron acceptor, molecular oxygen. Aknost all electrons pass 
through this pathway. However，about 1-3 % of electrons leak out from inner 
mitochondrial membrane and react with molecular oxygen directly, and 02*" is formed 
Pawson and Dawson, 1996). Then, 02*" is converted into H2O2 or water, depends on the 
catalytic pathway. Excessive production ofROS may cause cell death. 
ROS attack different targets inside the cells. Proteins, lipids, D N A and RNA are 
the major targets. ROS cause modification of thiol groups on mitochondrial membrane, 
therefore, increase the [Ca^^]i level by releasing the mitochondrial Ca^^ into cytosol 
(review: Vercesi, 1993). ROS cause lipids peroxidation that increase the membrane 
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Metabolic pathways for the generation of 02*", H2O2 and OH* in the inner 
mitochondrial membrane. 
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permeabUity (Radi et al., 1991). ROS may induce base damage on DNA or RNA (Park et 
a!.，1998; Wiseman and HaUiweU, 1996). Consequently, protein synthesis is inhibited. 
There are two main defence mechanisms for removing ROS inside the ceUs. They 
can be categorized into enzymatic and non-enzymatic defences. The enzymatic defence 
includes the manganese dependent superoxide dismutase (MnSOD) that locaUzed in 
mitochondria; copper and zinc dependent SOD (CWZnSOD)，catalase, glutathione 
peroxidase and glutathione reductase system in cytosol. The non-enzymatic defence 
includes a-tocopherol, ascorbic acid and p-carotene (review: Briehl and Baker, 1996). 
The excessive production ofROS impairs the antioxidant system. It is interesting that low 
level o f oxidants stimuhtes ceU proUferation. Different concentrations of redox-cycUng 
quinone DMNQ in RCvfm5F ceUs induce different responses. At low concentration about 
10 | iM, DMNQ induces ceU proUferation. At medium concentration about 30 jiM，it 
inhibits ceU growth and induces apoptosis. At high concentration such as 100 ^M, it 
causes glutathione and ATP depletion, Ca^^ overload and acute necrosis (Dypbukt et al., 
unpubUshed data). 
Release ofROS after TNF treatment 
Tsujimoto et al found that TNF provokes 02*" generation from human 
neutrophik (Tsujimoto et al, 1986b). Treatment o f murine tumor ceUs such as L929, 
P388 and Pan-02 with rHuTNF induces oxidative damage in vitro (Zimmerman et al., 
1989). Wong and Goeddel found that TNF induced the production ofMnSOD mRNA in 
‘ a U ceU Unes and normal ceUs in vitro and in various organs of mice in vivo (Wong and 
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Goeddel, 1988). Moreover, the antioxidants desferrioxamine and butyIated hydroxyanisol 
inhibited TNF-induced apoptosis in L929 ceUs. However, enforced expression of Bcl-2 
had no effect against TNF-induced apoptosis (Gardner et al, 1997b). 
1.5.2 Release of IntraceUular Calcium 
Review ofCc^— homeostatsis 
There are many signaling pathways in cells. Phosphoinositide cycle (Tigure 1.6) is 
one of these pathways and it regulates the mobilization of calcium ion (Ca】+) (Berridge, 
1985). Cytosolic Ca^+ is important in the regulation of many cellular activities. For 
instance, secretory cell requires Ca^^ as the regulator for secretion. Nuclear calcium 
(Ca2+)n is important in the regulation of a number of nuclear activities such as DNA 
replication (Jindal et al., 1991), gene transcription ps4organ and Curran, 1986), DNA 
repair (Bachs et al., 1994) and apoptosis (Jones et al., 1989). In general, the concentration 
of Ca2+ in extracellular medium is in the range of mM level while the intracellular one is as 
low as nM. Moreover, Ca]+ cannot be synthesized or degraded, hence, the fine tune of 
Ca2+ concentration is very important. I f the concentration of Ca^^ is too high, it may 
induce apoptosis or programmed cell death pSTicotera et al., 1994). 
In general, there are three transporting systems for Ca^^ influx from extraceUular 
medium into cytosol. They include receptor-operated channel, voltage-operated channel 
and Na7Ca2+ exchanger. On the other hand, Ca^^ efflux is regulated by Ca^^-ATPase 
(Figure 1.6a). Ca^^ is sequestered by intraceUular Ca^^ stores such as nucleus and 
endoplasmic reticulum and mediated by Ca^^-ATPase OFigure 1.6b). Ca】+ efflux can be 
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Figure 1.6 
Calcium homeostatsis inside a cell, (a) Ca^ ^ transport systems on plasma membrane, (b) 
Ca2+ sequestration by the ER and nucleus and (c) Ca^^ cycling in a mitochondrion. 
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regulated by inositol l,4,5-trisphosphate (EP3). The binding of EP3 to ff3-sensitive Ca^^ 
channel induces Ca^^ release from Ca^^ stores (review: Berridge, 1993). Moreover, Ca^^ 
cycling exists in mitochondrion. The uniporter on inner mitochondrial membrane for Ca?+ 
transport is regulated by mitochondrial membrane potential (Avj/m) (Figure 1.6c). The 
membrane potential of mitochondria is about -180 mV inside. The mitochondrial Ca:+ 
efflux is mediated by Na+-dependent and Na+-independent exchanger (review: Vercesi, 
1993). 
Figure 1.7 shows the phosphoinositide cycle. At first, agonist binds to receptor 
that induces the activation of G protein which in tum acts on phosphatidylinositol 4,5-
bisphosphate phosphodiesterase (PDE), or phospholipase CP (PLCp). PLCP is an enzyme 
that degrades phosphatidylinositol 4,5-bisphosphate (^TP2) into two products, EP3 and 1,2-
diacylglycerol (1,2-DAG). 1,2-DAG acts on inactive form of Ca^^-dependent protein 
kinase (PKC) and changes it to an active form. The active form of PKC is very important 
for various functions and also for mitogenesis OBerridge, 1993). On the other hand, ff3 
binds to the EP3-sensitive receptor that induces the release of Ca^ .^ In general, ff3 
receptors localize on the cytosolic endoplasmic reticulum. To date, several lines of 
evidence show that nuclear membrane may have EP3 receptor OHennager et cd., 1995， 
Malviya, 1994). Therefore, endoplasmic reticulum and perinuclear space are both Ca^+ 
pools that contain 10^ M Ca^^ inside. Moreover, ff3 is phosphorylated to phosphoinositol 
1,3,4,5-tetrakisphosphate (ff4) by the enzyme, HV3 kinase. EP4 binds to its receptor, 
which localized on the plasma membrane and also on the nuclear membrane (Hennager et 
al., 1995). n*4 receptor itself is a Ca?+ channel that permits Ca^^ influx from the extemal 
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The phosphoinositide cycle. The first messenger binds to its specific receptor, activating 
a G protein that in tum stimulates phospholipase Cp (PLCP). Phospholipase Cp cleaves 
phosphatidylinositol 4,5-bisphosphate (PEP2) into two products, inositol 1,4,5-
trisphosphate (0^ ) and l,2-diacylglycerol ( l ,2-DAG). ff3 binds to the DP3 receptor on the 
Ca2+ pool and releases Ca:+ into cytosol. 1,2-DAG acts on inactive PKC and produces 
activated PKC Both Ca^^ and PKC act on other cellular effector molecules. 
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medium into the cytosol. After finishing the mobUization of Ca^^ from Ca^^-pool, IP3 was 
degraded (Berridge, 1985). 
Sustained increase in the [Ca^^]i induces the activation of Ca^^-dependent protease, 
phosphoHpases and endonucleases (review: Orrenius et al., 1989) that may induce 
apoptosis. Accumuhtion of [Ca^^]i activates proteases such as calpains. The major target 
for proteases are the cytoskeletal proteins such as a-actinin and actin-binding protein. 
Exposure of isolated hepatocytes to Ca，+ ionophore A23187 was associated with an 
increase in [Ca^^]i, a stimulation of intraceUular proteolysis and the appearance o f phsma 
membrane blebs (Nicotera et al., 1986). PhosphoHpases can be activated by Ca^^. PLA2 
catalyzes the hydrolysis of membrane phosphoUpids that requires Ca^^ for activation, 
which could cause ceU damage (Chien et al., 1979). Ca]+ activates endonucleases that 
cleaves ceU chromatin into oUgonucleosomal fragments. Accumuktion of Ca:+ 
concentration induced DNA fragmentation in rat Uver nuclei (Jones et al., 1989). 
Release of calcium after TNF treatment 
I t is stiU controversial that TNF does affect the [Ca^^]i level and involves in 
cytotoxicity. TNF induces a rapid release o f [Ca^^]i in human neutrophik (Schumann et 
cd., 1993). Moreover, several reports found that TNF induces a slow rise in [Ca^^]i level 
in mammary adenocarcinoma ceUs BT-20 (BeUomo et al., 1992), glial ceUs (KoUer et al., 
1996), and L929 ceUs (Kong et al, 1997). In contrast, Hasegawa and Bonavida reported 
that human peripheral blood lymphocytes shows a Ca^^-independent pathway o f TNF-
• mediated lysis ^Iasegawa and Bonavida, 1989). 
Chapter 1. General Introduction Page 36 
1.5.3 Miscellaneous Mechanisms 
Other mechanisms may be involved in the cytotoxic effects ofTNF. TNF-mediated 
cytotoxic action involves ADP-ribosylation in target ceUs. ADP-ribosyktion induces 
NAD+ and ATP depletion that causes ceU death (Weilckens et al., 1982). Agarwal et al. 
found that ADP-ribosylation in TNF-treated L929 ceUs increases in a time- and dose-
dependent manner and the inhibitors o f ADP-ribosyl transferase, such as 3-
aminobenzamide and nicotinamide, block TNF-mediated cytotoxicity (Agarwal et al., 
1988). Reports of the synergistic effects of other cytokines EFN-y ^Fransen et al., 1986) 
and inhibitors of DNA topoisomerases O^tsugi et al., 1990) may uncover other 
mechanisms of TNF cytotoxicity. Moreover, the potentiation of TNF cytotoxicity by 
increased temperatures has been reported ^Dubois et al., 1989). 
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1.6 Objectives of Study 
As mentioned before, TNF induces cytotoxic ,effect in some cell lines. The 
mechanisms involve the release of ROS and Ca^ .^ However, their relationship is still 
unknown. Therefore, the objectives ofthis study is to investigate the effects o fTNF on the 
release ofROS and Ca】+ in L929 cells. Moreover, the relationship between ROS and Ca^^ 
wil l be examined. The role ofCa^^ and ROS in the TNF-induced cytotoxicity wiU also be 
investigated, b i this connection, the release of ROS and Ca】+ were investigated. The 
effects of antioxidants, mitochondrial inhibitors, and Ca:+ chelating agent were studied 
also. Moreover, the mitochondrial membrane potential, pH and ceU cycle were explored. 
L929 cells are one ofthe TNF-sensitive cell Unes that is widely used in the field of 
TNF studies, b i fact, cytotoxicity o fTNF on L929 ceUs was first described by CarsweU et 
al. in 1975 (Carswel et al., 1975). In this study, L929 ceUs were chosen as a model since 
L929 cells is well studied in many reports. The data obtained in this project can be easily 
compared with others. Moreover, in this study, the effects of TNF on resistant-L929 
(rL929) cells were investigated as well. The differences between TNF-sensitive and 
resistant cell lines and the possible mechanisms account for the resistance to TNF were 
examined in this project. The effect o fTNF on the (1) cytotoxicity,⑵ release ofROS, (3) 
release of C ^ \ and (4) cell cycle were investigated and the responses to TNF in both 
sensitive and resistant L929 cells were compared. 
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As described before, the specific activity of MuTNF is about threefold higher than 
HuTNF on the cytotoxicity of L929 cells. Fiers et al, have repeatedly reported on the 
considerable difference in response in vivo between MuTNF and HuTNF (Brouckaert et 
al., 1986). In normal mice, HuTNF is about 50-fold less toxic than MuTNF (Brouckaert 
et al., 1992). Therefore, in this study, the effects of recombinant murine TNF (rMuTNP) 
was selected. 
Several approaches were used for studying the effects of TNF on L929 ceUs. For 
instance, agarose gel electrophoresis and cytotoxicity assay were used for investigating 
cell death. Confocal laser scanning microscopy and flow cytometry were used for 
exploring the release of ROS and Ca】+，pH, mitochondrial membrane potential and ceU 
cycle after TNF treatment. 
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Chapter 2. Materials and Methods 
2.1 Materials 
Table 2.1 shows a summary of the common name, chemical name, formula, 
formula weight and source of chemicals. 
2.1.1 Buffer 
Preparation of buffer 
Buffer was prepared from dissolving chemicals in distiUed water and titrated to 
suitable pH with either HC1 or NaOH except specified. 
Calcium-free bufTer was composed of 130 mM NaCl, 5 mM KC1, 1 mM MgSO4-
7H2O, 1 mM Na2HPO4-2H2O, 10 mM Tris-HEPES, 0.3 % (w/v) glucose and 5 mM 
EGTA. Tris-HEPES was prepared from dissolving HEPES into water and titrated to pH 
7.4 with Tris-base. Calcium-free buffer was titrated to pH 7.4 by Tris-base. Subsequently, 
buffer was filtered by bottle-top filter (0.22 ^im cellulose acetate membrane, 7111，Falcon, 
Becton Dickinson, NJ, USA). Buffer was stored at 4 °C. 
Lysis buffer for agarose gel electrophoresis was composed of 5 mM Tris, 100 
mM EDTA and 1 % SDS (w/v). pH was adjusted to 8.0. Buffer was stored at 4 T . 
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Table 2.1 
Table of the common name, chemical name, formula, formula weight and source of 
chemicals used in this project. 
Common Name， Formula Source 
Chemical name and formula Weight 
Actinomycin D 1255.4 Sigma Chemical Co.， 
St. Louis，MO, USA 
Agarose — Sigma Chemical Co., 
St. Louis, MO, USA 
Ammonium chloride 53.49 Riedel-de Haen, AG, 
CNH4Cl) Germany 
Ant imycin A Sigma Chemical Co., 




C25H34N2O9) 5 0 ^ 
B A P T A / A M 764.69 Molecular Probes, 
([1,2-bis(2)aminophenoxy]ethane-N,N,N^N^-tetra- Eugene, Oregon, USA 
acetic，acetoxymethyl ester) 
Boric acid 61.83 Riedel-de Haen, AG, 
(H3BO3) Germany 
Calcium chIoride-2-hydrate 147.02 Riedel-de Haen, AG, 
(CaCl2-2H2O) Germany 
CataIase — Sigma Chemical Co.， 
(from bovine Uver) (200QU/mg protein) St. Louis, MO, USA 
Chloroform 119.3 8 Merck, Germany 
(CHCl3) 
DCF 487.29 Molecular Probes, 
(2',7'-dichlorofluorescm diacetate) (H2DCFDA) Eugene’ Oregon, USA 
DiItiazem 451 Sigma Chemical Co., 
(C22H26N2O4S) St. Louis’ MO, USA 
2,4-Dinitrophenol 184.1 Sigma Chemical Co., 
QDNP) (C6H4OsN2) St. Louis’ MO, USA 
DMSO 78.13 B D H Chemicals Ltd., 
(dimethylsulphoxide) (CH3SOCH3) Poole, England 
DNA marker — Pharmacia Biotech, 
(100 base pair) USA 
EthanoI 46.07 B D H Chemicals Ltd., 
(EtOH) (C2HsOH) Poole, England 
Ethd ium bromide 394 Molecular Probes, 
(EtBr) Eugene, Oregon, USA 
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Continue Table 2.1 
Ethylenediaminetetraacetic acid 292.2 Sigma Chemical Co., 
(EDTA) (C10Hi6N2O8) St. Louis, MO, USA 
Ethylene gIycoI-bis(P-aminoethyl ether) 380.4 Sigma Chemical Co., 
N,N,N%N'-tetraacetic acid St. Louis, MO, USA 
(EGTA) (C14H24N2O10) 
Fetal bovine serum — GibcoBRL, Life 
(FBS) Technologies Inc. 
F luo-3/AM ~~1129.86~~~ Molecular Probes, 
(Fluo-3, acetoxymethyl ester) Eugene, Oregon, USA 
Fura- red/AM 1089 Molecular Probes, 
(Fura-red, acetoxymethyl ester) Eugene，Oregon，USA 
Gel loading dye — Kindly provided by 
(bromphenol blue and glycerol) Prof. K. P. Fung 
Glucose 180.2 Sigma Chemical Co., 
(C6H12O6) St. Louis, MO, USA 
HEPES 2 ^ Sigma Chemical Co., 
fN-[2-hydroxyethyl]piperazine-N'-[2-ethanesulfonic St. Louis, MO, USA 
acid]) 
Hydrochlor ic acid 36.45 B D H Chemicals Ltd., 
(HC1) Poole, England 
Hydroethidine 315 Molecular Probes, 
(HE) Eugene, Oregon, USA 
Hydrogen peroxide 34.01 Merck, Darmstadt, 
(H2O2) (perhydrol 30 % H2O2) Germany 
4-Hydroxy-TEMPO 172.2 Sigma Chemical Co., 
(4-OH-TEMPO) (C9Hi8NO2) St. Louis，MO, USA 
Ionomycin ^ Calbiochem, CA, USA 
(C41H72O9) 
Isopropanol 60.1 B D H Chemicals Ltd., 
((CH3)2CHOH) Poole, England 
Isoamyl alcohol 88.15 Riedel-de Haen, AG， 
(3-methyl butanol-(l)) (CsH12O) Germany 
Magnesium sulfate-7-hydrate 246.48 B D H Chemicals Ltd., 
(MgSO4-7H2Q) Poole, England 
M T T 4 H l Sigma Chemical Co., 
(3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium St. Louis, MO，USA 
bromide; thiazolyl blue) (CigHieNsSBr) 
Molecular sieve — Sigma Chemical Co., 
(Potassium, Sodium alumino-siUcate) (nominal pore St. Louis, MO, USA 
diameter: 3 angstrom) 
N-acetyl-L-cysteine 163.2 Sigma Chemical Co., 
_ c ) (C5H9NO3S) St. Louis, MO, USA 
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Continue Table 2.1 
Neutral red 288.8 Sigma Chemical Co., 
(3-amino-7-dimethylamino-2-methyl-phenazine St. Louis, MO, USA 
hydrochloride) (C15Hi6N4) 
Penicillin-streptomycin 一 GibcoBRL, Life 
(penicillin: 5000U/ml protein Technologies Inc. 
streptomycin: SOOQ i^g/mii) 
Phenol 94.11 USB O^nited States 
(CgHsOH) Biochemical), 
Cleveland, OH, USA 
Potassium chloride 74.55 Sigma Chemical Co., 
QCCI) St. Louis，MO, USA 
Potassium phosphate 136.1 Sigma Chemical Co., 
(monobasic anhydrous) OKH2PO4) St. Louis，MO, USA 
Propidium iodide 668.4 Sigma Chemical Co.， 
2 2 St. Louis，MO, USA 
Proteinase K 一 Sigma Chemical Co., 
(from tritirachium album) (16 U/mg protein) St. Louis, MO，USA 
Rhodamine 123 381 Molecular Probes, 
Eugene, Oregon, USA 
Ribonudease A 一 Sigma Chemical Co., 
QRNase A) (102 U/mg protein) St. Louis’ MO，USA 
Rotenone 384.4 Sigma Chemical Co., 
(C23H22O6) St. Louis, MO，USA 
R P M I — GibcoBRL, Life~~~ 
(with phenol red) Technologies hic. 
R P M I — GibcoBRL, Life 
(without phenol red) Technologies hic. 
Ruthenium red 786.35 Sigma Chemical Co., 
St. Louis，MO, USA 
§ 5 § 288.38 USB ^Jnited States 
(sodium dodecyl sulfate) (CH3(CH2) 11SO4Na) Biochemical), 
Cleveland, OH，USA 
Sheath f lu id — Becton Dickinson, NJ, 
y s A 
S N A R F - l / A M 5 ^ Molecular Probes,~~ 
(carboxy-seminaphthorhodafluor-1, acetoxymethyl Eugene, Oregon, USA 
ester) 
Sodium chloride 58.44 Riedel-de Haen, AG, 
0<[aCl) Germany 
Sodium hydrogen carbonate 84.01 Riedel-de Haen, AG, 
O^aHCO3) Germany 
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Continue Table 2.1 
Sodium hydrogen phosphate 141.96 Riedel-de Haen, AG, 
O^a2HPO4) Germany 
Super oxide dismutase — Sigma Chemical Co., 
(manganese-containing) ^ ^ S O D ) St. Louis, MO, USA 
(4400U/mg protein) 
Thapsigargin 650.76 Molecular Probes, 
Eugene, Oregon, USA 
ThenoyItrifluoroacetone 222.2 Sigma Chemical Co., 
(TTFA) (4,4,4-trifluoro-1 -[2-thienyl]-1,3- St. Louis, MO, USA 
butanedione) (C8H5F3O2S) 
Thimersol 404.8 Sigma Chemical Co., 
(sodium ethylmercurithio-salicylate; mercury-[(o- St. Louis, MO, USA 
carboxyphenyl)thio] ethyl sodium salt) 
(C9H9HgO2SNa) 
TNF 一 Boehringer Mannheim, 
(recombinant murine tumor necrosis factor-alpha) Germany 
Tris 121.14~~ USB (United States 
OOT2C(CH2OH)3) Biochemical), 
Cleveland，OH, USA 
Trypsin-EDTA — GibcoBRL, Life 
(0.25 % trypsin, 1 m M EDTA) | Technologies Inc. 
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Phosphate buffered saline (PBS) was composed of 136 mM NaCl, 2.7 mM KC1, 
1.5 mM KH2PO4 and 8 mM Na2HPO4. PBS was titrated to pH 7.4 and steriUzed by 
autoclave. PBS was stored at room temperature. 
Sodium-HEPES buffer was composed of 130 mM NaCl, 5 mM KC1, 1 mM 
MgSO4-7H2O, 1.2 mM Na2HPO4, 10 mM Tris-HEPES, 0.3 % (w/v) glucose and 1 mM 
CaCl2-2H2O. Buffer was titrated to pH 7.4 with Tris-base and filtered by bottle-top filter. 
Buffer was store at 4 °C. 
TBE buffer was composed of 890 mM Tris, 890 mM boric acid and 20 mM 
EDTA. Buffer was adjusted to pH 7.4. TBE buffer was stored at room temperature. 
TE buffer was composed of 10 mM Tris and 0.5 mM EDTA. Buffer was adjusted 
to pH 7.4. Buffer was stored at room temperature. 
2.1.2 Culture Media 
RosweU Park Memorial Institute tissue culture medium 1640 ORPMI 1640 
medium) was used for cell culture. Each pack of the powder o fRPMI 1640 medium with 
phenol red, L-glutamine and 0.5 mM HEPES was dissolved in 1 Uter of dH2O. The 
medium was supplemented with 24 mM NaHCO3. The pH of the medium was adjusted to 
7.4. Finally, medium was filtered by bottle-top filter. The complete RPMI 1640 medium 
was supplemented with 1 % penicillin-streptomycin (v/v) and 10 % FBS (v/v). In some 
experiments, phenol red-free RPMI 1640 medium was used. Colorless RPMI 1640 
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medium was prepared by dissolving each pack of the powder of RPMI 1640 medium, 
without phenol red but with L-glutamine, in 1 Uter of dH2O. The medium was 
supplemented with 24 mM NaHCO3 and 25 mM HEPES. The pH of medium was adjusted 
to 7.4. The medium was filtered by bottle-top filtered. The serum-free, colorless RPMI 
1640 medium was supplemented with 1 % peniciUin-streptomycin only. Culture media 
were stored at 4 °C. 
2.1.3 Chemicals 
Antioxidants such as NAc, 4-OH-TEMPO, catalase and MnSOD were used. M 
ofthem were dissolved in culture medium. Antioxidants should be prepared freshly except 
MnSOD (stock concentration was 6.25 mgy^ml) that was stored at -70 X after dissolving 
in medium. NAc was acidic after dissolving in medium, therefore, pH should be adjusted 
to 7.4. 
CaIcium-chelator such as BAPTAAAM was used. It was dissolved in DMSO 
(excess water was absorbed by molecular sieve). The stock concentration was 2.5 mM and 
it was stored at 4 °C. 
Calcium-inducing agents such as thapsigargin, ionomycin and thimersol were 
used. Thapsigargin and ionomycin were dissolved in DMSO whereas the stock 
concentration were 0.5 mM and 2 mg/ml, respectively. Thimersol was dissolved in dH2O 
and the stock concentration were 5 mM. Thapsigargin and thimersol were stored at 4 °C 
whereas ionomycin was store at -70 °C. 
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Dye for cytotoxicity assay such as neutral red and MTT were prepared. 0.5 g 
neutral red powder was dissolved in 100 ml 0.9 % NaCl (normal saline). The final 
percentage of neutral red was 0.5 % (w/v) and it was stored at room temperature. The 
precipitate of neutral red was filtered by filter paper O^hatman). 5 mg/ml MTT was 
prepared by dissolving MTT powder in PBS and filtered by filter paper. MTT solution 
was stored at 4 °C. 
Fluorescence dye such as fluo-3/AM，fiira-red/AM, DCF, HE, SNARF-l/AM, 
rhodamine 123 and PI were used. The fluorescence dyes for Ca?+ studies include fluo-
3 /AM and fura-red'AM. The fluorescence dyes for ROS were DCF and HE. Al l o f them 
were dissolved in DMSO and the stock concentration was 2.5 mM. The fluorescence 
indicators for pH was SNARF-l /AM. SNARF- l /AM was dissolved in DMSO and the 
stock concentrations was 2.5 mM. Rhodamine 123 is the indicator for mitochondrial 
membrane potential. It was dissolved in absolute EtOH and the stock concentration was 
0.5 mM. D N A chelating dye such as PI was prepared. PI was dissolved in PBS. The stock 
concentration of PI was 2 mg/ml. Except rhodamine 123 that was stored at -20 °C，all 
fluorescence dyes were kept at 4 °C. 
Lysis buffer for cytotoxicity assay such as 1 % SDS (w/v) in dH2O and 0.04 N 
HC1 in isopropanol were prepared. Both SDS and acidified isopropanol were stored at 
room temperature. 
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MitochondriaI-calcium-cycling inhibitors such as ruthenium red and diltiazem 
were used. Ruthenium red and diltiazem were dissolved in Na+-HEPES buffer and dH2O 
respectively. The stock concentration of ruthenium red was 5 mM and diltiazem was 50 
mM. They were stored at 4 °C. 
Mitochondrial inhibitors include rotenone, TTFA, antimycin A and DNP. 
Rotenone was dissolved in DMSO. TTFA, antimycin A and DNP were dissolved in 
absolute EtOH. The stock concentration of rotenone, antimycin A and DNP were 5 mM 
whereas TTFA was 50 mM. M mitochondrial inhibitors were kept at 4 °C, 
Protein inhibitor such as actinomycin D was used. The powder of actinomycin D 
was dissolved in serum-free RPMI and the stock concentration was 1 mg/ml. It was 
stored at -20 "C. 
Recombinant murine TNF-a is produced from Escherichia coli and purified by 
standard chromatographic techniques pVIanuel from Boehringer Mannheim, Germany). It 
was dissolved in PBS. The specific activity is = 6.0 x 10^ U/mg. One unit is defined as the 
amount of TNF that is required to mediate half-maximal cytotoxicity with L929 ceUs in 
the presence of actinomycin D. The stock concentration of TNF was 5^g/ml. TNF was 
aliquot and stored at -70 °C. Repeated freezing and thawing should be avoided. 
Preparation of other chemicals such as MnCl2, NH4Cl, agarose, proteinase K, 
RNase A and EtBr were used. MnCl2 was dissolved in Ca^^-free buffer and the stock 
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concentration was 1 M. NH4Cl was dissolved in dH2O and stock concentration was 3.75 
M. Both MnCl2 and NH4Cl were kept at 4 °C. The powder of agarose was dissolved in . 
TBE buffer and final percentage was 1.5 % (w/v). Proteinase K and EtBr was dissolved in 
dH2O and the stock concentrations were 20 mgAnl and 0.5 ^lg/ml, respectively. RNase A 
was prepared from dissolving in TE buffer and the stock concentration was 10 mg/ml. 
Proteinase K and RNase A were stored at -20 °C whereas EtBr was kept at room 
temperature. 
Chemicals such as H2O2, phenol, chloroform, isoamyl alcohol, gel loading dye, 
DNA marker, trypsin and sheath fluid were also applied. H2O2 should be freshly diluted 
from stock (9.8 M). 
2.1.4 CuItureofCells 
2.1.4.1 Tumor Necrosis Factor-Alpha-Sensitive Cell Line, L929 
L929 cells were purchased from American Type Culture Collection (ATCC, 
Rockville, MD, USA). They were derived from transformed fibroblasts in C3H mice. They 
were maintained in RPMI 1640 medium and supplemented with 10 % FBS and 1 % 
Penicillin-streptomycin (complete RPMI). L929 cells were kept at 37 °C，5 % CO2 
incubator (SHEL LAB) with humidified atmosphere. CeUs were cultured in 25 cm^, 75 
cm^ or 150 cm^ culture flask (Coming) and were kept the passage every 3 or 4 days. For 
every passage, medium was discarded and washed once with PBS. Cells were trypsinized 
by the appHcation of trypsin. The cells suspension was coUected by addition of complete 
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RPMI and was centrifuged at 1500 r.p.m. for 3 min. Cells were then resuspended in 
complete RPMI and passaged to a new flask. 
2.1.4.2 Tumor Necrosis Factor-Alpha-Resistant CeU Line，rL929, rL929-llE and 
rL929-4F 
rL929, rL929-l l E and rL929-4F were kindly provided by Prof. K. P. Fung and H. 
K. Cheng (Department of Biochemistry, CUHK). The isolation of TNF-resistant variants 
of L929 ceUs were according to the methods described by Zimmerman et al. with 
modifications (Zimmerman et al., 1989). The modified methods were described by Kwan 
(Kwan, 1995). Briefly, L929 ceUs were subcultured into 25 cm^ culture flasks and 20 
units/ml TNF was added into medium. The ceUs were maintained in this medium for a 
period of two weeks with a change of fresh medium every 3 days. Dead ceUs were washed 
away and Uving ceUs were aUowed to grow to confluence again. TNF concentration was 
then increased to 50, 100，200, 1000, and 2000 units/ml in a stepwise manner. FinaUy, 
three ceU clones, rL929, rL929 - l lE and rL9294F, were isolated. Resistant ceUs were 
kept at 37 °C, 5 % CO2incubator. The method of passage was the same as that ofL929. 
2.2 Methods 
2.2.1 Agarose Gel Electrophoresis 
The D N A fragmentation resulting from apoptosis was investigated with 
electrophoresis o f D N A extracts according to Park et al. with modifications OPark et al., 
1996). 
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One miUion ofL929 ceUs in complete RPMI 1640 medium were seeded in 6-well 
plate (Corning) and incubated at 37 °C, 5 % CO2 ovemight until confluence. Cells were 
then treated with TNF for various time intervals. The suspension of dead ceUs were 
collected. The adherent cells were washed with PBS and trypsinized. L929 cells were 
resuspended in lysis buffer and proteinase K (200 昭）and incubated at 37 ®C ovemight. 
D N A was extracted by phenol-chloroform:isoamyl alcohol (24:1) method and spun by 
centrifuge (MSE, MicroCentaur, Sanyo) at 10,000 r.p.m. for 1 min. After centrifugation, 
the aqueous layer was extracted, mixed with chloroform:isoamyl alcohol and centrifuged 
at 10,000 r.p.m. for 1 min. The aqueous layer was extracted and was mixed with 5 M ice-
cold NaCl and absolute ice-cold EtOH, and stored at -20。C ovemight. Mixture was spun 
at 10,000 r.p.m. by using Heraeus Centrifuge (Sepatech Biofuge B, Heraeus) for 5 min 
and then centrifuged at 14,000 r.p.m., 4 X by Eppendorf Centrifuge (5402, Eppendorf) 
for 25 min. EtOH was drained away and air-dry ovemight. 20 ^ig RNase A and TE buffer 
were added, and incubated at 37 X for 2 hr. The D N A content in the final preparation 
was estimated by spectrophotometer (U-2000, Hitachi) at O.D. 260. D N A solution was 
diluted so that O.D. 260 o f the 4 pil-to-0.5 ml D N A solution become 0.1. 10 ^ll o f the 
diluted D N A solution was mixed with 2 ^il gel loading dye and D N A marker (100 b.p.), 
and loaded in 1.5 % agarose gel in TBE. D N A was run for 2 hr at 60 volts. D N A was 
stained with EtBr for 30 min and washed twice with dH2O. The image of the gel was 
taken by photographing with polaroid film (type 667，Polaroid QJ.K.) Ltd., England) 
under U V illumination. 
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2.2.2 Cytotoxicity Assay 
The viabiHty of cells can be determined by various assays such as neutral red assay, 
[^] thymidine release assay, crystal violet assay (FUck and GifFord, 1984) and MTT assay 
(Schulze-Osthoff et al., 1992). In this study, neutral red and MTT assays were used for 
determining cell viability since both of them are easier to be applied. 
Neutral red assay 
L929 cells were seeded at 3 x 10^/well in 100 [x\ of complete RPMI 1640 medium 
in 96-well flat bottom microtiter plates (Coming) and incubated for 20 hr at 37。C，5 % 
CO2 incubator until confluence. Spent medium was removed. Cells were washed twice by 
serum-free RPMI medium and 100 \x\ of diluted TNF of various concentrations and drugs 
in serum-free RPMI medium were added to wells. Control weUs contained serum-free 
medium only. Plates were re-incubated at 37。C，5 % CO2 for another 20 hr. After 
incubation, cells were washed twice with PBS. 50 ^il/weU 0.5 % neutral red (w/v) was 
added to each well and incubated for 1 hr at 37 °C, 5 % CO2. Subsequently, dye was 
removed and the wells were washed twice with PBS. Plates were air-dry in oven 
overnight. The cells were lyzed with 1 % SDS (w/v). Absorbance of weUs at 540 nm was 
determined by using microplate reader (BIO-RAD). 1 % SDS was used as blank. 
MTTassay 
The procedure for MTT assay is similar to that of neutral red assay. Briefly, L929 
cells were seeded at 3 x loVwell in a 96-weU plate and were treated with various 
concentrations of TNF and drugs in serum-free medium. After incubation, medium was 
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discarded. 100 [i\ serum-free RPMI and 20 [i\ MTT were added per well. Plates were 
incubated at 37 °C, 5 % CO2 incubator for 2 hr. MTT solution was discarded and 100 
^dAvell ofacidified isopropanol was added to each well. Plates were incubated at 37 °C for 
15 min. Absorbance of wells at 540 nm was determined by using microplate reader. 
Acidified isopropanol was used as blank. 
Statistical calculations 
Samples were tested in triplicate or septupUcate in each plate. Percentage 
cytotoxicity is means 士 standard deviation (S.D.). Percentage cytotoxicity is defined as 
follows: 
Percentage cytotoxicity = 100 % x (O.D. control - O.D. test) / (O.D. control) 
whereas control ceUs were incubated with medium only. Statistical significance was 
claimed only at p-value less than 0.05 or 0.005. The smaller the p-value is，the more the 
significance for the test. 
2.2.3 Confocal Laser Scanning Microscopy 
Introduction 
Confocal laser scanning microscopy (CLSM) aUows 3-D measurements of • 
biological structures with little blur and high spatial contrast (review: Schild, 1996, 
Lichtman, 1994). CLSM achieves high resolution of a selected plane in a specimen by 
means ofthree basic steps (Figure 2.1). First，light is focused by an objective lens into an 
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hourglass-shaped beam so that the beam strikes one spot at some chosen depth in a 
specimen ^Figure 2.1). Next, light reflected from that spot is focused to a point and 
allowed to pass in its entirety through a pinhole aperture in a mask positioned in front of a 
detecting device such as photomultiplier tube ^*MT). Meanwhile the opaque regions 
around the pinhole block out most of the rays that would tend to obscure the resulting 
image, those reflected by illuminated parts of the specimen lying above and below the 
plane of interest. Finally, the light is moved rapidly from point to point in the specimen 
until the entire plane has been scanned. 
Procedure for detecting cell activity by CLSM 
About 2,000 L929 cells were seeded on a round cover glass with complete RPMI 
1640 medium and incubated at 37 °C, 5 % CO2 for 3 or 4 days. 
Detection of [Ca^^i by CLSM; During the experiment, cover glass was mounted 
on a home-made holder. Cells were then washed twice with Na+-HEPES buffer and 
loaded with fluo-3/AM (final concentration: 10 ^M) at room temperature for 1 hr. After 
loading of dye, cells were washed twice with Na+-HEPES buffer or Ca^^-free buffer. The 
final volume of buffer was 0.5 ml in aU experiments since change of volume of buffer 
during the experiment wil l affect the position of the confocal plane (Lui et al., 1997). Cells 
were then observed under CLSM at room temperature and TNP was added during 
scanning. At various time intervals, x-y images of cells were acquired on a system of 
CLSM (Multiprobe 2001, Molecular Dynamics (MD)), or biSight Plus, OVleridian, Miss.， 
USA) that fitted with an argon laser (6 mW at excitation for CLSM-MD, 5 mW at 
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Figure 2.1 
Principle o f C L S M . 
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excitation for Meridian) and Nikon diaphot inverted microscope. For fluorescence 
determination by CLSM-MD, an excitation filter with 488 nm wavelength and a long-pass 
emission filter of510 nm were used. For CLSM-Meridian, an excitation filter with 488 nm 
wavelength and a clear filter was used. L929 cells were scanned by using a 60X QSFikon 
PlanApo) or 100X (Nikon, Fluor) oil objectives with low-fluorescence immersion oil 
(T |#c= 1515，Stephens Scientifics, USA). The voltage of the PMT was set at optimum. 
Images and fluorescence intensities were processed and averaged by an image analysis 
software (Imagespace 3.1 for CLSM-MD, or Insight IQ Master Program ver. 1.12 for 
CLSM-Meridian). In the pseudo-color images, cool and warm colors indicate a lower and 
higher fluorescence intensity, respectively. 
Detection of intracellular ROS by CLSM: Cover glass with L929 ceUs was 
mounted on a home-made holder and washed twice with Na+-HEPES buffer. Cells were 
incubated with TNF or drugs for 15 min and then washed twice with Na^-HEPES buffer 
again. Cells were loaded with DCF or HE in Na+-HEPES buffer and measurement by 
CLSM was started simultaneously. The setting of detection was similar to that o f [Ca^^]i. 
Detection of intracellular pH by CLSM: Cover glass with L929 cells was 
mounted on a home-made holder and washed twice with Na+-HEPES buffer. CeUs were 
then loaded with SNARF- l /AM in Na^-HEPES buffer (final concentration: 10 \ M ) for 1 
hr at room temperature. After loading, ceUs were washed twice with Na+-HEPES buffer. 
Cells were then observed by CLSM and the setting of detection was similar to that of 
[Ca2+]i. 
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2.2.4 Flow Cytometry 
Introduction 
Flow cytometry (FCM) has been used extensively to analyze various biological 
properties of cells (Ormerod, 1994). FCM is the measurement of cells in a flow system 
that has been designed to deliver particles in single file past a point of measurement. A 
basic flow cytometer consists of a source of light such as laser beam, a flow cell, optical 
components to focus light of different colors on to the detectors, electronics to amplify 
and process the resulting signals and a computer (Figure 2.2). The flow cell is to deliver 
cells singly to a specific point by hydrodynamic focusing at which the source of light is 
focused. This is achieved by injection of the sample into the center of a stream of Uquid 
called the sheath fluid. Light source strikes on the ceUs and the emission of light is 
collected by detectors. Image analysis by computer was then made to study the 
distribution oflight signals emitting from a population of cells. 
Procedure for detecting cell activity by FCM 
One million ofL929 cells in complete RPMI 1640 medium were seeded in a 6-well 
plate and incubated at 37 °C, 5 % CO2 overnight until confluence. Cells were then treated 
with TNF and different drugs for various time intervals. The procedure for detecting Ca:+, 
ROS, mitochondrial membrane potential (vjv) and ceU cycle are different. 
Detection of [Ca^^i by FCM: After incubation with TNF or drugs, cells were 
washed twice with serum-free RPMI 1640 medium for removing non-adherent cells. The 
adherent cells were loaded with fluo-3/AM and fura-red/AM in serum-free R P M medium 
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Figure 2.2 
Principle o f F C M (Becton Dickinson, FacSort model). 
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for 1 hr. Only the adherent cells were loaded with fluorescence dyes. Cells were then 
trypsinized and washed twice with Na+-HEPES buffer. L929 cells were suspended in Na+-
HEPES buffer. Cells were acquired on a system of FACSort flow cytometer (Becton 
Dickinson). The acquisition of cells were analyzed by lysys I I program (Becton 
Dickinson). For fluorescence determination by FCM, an excitation filter with 488 nm 
wavelength (argon laser) was selected. The population of ceUs were determined by 
forward scatter (FSC) light and side scatter (SSC) Ught. FSC and SSC determine the size 
and the granularity of a cell, respectively. The signals of fluo-3/AM and fura-redy'AM 
were collected at channels of FL-1 (green fluorescence) and FL-3 (red 
fluorescence), respectively. FL-1 and FL-3 were set at linear scale. For one single analysis, 
the fluorescence properties of 10,000 cells were coUected. The sample flow rate was 
adjusted to about 1,000 cells/sec. 
Data analysis of[Cc^^]t 
The mean of fluorescence of fIuo-3 and fura-red were collected. The ratio of fluo-
3 to fura-red was calculated and used for comparing the extent of the release of Ca^ .^ The 
ratio of fluo-3 to fura-red in different treatments was compared with that of control group 
and presented in percentage of control. Furthermore, the dot plots of fluo-3 against fura-
red was analyzed. Each dot represented one ceU. The dot plot was divided by a diagonal 
line into two regions, R1 and R2 (Figure 2.3), Number of dots in both R1 and R2 were 
recorded. Addition of ionomycin (40 p,g/ml) for 10 min induced Ca^^ release and was used 
for positive control. When the [Ca^^]i level increased, fluorescence of fluo-3 increased 
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Figure 2.3 
Analysis of [Ca^^i changes by the use of fluo-3 and fura-red. L929 ceUs (10Vml) were 
seeded in a 6-weU plate and were incubated overnight at 37 °C, 5 % CO2. Cells were 
loaded with 10 p M fIuo-3/AM and 10 [ jM fura-redy'AM for another hr. Cells were then 
trypsinized. After washing, ceUs were re-suspended in the Na^-HEPES buffer and the 
fluorescence of fluo-3 and fura-red were determined by FCM with an argon laser. Y-axis 
represents the fluorescence intensity of fluo-3 whereas x-axis represents the fluorescence 
intensity of fura-red. Panels (a), (c) and (e) are control group from different experiments. 
Panels (b), (d) and (f) are three experiments in which L929 ceUs were treated with 40 
^ig/ml ionomycin 10 min before measurement. Note that a shift in the ceU population at the 
upper-left in panels (b), (d) and (f) indicates an increase in fluo-3 fluorescence with a 
decrease in fura-red. These imply an increase in [Ca^^]i. Dot plots were divided arbitrarily 
by a diagonal line into two regions, R1 and R2. And the % of cells in each region was 
calculated. 
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whereas fluorescence of fura-red decreased, the ceU population shifted to the upper-
left fFigure 2.3). H*the [Ca^^]i level was high in L929 cells, more dots should occur in R1 
and vice versa in R2. Table 2.2 summarizes the results from Figure 2.3. The summation of 
the number of dots in R1 and R2 was 10,000, that was the total number of cells in 
analysis. Addition ofionomycin induced a drastic shift of dots from R1 to R2 (Figure 2.3b, 
d and f). 
Detection of ROS and cell death by FCM: After incubation with TNF and 
drugs, cells were washed twice with serum-free RPMI 1640 medium and trypsinized. Cells 
were washed twice with serum-free medium and re-suspended. DCF, DCF with PI, or HE 
was added to the suspension and measurement was started simultaneously. The 
fluorescence signals of DCF and PVHE were collected at channels of FL-1 and FL-3, 
respectively. FL-1 and FL-3 were set at log scale. HE and PI cannot be applied 
simultaneously since they have the same emission wavelength (collected at FL-3). Other 
settings for detection of ROS was similar to that of [Ca^^]i. The mean of DCF was 
collected and used for determining the extent of ROS release in different treatments and 
compared to control group. 
Data analysis of cell death 
The proportion of dead cells could be analyzed by the dot plots of PI against DCF 
(Figure 2.4). Dot plot was divided into three regions, R1, R2 and R3. Population R1 with 
PI-negative fluorescence properties, indicating viable ceUs. Population R2 with PI-positive 
fluorescence properties, indicating dying cells population. Population R3 with PI-positive 
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Table 2.2 
Ionomycin induced Ca:+ release. 
Treatment control 1 + 40 ^ig/ml control 2 + 40 ng/ml control + 40 ^igAnl 
ionomycin ionomycin 3 ionomycin 
Fluo-3 intensity 74.68~~ 395.34 65.15 455.11 89.49 285.34 
(arbitrary unit) 
Fura-red 406.65 303.30 274.39 281.27 304.80 174.81~" 
intensity 
(arbitrary unit) 
Fluo-3 /Fura-red 0.18 1.30 — 0.24 1.62 ~ 2 9 1.63 
% ofcontrol * 722 675 562 
m 
Number ofceUs 9684 2285 9176 1286 9550 1883 
in R1 
Number ofcells 3i6 WTs ^ m 4 450 ^ ~ ~ 
inR2 
Results from Figure 2.3 were summarized and the peak fluorescences at the x- and y-axis 
were acquired. The ratio of fluo-3 to fiira-red was then calculated and the % of control 
was obtained according to the foUowing formula: 
• % ofcontrol (%) 
=[f luo-3 / fura-red (TNF treatment)] / [fluo-3 / fura-red (control)] x 100 % 
Moreover, the number of dots in R1 and R2 were determined. 
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Figure 2.4 
Dot plots of PI against DCF. L929 cells (10Vml) were seeded in a 6-well plate and were 
incubated ovemight at 37 °C, 5 % CO2. Cells were then trypsinized and were re-
suspended in the serum-free RPMI. Cells were then loaded with 10 j j M DCF and 8 pig/mi 
PI. Measurement was made by FCM. Y-axis represents the fluorescence intensity of PI 
whereas x-axis represents the fluorescence intensity of DCF. The dot plot was divided by 
two Une into three regions, R1, R2 and R3. The % of ceUs in each region was also 
calculated. 
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fluorescence properties, indicating dead cells. Number of dots in the three regions were 
recorded. 
Detection of Ay™ by FCM; After incubation with TNF and/or drugs, cells were 
washed twice with serum-free RPMI 1640 medium and trypsinized. Cells were washed 
twice with serum-free medium and re-suspended. Rhodamine 123 was added to the 
suspension and incubated at 37 °C for 15 min. The fluorescence was collected at channel 
o fFL-1 (linear scale). 
Detection of cell cycle by FCM: After incubation with TNF and drugs, cells were 
washed twice with serum-free RPMI 1640 medium and trypsinized. Cells were washed 
twice with serum-free medium and re-suspended in ice-cold 70 % EtOH. CeU suspension 
was stored at 4 °C overnight. Cells were then re-suspended in 800 ^il PBS, 100 ^il RNase 
A (1 mg/ml) and 20 U^ PI (2 mg/ml). The mixture was incubated at 37 °C for 30 min. Cells 
were analyzed by selecting the coUection of fluorescence o fP I at channel o fFL-2A (linear 
scale) andA)r FL-2H (log scale). 
Al l data from FCM were analyzed by WinMDI version 2.6 that was downloaded 
from intemet (www site: 'http://facs.scripps.eduy'software.html'). 
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Chapter 3. Results 
3.1 Tumor Necrosis Factor-Alpha Induced Apoptosis in L929 Cells 
3.1.1 Introduction 
Carswell et al. firstly described that L929 cells are sensitive to TNF action 
(Carswell et al., 1975). Since then, L929 cells are widely used as a model to study the 
mechanisms of cytotoxicity mediated by TNP. 
For determining cell viability, two assays were used in this project, the MTT and 
the neutral red assay. MTT is a pale yellow substrate that produces a dark blue formazan 
product. MTT is cleaved to form formazan by active mitochondria in aU living, 
metabolically active cells but not dead cells. MTT is converted into formazan derivative 
via mitochondrial dehydrogenase activity by viable cells OPagUacci et al., 1993). The MTT 
formazan reaction product is partially soluble in medium, and so an alcohol such as 
acidified isopropanol is used to dissolve the formazan and produce a homogeneous 
solution suitable for measurement of optical density. The amount of formazan generated is 
therefore directly proportional to the number of viable cells (Mosmann, 1983). On the 
other hand, neutral red is a dye that is commonly used for staining viable ceUs. Neutral red 
is taken up by viable cells but not by dead cells. The uptake is an energy-dependent 
process. The stained cells are solublized by SDS and a homogeneous colored solution is 
produced for the measurement of color intensity. 
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L929 cells were seeded in a 96-well plate and the optimal cell density ofL929 cells 
was determined. Figure 3.1 and Figure 3.2 show the relationship between the optical 
density (O.D.) at 540 nm and the cell density of L929 ceUs by the M T T and neutral red 
assays，respectively. It was found that the density of cell at or below 3 x 10Vwell was an 
optimum for MTT assay since the slope of the curve is ahnost Unear in this region. As the 
density of cell increased, the O.D. 540 nm for neutral red assay increased also. Similar 
result was obtained by neutral red assay. Moreover, L929 cells reached confluence in a 
96-well plate 20 hr after seeding with a cell density of 3 x 10Vwell. Therefore, the density 
ofL929 cells was set at 3 x 10Vwell in cytotoxicity assays. 
Figure 3.3a shows that TNF induced cell death by using neutral red assay. Similar 
results were obtained by using M T T assay (Figure 3.3b). It was found that the cytotoxicity 
of TNF-treated L929 cells is concentration dependent. As TNP concentration increased, 
cytotoxicity increased also. In a 20-hr treatment, the LCso o f T N F on L929 cells was less 
than 5 ng/ml (with cell density: 3 x 10Vml) (Figure 3.3a and 3.3b). As the ceU density of 
experiments of FCM was 1 millionAnl，higher concentration of TNF should be used and 
the concentration o fTNF was arbitrarily set as 50 ng/ml. 
3.1.2 TNF Induced DNA Fragmentation in L929 ceUs 
To determine whether TNF induces apoptosis or necrosis in L929 cells, gel 
electrophoretic analysis o f D N A fragmentation was applied. 
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Figure 3.1 
Optical density (O.D.) 540 nm was proportional to the cell density of L929 ceUs in 
M T T assay. As described in materials and methods, L929 ceUs were seeded at different 
density (10^ - 10Vwell) in complete RPMI 1640 medium and incubated for 20 hr at 37 X , 
5 % CO2. After incubation, spent medium was discarded and washed twice by serum-free 
medium. 100 ^il of serum-free medium was added to each weU and incubated for 20 hr at 
37�C，5 % CO2. MTT assay was then applied and O.D. 540 nm was read by a microplate 
reader (n = 5，expt = 2). 
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Figure 3.2 
Optical density (O.D.) 540 was proportional to the cell density of L929 cells in 
neutral red assay. L929 cells were seeded at different density (10^ - 10Vwell) in complete 
RPMI 1640 medium and incubated for 20 hr at 37 °C, 5 % CO2. After incubation, spent 
medium was discarded and washed twice by serum-free medium. 100 [il of serum-free 
medium was added to each weU and incubated for 20 hr at 37。C, 5 % CO2. Neutral red 
assay was then applied and O.D. 540 nm was read by a microplate reader (n = 5, expt = 
2). 
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Figure 3.3 
TNF induced cytotoxicity in L929 cells in a concentration dependent manner L929 
cells were seeded at 3 x 10Vwell in complete RPMI 1640 medium and incubated for 20 hr 
at 37 °C, 5 % CO2 After incubation, spent medium was discarded and washed twice by 
serum-free medium. 100 ^il of serum-free medium with various concentrations o f T N F as 
indicated was added to each well and incubated for 20 hr at 37 °C, 5 % CO2. (a) Neutral 
red assay (n = 7，expt = 4)，and (b) MTT assay (n = 7，expt = 2) were then applied and the 
% of cytotoxicity was then calculated. 
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Figure 3 .4 shows the result o f D N A fragmentation by agarose gel electrophoresis. 
It was found that in the absence of serum, L929 cells treated with 50 ng/ml TNF for 3 hr 
did not induce cell death since no dead cell detached from the bottom of plate and no 
DNA fragmentation was detectable. However, for the 6 and 10 hr treatment o fTNF, some 
L929 cells were detached from the bottom. The adherent and non-adherent cells were 
collected separately and DNA were extracted for electrophoretic analysis in order to 
determine the source of DNA fragmentation. It can be seen that no detectable DNA 
fragmentation occurred in adherent cells with 3 hr TNF (50 ngAnl) treatment (Figure 3.4). 
In contrast, the non-adherent cells from 6 or 10 hr treatment showed a faint, but clearly 
visible DNA ladders. These indicate that incubation ofL929 ceUs with TNF for 6 or 10 hr 
induced DNA fragmentation. Moreover, DNA fragmentation progressively increased as 
the incubation time o fTNF with L929 cells was increased. 
These results are consistent with the previous report that TNF induced DNA 
fragmentation in L929 ceUs (review: Kerr et al., 1995). It seems very Ukely that after TNF 
treatment, the apoptotic cells detached from the bottom of plate. Moreover, our results 
indicate that DNA fragmentation was more significant in the non-adherent cells after TNF 
treatment. At present, we do not know the relationship between the DNA fragmentation 
and matrix adherence. However, recent reports have shown that surface adherence is an 
important factor to keep cell survival (Chen et al., 1998). 
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Figure 3.4 
Agarose gel electrophoresis of DNA extracted from TNF-treated L929 cells, bi the 
serum-free condition, there was no DNA fragmentation for 3 hour-treatment with 50 
ng/ml TNF. Moreover, for 6 and 10 hr incubation, the adherent cells did not show DNA 
fragmentation. In contrast, DNA fragmentation occurred only in non-adherent cells after 
TNF treatment for 6 or 10 hr. 
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3.2 Effect of Tumor Necrosis Factor-Alpha on Cell Cycle 
3.2.1 Introduction 
The cell cycle can be divided into several phases ^^igure 3.5). A non-cycUng ceU is 
said to be in GO phase. Cells in G1 phase are sitting around either just recovering from 
division or preparing for the initiation of another cycle. CeUs are said to be in S phase 
when they are in the process of making new DNA. Cells in the G2 phase are those that 
have finished DNA synthesis and therefore possess double the normal amount of DNA. 
Cells in M phase are undergoing the chromosome condensation and organization of 
mitosis that occur immediately prior to cytokinesis with the production of two daughter 
cells. 
One of the most common application of FCM is the measurement of DNA to give 
a picture of the cell cycle by showing the DNA histogram O^igure 3.5). By measuring the 
DNA content, it can be determined whether a ceU is in G0/G1, S or G2/M phases of the 
cycle. Any change in cell cycle parameters wiU be reflected in the appearance of the DNA 
histogram. Changes in the DNA histogram are used to study the mechanism of action of 
cytotoxic drugs since such compounds generally disrupt the cell cycle. The most widely 
used dye to determine the DNA content is propridium iodide ^PI) (Sherwood and 
Schimke, 1995). It intercalates into double-stfanded nucleic acids, is excited by the 488 
nm line of an argon-ion laser and fluoresces red. Since it is excluded by viable cells, ceUs 
must be fixed or permeabilized before adding the dye. 
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Figure 3.5 
The cell cycle and DNA content of the cell. 
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3.2.2 Effect ofTNF on Cell Cycle 
Figure 3.6 shows the DNA histogram ofTNF-treated L929 cells. It was found that 
addition of 50 ngAnl TNF for 15 min, 3 or 6 hr did not cause any significant change in the 
G0/G1, S or G2M phases as compared to control. However, addition o fTNP for 10 hr 
produced a peak before the G0/G1 phase (Figure 3.6e). Since the x-axis represents the 
DNA content, the peak before the G0/G1 phase implied that there were some fragmented 
DNA in the TNF-treated L929 cell population. The fragmented DNA may come from the 
apoptotic cells. The data from the cell cycle are consistent with the results from our 
previous agarose gel electrophoresis study (Figure 3.4) that DNA was fragmented in the 
10-hour-TNF treatment. In addition, the number of cells in the G0/G1 and S phase in 10-
hour-TNF treatment decreased. Therefore, cells in S phase were more susceptible to TNP 
since the % of cells in S phase dropped significantly with the 10-hour-TNF treatment. 
In another experiment, the presence of serum affected the TNF effect on the ceU 
cycle. It was found that in the control group, addition of serum caused more cells in the S 
phase (Figure 3.7a)，as compared with the control group in the serum-free condition 
(Figure 3.7e), possibly by shifting cells from the G0/G1 phase to the S phase. This implies 
that more cells were making DNA in the presence of serum whereas the rate of DNA 
duplication was decreased in the absence of serum. Furthermore, serum might afFect the S 
phase in TNF-treated cells. In the presence of serum, the adherent cells show DNA 
fragmentation as indicated in Figure 3.7b. The combination of adherent and non-adherent 
cells produced a higher proportion in the DNA fragmentation (Figure 3.7c). 
Chapter 3. Resutis Page 76 
(a) control (d) + TNF for 6 hr 
o o 
^2 G0/G1 = 38.8 ! 2 G0/Gl = 38.0 
S = 42.6 S = 38.4 
G2/M = 8.4 G2M = 16.2 
other=10.2 other = 7.1 
WA wu^\ 
0 !• - J *"^ >^ ^^ -^  0 ^ '« I *^ ^^vs».# 
0 1023 0 1023 
(b) + TNF for 15 min (e) + TNF for 10 hr 
o o 
^ G0/Gl = 42.8 1^ GO/Gl = 31.3 
r S = 39.4 r S = 21.4 
G2/M=10.0 G2/M=11.1 
^ other = 7.8 other = 36.2 
M J L .LL^ 
0 1023 0 1023 
(c) + TNF for 3 hr 
o 
^ G0/Gl = 40.0 
I S = 44.2 
G2M = 8.5 
other = 7.1 
UuA 




DNA histograms ofTNF-treated L929 ceUs. L929 cells (1 x 10Vml) were seeded in a 6-
well plate and incubated at 37 °C and 5 % CO2 ovemight. Cells were then treated with (a) 
complete RPMI medium alone; 50 ng/ml TNF for (b) 15 min, (c) 3 hr, (d) 6 hr and (e) 10 
hr. Cells were then trypsinized and fixed with 70 % ethanol overnight. Cells were then 
stained with 43 ^igAnl PI for 30 min and the cell cycle was determined by FCM. 
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Figure 3.7 
DNA histograms of TNF-treated L929 cells in the presence and absence of serum for 
10 hours. L929 cells (1 x 10Vml) were seeded in a 6-well plate and incubated at 37 °C and 
5 % CO2 overnight. Cells were then treated with (a) complete RPMI. L929 cells were 
treated with complete RPMI plus 50 ng/ml TNF for 10 hr and (b) adherent cells (c) 
adherent and non-adherent cells and (d) non-adherent cells were coUected. In addition, 
ceils treated with (e) serum-free RPMI, adherent cells after incubaiton with serum-free 
RPMI plus 50 ng/ml TNF for 10 hr (f) adherent and non-adherent cells (g) and non-
adherent cells (h) with TNF treatment were also collected. 
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Figure 3.7d shows that almost all non-adherent cells were mainly in the D N A fragmented 
state. In contrast, in the absence of serum, the adherent cells did not produce a large 
amount of D N A fragmentation. Serum is a good source of growth factors that provides 
enough energy for cells and therefore，apoptosis (an ATP-dependent process) might occur 
in the presence of serum even in the adherent cells (Figure 3 .7b). As shown in Figure 3.71f 
-3 .71h, the D N A fragmented cells were all from the non-adherent cells which is in 
agreement with the results from D N A gel electrophoresis (Figure 3.4). Furthermore, in the 
TNF-treated cells, the number o f cells in G0/G1, S and G 2 M phase decreased as 
compared with the control group. 
In conclusion, TNF induced apoptosis by examining the pattem of cell cycle after 
TNF treatment. In the presence of serum, the number of cells in S phase was higher than 
that in the serum-free condition and the cells might shift from G0/G1 phase to the S phase. 
Moreover, in the presence of serum, addition o f T N F for 10 hr induced apoptosis whereas 
a shorter incubation period did not induce apoptosis. Most of the non-adherent cells were 
the apoptotic cells. 
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3.3 Release of Reactive Oxygen Species in Tumor Necrosis Factor-Alpha 
Treated Cells 
3.3.1 Introduction 
It was found that one of the mechanisms of cytotoxicity after TNF treatment on 
murine cells involved the release ofROS such as H2O2 or 02®~ (Zimmerman et al‘, 1989). 
However, the mechanism and the triggering messengers in this regard are not clear. Jn this 
project, the release o fROS from L929 cells after treatment with rMuTNF was examined. 
For investigating ROS inside the ceUs, two fluorescent dyes，the diacetate form of 
dichlorofluorescin and hydroethidine, were applied. 
The diacetate form of dichiiorofluorescin (DCF-DA) was employed for detecting 
the formation ofH2O2 ^"igure 3.8a). The DCF assay for the quantification of intracellular 
H2O2 was described previously (Cathcart et al, 1983). The principle is that DCF-DA 
diffuses into the cell and is converted into the non-fluorescent intermediate 
dichlorofluorescin (DCFH) by hydrolysis. The non-fluorescent form of DCFH is then 
converted into fluorescent form of dichlorofluorescein ^ )CF) by cellular H2O2. It was 
found that 1:1 stoichiometry is observed between H2O2 and dichlorofluoroscein (Cathcart 
etal, 1983). 
On the other hand, 62*" can be detected by hydroethidine (HE). The HE assay for 
the quantification o f intracellular 02*" has been described (Gorman et al., 1997). HE is 
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Figure 3.8 
Detection of intraceUular H2O2 and 02*" by fluorescence dyes dichlorofluorescin 
diacetate and hydroethidine. (a) Detection ofH2O2: non-fluorescent form ofDCFH can 
be oxidized to fluorescent form of DCF by H2O2. (b) Detection of 62*": non-fluorescent 
form ofHE can be oxidized to fluorescent form ofEtBr by 62*". 
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oxidized by 62*" within the cell to produce ethidium bromide, which emits fluorescence 
when it intercalates into D N A (Figure 3.8b). 
In this section, several techniques such as CLSM, FCM were applied to monitor 
the release ofROS inside L929 cells in the presence or absence o fTNF. 
3.3.2 Release ofROS in TNF-Treated L929 Celis is Time Dependent 
The release o fROS can be monitored by CLSM and the DCF assay. Figure 3.9 
shows the confocal images of L929 ceUs treated with TNF or medium alone. Jn these 
pseudocolor images, the upper panel shows the control cells while the lower one shows 
the TNF-treated ceUs. Confocal scannings were made at the time indicated (15, 30 and 45 
min). As shown in Figure 3.9，TNF caused an increase in the rate ofH2O2 production in 
L929 cells as compared to the control group. The fluorescence intensity was 
heterogeneously distributed inside the cells. Moreover, it was also found that either in 
control or TNF-treated group, the rate of release of H2O2 was heterogeneous in different 
cells. It was noted that in the 30 min of the control group, some hot spots occurred inside 
the cells. These spots may be the sites of mitochondria since redox rate is high in that site. 
Figure 3.10 illustrates the effect o f T N F on the 02*~ production in L929 cells by 
using the HE assay. Similar to the results from DCF assay, TNF caused an increase in the 
rate of02*"product ion in L929 cells as compared to the control group. Since HE can be 
converted into EtBr by 02*", the emission of fluorescence of EtBr-chelated D N A clearly 
shows the location o f nucleus. 
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Figure 3.9 
TNF caused an increase in the rate of H j O j production in L929 ceUs. The upper panel 
shows the control cells and the lower panel shows the TNF-treated cells at the time 
indicated. L929 cells (2 x lOVml) were seeded on a cover glass and incubated at 37。C，5 % 
CO2for 3 days. TNF (50 ng/ml) was then appUed to L929 cells. 15 min after the addition 
of TNF, DCF (final concentration 10 p,M) was added at time zero and measurement 
(CLSM-MD) was made at room temperature. Cells were scanned at a 5-minute-interval. 
The cool and the warm color indicate the lower and the higher fluorescence intensity, 
respectively. Note that TNF caused an increase in the rate of H p : production in L929 cells 
when compared to the control group (expt = 9). 
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Figure 3.10 
TNF caused an increase in the rate of O!.— production in L929 ceUs. The upper panel 
shows the control cells and the lower panel shows the TNF-treated cells at the time 
indicated. L929 ceUs (2 x lOVml) were seeded on a cover glass and incubated at 37 °C, 5 % 
CO2 for 3 days. TNF (50 ng/ml) was then applied to L929 cells. 15 min after the addition 
of TNF, HE (final concentration 10 ^iM) was added at time zero and measurement 
(CLSM-MD) was made at room temperature. Cells were scanned at a 5-minute-interval. 
The cool and the warm color indicate the lower and the higher fluorescence intensity, 
respectively. Note that TNF caused an increase in the rate of 62*" production in L929 cells 
when compared to the control group (expt = 6). EtBr-chelated DNA presented in the cells. 
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For a longer time measurement, the release of ROS can be monitored by FCM. 
Figure 3.11 shows the results from FCM. bi general, as time increases，DCF (Figure 
3.11a) and HE (Figure 3.11b) fluorescence intensities increase. These results indicate that 
H2O2 and 02*~ are produced in cells continuously even in the absence o f T N F stimulation. 
Next，the effect of TNF on the release of ROS was investigated. Incubation of 
L929 cells with 50 ng/ml TNF for 15 min (Figure 3.12a) or 3 hr (Figure 3.12b) did not 
cause more H2O2 production. Interestingly, when ceUs were treated with TNF (50 ng/ml) 
for 6 or 10 hr, a significant increase in H2O2 production was observed ^Figure 3.13). It is 
clear in Figure 3.13 that two peaks (two populations of cells) were seen in terms of DCF 
fluorescence. These results again suggest that the response of cells was heterogeneous. 
Moreover，in the control and TNF-treated group, the large population shifted to the right 
and then to the left, that is，the fluorescence intensity of DCF increased and then 
decreased. It might be due to the efflux of fluorescence product, DCF, from the cytosol to 
the extracellular medium as indicated by other groups (Gorman et al., 1997). Figure 3.14 
summaries the above results. It can be seen that the amount of H2O2 produced in L929 
cells upon TNF treatment was dependent on the incubation time. 
After monitoring the production o f H2O2 by TNF, the release of 62*" was also 
examined by applying fluorescence dye, HE. It was found that incubation of ceUs with 50 
ng/ml TNF for 15 min, 3 or 6 hr, did not cause more production of 02*~ (Figure 3.15). 
However, there was no significant changes as compared to the control group even L929 
cells were incubated with 50 ng/ml TNF for 6 hr (Figure 3.15c). Only a small 
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Figure 3.11 
Time-dependent conversion of non-fluorescent indicators into fluorescent ones. 
L929 cells (1 x 10Vml) were seeded in a 6-well plate and were incubated overnight at 37 
。C：，5 % CO2. Cells were then trypsinized. After washing, DCF (10 ^M) (a) or HE (10 
pM) (b) was added and measurement was made at the time indicated. Y-axis represents 
the number of events (total = 10,000) whereas x-axis represents the fluorescence intensity. 
Note the shifting of the population from left to right indicating the time-dependent 
conversion of non-fluorescent indicators to the fluorescent one (expt > 10). 
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Figure 3.12 
Incubation of L929 ceUs with TNF for 15 min or 3 hr did not produce more H2O2 
production. Incubation of L929 cells with 50 ng/ml TNF (purple line) for (a) 15 min 
(expt = 9) or (b) 3 hr (expt = 8) did not cause more H2O2 production as compared to 
control group (black line). The time on the left indicates the incubation period of cells with 
DCF. 
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Figure 3.13 
Incubation of L929 cells with TNF for 6 or 10 hr produced more H2O2 production. 
Incubation ofL929 cells with 50 ng/ml TNF (purple line) for (a) 6 hr (expt > 10) or (b) 10 
hr (expt = 3) caused more H2O2 production as compared to control group (black line). 
The time on the left indicates the incubation period of cells with DCF. 
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Figure 3.14 
The release of H2O2 in TNF-treated L929 cells is time dependent The H2O2 
production in cells treated with or without TNF (50 ng/ml) for various time intervals as 
shown in Figure 3.12 and 3.13 were normalized by dividing the peak fluorescence of the 
TNF-treated group with the one of control group. The x-axis represents the incubation 
time of ceUs with DCF. Results are mean 土 SD from 3 experiments. Note the increase in 
the amount ofH2O2 produced in ceUs with longer TNF treatment time intervals. 
Chapter 3. Resutis Page 89 
(a) (b) (c) (d) 
0 min 0 min 0 min 0 min 
0 o o o 
U*) • U^  I u^  u^  
1 1 1 1 
0 J\ >,, .m^ . , o J .L*>_,I '^~~~, 0�_L^ ._,»«?<V^…丨 o j/^^!^::^^tWt^,, 
10M0M0210M0^ 10010M02103104 IOOlOMO^IOMO^ IQOlOMO^IOMO^ 
i. � ^ ^ 
15 mm 15 min 15 min 15 min 
o o o g lO V) ^ ^ 
I ^ ] I ，^| L t 
« 。10° fO H 0 2 i ^ ' 104。10。10 1102103 104 °10°10M0 2 103 104°0°10'10^10^10^ 
名 、 ‘ V > 
M 
30 min 30 min 30 min 30 min 
S S § s 
, 儿 � . 1 � . • • Ai^  0, A^  • 
100'10M0 2 1'0 3 104 10°10il0 2l0M'04 lOOfOMOMOMO^ IOOlOMOMOMO^ 
45 min 45 min 45 min 45 min 
0 0 0 ° m in if) ^ 
A ^ L L j 1 
°10。To i'l02l03104°10。101102103104 ^10010M0210M0^ IQOlOMO^loMO^ 
^ 
HE • EtBr 
Figure 3.15 
Incubation of L929 cells with TNF for 15 min, 3 or 6 hr did not cause more Oz*" 
production but produced a small increase in a 10 hr assay. Incubation of L929 cells 
with 50 ng/ml TNF (purple line) for (a) 15 min (expt = 3)，(b) 3 hr (expt = 4) or (c) 6 hr 
(expt = 3) did not cause more 02*" production as compared to control group (black line). 
In another experiment，Incubation of L929 cells with 50 ng/ml TNF (purple line) for (d) 
10 hr caused a small increase in 02*~ production as compared to control group (black 
line). The time on the left indicates the incubation period of cells with HE. 
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increase in 02®" production was seen in the group for 10 hr TNF (50 ng/ml) incubation 
(Figure3.15d). 
L929 cells with TNF for 6- or 10-hour incubation produced more release of H2O2 
than that of O j * ' This discrepancy might be due to the protective mechanism inside the 
cells. As mentioned in section 1.5.1，TNF induced MnSOD mRNA in aU cell lines and 
normal cells (Wong and Goeddel, 1988). As indicated in Figure 1.5, 02*" is converted into 
H2O2 by MnSOD inside mitochondria. Therefore, addition of metabolic inhibitor such as 
actinomycin D (AMD), a transcriptase blocker that blocks transcription (Ostrove and 
GifFord, 1979)，should reduce the expression of MnSOD mRNA (Wong and Goeddel, 
1988). This explains why the sensitivity o f T N P cytotoxicity assay is markedly increased 
when cells were incubated with TNF in the presence of AMD 
In light of this, cells were treated with TNP in the presence of A M D (2n,g/ml). It 
can be seen that there was no response in the 15-minute-incubation of cells with TNP and 
A M D (Figure 3.16). However, Figure 3.17 shows that addition of TNF plus A M D did 
increase the rate of 02*" production after incubation for 3 or 6 hr. Moreover, It was found 
that the response of cells was heterogeneous in TNF plus A M D treatment. There were 
two populations of ceUs, the fast and the slow responding cells. Since ceUs incubated with 
TNF plus A M D for 10 hr induced cell death (most of the cells were detached from the 
bottom of the plate) and 02*~ level was not measured (data not shown). 
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Figure 3.16 
Incubation of TNF with or without AMD for 15 min did not cause more Oz*" 
production in L929 cells. L929 cells (1 x 10Vml) were seeded in a 6-well plate and were 
incubated ovemight at 37 °C, 5 % CO2. Cells were pre-treated with 50 ng/ml TNF (purple 
line) with or without 2 ^ig/ml AMD for 15 min. Cells were then trypsinized. 10 ^iM HE 
was added and measurement was made at the time indicated. It was found that cells 
incubated with TNF (a) in the absence of AMD (expt = 3) or (b) presence of AMD (expt 
二 2) for 15 min did not cause 02*" release as compared to control (black line). 
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Figure 3.17 
Incubation of TNF with AMD for 3 or 6 hr produced more Oz*" release in L929 
ceUs. It was found that cells incubated with 50 ng/ml TNF in the absence of AMD (a) did 
not increase Oi*" production (expt = 4)，(b) in the presence of AMD (2 ng/ml), L929 cells 
incubated with 50 ng/ml TNF for 3 hr produced more Oz*" release (expt = 3). Incubation 
of TNF in the absence of AMD (c) did not increase 02*" production (expt = 3) whereas 
(d) TNF plus AMD produced more 02*" release in 6-hour treatment (expt = 3). 
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3.3.3 Effect ofAntioxidants on TNF-Mediated Cytotoxicity 
As described earlier, our data indicate that treatment of L929 with TNF produces 
oxidative damage. In this section, the effect of antioxidants such as catalase, MnSOD, 
NAc and 4-OH-TEMPO on the rMuTNF induced cytotoxicity of L929 cells was 
examined. 
It is well known that catalase removes H2O2 by the formation of water and 
molecular oxygen whereas SOD removes 62*" to form H2O2 (Briehl and Baker, 1996). 
Therefore, catalase and MnSOD are considered to be an antioxidant. Other antioxidants 
such as NAc and 4-OH-TEMPO were applied in this project as well. The actions o f N A c 
involve: (1) replenishment of GSH stores; (2) scavenging ofROS，and (3) prevention of 
mitochondrial membrane depolarization (Cossarizza et al., 1995). 4-OH-TEMPO is a low 
molecular weight SOD analogue that removes excess O i * ' inside the cells. Moreover, it 
prevents lipid hydroperoxide formation (Reddan et al., 1993). 
The data from FCM indicated that addition of catalase, NAc and 4-OH-TEMPO 
did reduce the rate of TNF-mediated H2O2 release in an assay with 6-hour-incubation 
(Figure3.18). 
From the cytotoxicity assay, it was found that addition of antioxidants partiaUy 
reduced TNF-mediated cytotoxicity. Addition of 1000 U/ml catalase with 50 ng/ml TNF 
reduced about 10 % in cytotoxicity (Figure 3.19). The hydrogen peroxide-scavenging 
enzyme, catalase converts two molecules of H2O2 into two molecules of water and one of 
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Figure 3.18 
Addition of antioxidants reduced the amount of TNF-mediated H2O2 release in L929 
cells. L929 cells (1 x 10Vml) were seeded in a 6-well plate and were incubated overnight 
at 37 °C, 5 % CO2. CeUs were then treated with medium only (black line), 50 ng/ml TNF 
(purple line)，antioxidants only (green line), and TNF (50 ng/ml) plus antioxidants (orange 
line) for 6 hr. The dose of the antioxidants are: (a) 2000 U/ml catalase，(b) 10 m M NAc 
and (c) 20 m M TEMPO. Subsequently, cells were assayed with DCF by FCM. Note the 
antioxidants reduced the amount ofH2O2 production. 
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Figure 3.19 
Addition of catalase reduced TNF-mediated cytotoxicity in L929 ceUs. L929 ceUs 
were seeded at 3 x 10Vwell in complete RPMI 1640 medium in a 96-weU plate and 
incubated for 20 hr at 37 °C, 5 % CO2. After incubation, spent medium was discarded and 
washed twice by serum-free medium. 100 ^il o f TNF of various concentrations in the 
presence ( • ) or absence ( • ) of catalase (1000 U/ml) in serum-free medium was added 
and incubated for 20 hr at 37 X , 5 % CO2. M T T assay was then applied and O.D at 540 
nm was read by a microplate reader (n = 7). * * p < 0.005 indicates that there was a 
significant difference between control group and the treatment group. 
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oxygen. Catalase is not cell-permeable whereas H2O2 is freely permeable to the ceU 
(Gorman et al., 1997), The antioxidant effect of catalase that acts on L929 cells might 
probably due to the removal of H2O2 from the culture medium that would promote the 
exit of H2O2 from the cellular cytoplasm to the extracellular environment, and therefore, 
reduced TNF-mediated cytotoxicity. Application of MnSOD (25 ^ig/mO also reduced 
TNP-mediated cytotoxicity by about 5 - 10 % (Figure 3 .20). MnSOD is a relatively large 
molecule that is membrane-impermeable (Mitchell et al., 1990). The mechanism of the 
antioxidant effect of MnSOD was similar to that of catalase. The effect of MnSOD on 
L929 cells might probably due to the removal of Oi*" from the culture medium that 
promoted the efflux of 02*~ from the cytoplasm. Addition of 20 mM NAc suppressed the 
TNF-mediated cytotoxicity (about 5 - 10 %) (Figure 3.21). Furthermore, addition of 5 
mM 4-OH-TEMPO produced a lower TNF-mediated cytotoxicity (reduced about 20 - 40 
%) (Figure 3.22). These results implied that addition of antioxidants was capable of 
reducing the production ofROS thereby suppressing the ceU death. 
3.3.4 Effect ofMitochondrial Inhibitors on TNF-Mediated Cytotoxicity 
As mentioned before, mitochondria are considered to be the major site of ROS 
production. The primary source of ROS may come from the electron transport chain. 
Therefore, the application of mitochondrial inhibitors on electron transport chain may 
affect the release of ROS and the cytotoxicity of TNF. In this connection, several 
mitochondrial inhibitors such as rotenone (mitochondrial complex I inhibitor), TTFA 
(mitochondrial complex I I inhibitor), antimycin A (mitochondrial complex I I I inhibitor) 
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Figure 3.20 
Addition of MnSOD reduced TNF-mediated cytotoxicity in L929 ceUs. L929 cells 
were seeded at 3 x 10Vwell in complete RPMI 1640 medium in a 96-well plate and 
incubated for 20 hr at 37 °C，5 % CO2 100 ^il TNF of various concentrations in the 
presence ( • ) or absence ( • ) of MnSOD (25 p,g/ml) in serum-free medium was added and 
incubated for 20 hr at 37 °C，5 % CO2. Neutral red assay was then applied and O.D. at 
540 nm was read by a microplate reader (n = 7). ** p < 0.005 indicates that there was a 
significant difference between control and treatment group. 
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Figure 3.21 
Addition of NAc reduced TNF-mediated cytotoxicity in L929 cells. L929 cells were 
seeded at 3 x loVwell in complete RPMI 1640 medium in a 96-well plate and incubated 
for 20 hr at 37 °C，5 % CO2. 100 ^il TNF of various concentrations in the presence ( • ) or 
absence ( • ) of NAc (20 mM) in serum-free medium was added and incubated for 20 hr at 
37 °C, 5 % CO2. Neutral red assay was then applied and O.D. at 540 nm was read by a 
microplate reader (n = 3). * p < 0.05 and ** < p < 0.005 indicate that there was a 
significant difference between control and treatment group. 
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Figure 3.22 
Addition of 4 - O H - T E M P O reduced TNF-mediated cytotoxicity in L929 ceUs. L929 
cells were seeded at 3 x 10Vwell in complete medium in a 96-well plate and incubated for 
20 hr at 37 °C，5 % CO2. 100 M-1 TNP" of various concentrations in the presence ( • ) or 
absence ( • ) of 4-OH-TEMPO (5 mM) in serum-free medium was added and incubated 
for 20 hr at 37 °C，5 % CO2. Neutral red assay was then applied and O.D. at 540 nm was 
read by a microplate reader (n = 3). 
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and DNP (mitochondrial protonophorous uncoupler of electron flow) were used. Figure 
3.23 shows the site of the actions of these mitochondrial inhibitors. 
From the cytotoxicity assay, addition of 50 p M rotenone produced a lower TNF-
mediated cytotoxicity (reduced 20 - 40 %) (Figure 3.24). Rotenone is one of the 
mitochondrial complex I inhibitors that blocks the flow of electron from N A D H 
dehydrogenase to ubiquinone (UQ), it reduces 02*" production that mainly comes from 
the UQ site and therefore, it is protective against TNF. Figure 3.25 shows similar results 
with 250 [ M TTFA. TTFA is the mitochondrial complex I I inhibitor that prevents the 
flow of electron from succinate dehydrogenase to UQ and reduces O i * ' production also. 
In contrast, application of mitochondrial complex I I I inhibitor such as antimycin A (25 
^dVl) enhanced the TNF-mediated cytotoxicity (increased about 5 %) (Figure 3.26). 
Antimycin A blocks the electron flow from UQ to cytochrome Ci (cyt Ci), that strongly 
potentiated the production o f 02*" from the UQ site. This explains why TNF-mediated 
cell death was enhanced. In summary, TNF increases the release of ROS from 
mitochondria and the action o f T N F may be on mitochondrial complex HI. 
The data from CLSM further confirmed that rotenone reduced the amount of 
TNF-mediated 02*" production in L929 cells OFigure 3.27 and Figure 3.28). As shown in 
Figure 3.27, the total fluorescence intensities in TNF-treated group and control group 
were higher than that of TNF-plus-rotenone group and rotenone-treated group at 45 min. 
These results indicated that rotenone blocked the electron flow from complex I to UQ, 
therefore，reduced 02*" production. The release of 02*" converted HE into EtBr and 
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Figure 3.23 
T h e site of t he act ions of mi tochondr ia l inhib i tors . 
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Figure 3.24 
Addition of rotenone produced a lower TNF-mediated cytotoxicity in L929 cells. 
L929 cells were seeded at 3 x loVwell in complete medium in a 96-well plate and 
incubated for 20 hr at 37 °C，5 % CO2. 100 ^il TNF of various concentrations in the 
presence {M) or absence ( • ) of rotenone (50 \ iM) in serum-free medium was added and 
incubated for 20 hr at 37。C，5 % CO2. MTT assay was then applied (n = 7, expt = 2). 
Similar results were obtained in neutral red assay (data not shown). 
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Figure 3.25 
Addition of TTFA produced a lower TNF-mediated cytotoxicity in L929 ceUs. L929 
cells were seeded at 3 x 10Vwell in complete medium in a 96-well plate and incubated for 
20 hr at 37 °C, 5 % CO2. 100 \x\ TNF of various concentrations in the presence ( _ or 
absence ( • ) of TTFA (250 ^iM) in serum-free medium was added and incubated for 20 hr 
at 37 °C, 5 % CO2 Neutral red assay was then applied (n = 7, expt = 2). 
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Figure 3.26 
Addit ion of antimycin A enhanced TNF-mediated cytotoxicity in L929 cells. L929 
cells were seeded at 3 x 10VweU in complete medium in a 96-well plate and incubated for 
20 hr at 37 °C, 5 % CO2. 100 ^il TNF of various concentrations in the presence (Wi) or 
absence ( • ) of antimycin A (25 ^dVf) in serum-free medium was added and incubated for 
20 hr at 37 °C，5 % CO2. MTT assay was then applied (n = 7). 
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Figu re 3.27 
T h e confocal images show t h a t ro tenone r educed the a m o u n t of T N F - m e d i a t e d O^*" 
product ion in L929 ceUs. L929 cells (2 x lOVml) were seeded on a cover glass and 
incubated at 37 °C, 5 % CO^ for 4 days. Cells were then incubated with Na+-HEPES 
buffer (a), 50 ng/ml TNF for 15 min (b), 50 ^ M rotenone for 15 min (c), and 50 ng/ml 
TNF and 50 \ i M rotenone for 15 min (d) at room temperature and the abiUty of cells to 
produce Oj*" was then detected by HE (final concentration 10 p,M) with a CLSM-MD at 
time zero. 
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Figure 3.28 „ _ . 
Rotenone reduced the rate of TNF-mediated Oj*" production in L929 cells. This 
graph summaries the results of the confocal images from figure 3.27. The y-axis, FA i^ast, 
represented the summation offluorescence intensity from aU ceUs at each time interval that 
was divided by the total fluorescence intensity ofthe last image. 
Chapter 3. Results Page 107 
therefore, it chelated D N A and emitted fluorescence from the nucleus. In contrast, 
antimycin A enhanced the rate of TNF-mediated 02®" production in L929 cells (Figure 
3.29 and Figure 3.30). At the 45 min, the total fluorescence intensities in antimycin A-
treated group and TNF-plus-antimycin A-treated group were higher than that of TNF-
treated group and control group. This implied that antimycin A blocked electron flow 
from complex IE to cyt Ci that enhanced 02*" production. 
Furthermore, addition o f protonophorous uncoupler DNP (30 pM) reduced TNF-
mediated cytotoxicity (about 10 - 30 %) ^"igure 3.31). DNP allows electron transport in 
mitochondria but prevents the phosphorylation of ADP to ATP by uncoupling the 
essential linkage between electron transport and ATP synthesis. In the presence of 
uncoupler, the free energy released by electron transport appears as heat rather than as 
newly made ATP since uncoupling agents greatly increase the permeability of inner 
membrane to proton. As mentioned in section 1.4.1，depletion o f intraceUular ATP 
blocked apoptosis since apoptosis is ATP-dependent (review: Nicotera and Leist, 1997). 
Therefore, addition of uncoupler DNP, that reduces ATP synthesis, might block apoptosis 
and reduced TNF-mediated cytotoxicity. 
L i conclusion, TNF increased the release of ROS such as H2O2 and Oi*" which 
may involve in cell death. The release of H2O2 by TNF was time dependent. As the 
incubation time of TNF increased, the amount of production of H2O2 increased. Addition 
o f metabolic inhibitor such as AMD, that may block TNF-induced MnSOD production, 
increased the release of 02*~. Application of antioxidants such as catalase, 
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Figu re 3.29 
T h e confocal images show t h a t an t imycin A e n h a n c e d the a m o u n t of T N F - m e d i a t e d 
02*" product ion in L929 ceUs. L929 cells (2 x lOVml) were seeded on a cover glass and 
incubated at 37。C，5 % CO^ for 4 days. Cells were then incubated with Na+-HEPES 
buffer (a), 50 ng/ml TNF for 15 min (b), 25 ^ iM antimycin A for 15 min (c), and 50 ng/ml 
TNF and 25 ^ iM antimycin A for 15 min (d) at room temperature and the abiUty of cells to 
produce Oj*" was then detected by HE (final concentration 10 ^ M ) with a CLSM-MD at 
time zero. 
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Figure 3.30 
Antimycin A enhanced the rate of TNF-mediated O：*" production in L929 cells. This 
graph summaries the results of the confocal images from figure 3.29. The y-axis, F/Fiast, 
represented the summation of fluorescence intensity from aU cells at each time interval that 
was divided by the total fluorescence intensity of the last image. 
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Figure 3.31 
Addition of DNP produced a lower TNF-mediated cytotoxicity in L929 cells. L929 
cells were seeded at 3 x 10Vwell in complete medium in a 96-well plate and incubated for 
20 hr at 37 °C, 5 % CO2. 100 ^d TNF of various concentrations in the presence ( • ) or 
absence ( • ) of DNP (30 ^iM) in serum-free medium was added and incubated for 20 hr at 
37 °C, 5 % CO2. MTT assay was then applied (n = 7, expt = 2). Similar results were 
obtained in neutral red assay (data not shown). 
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MnSOD, NAc and 4-OH-TEMPO reduced TNF-mediated cytotoxicity. Furthermore, 
TNF potentiated the release of 02*" from mitochondria and the action o f TNF may be on 
mitochondrial complex HI. The evidence was that addition of mitochondrial complex I and 
I I inhibitors, rotenone and TTFA, that blocked the electron f low from N A D H 
dehydrogenase and succinate dehydrogenase, respectively, reduced the release of 62*" and 
produced a lower TNF-mediated cytotoxicity. Jn contrast, application o f mitochondrial 
complex i n inhibitor antimycin A, that blocked the electron flow from mitochondrial 
complex I I I to cyt Ci, enhanced the production of 62*" and induced a higher TNP-
mediated cytotoxicity. Moreover，the mitochondrial uncoupler DNP reduced ATP 
production and TNF-mediated cytotoxicity. 
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3.4 The Role of Calcium in Tumor Necrosis Factor-Alpha Treatment 
3.4.1 Introduction 
Since [Ca^^]i plays an important role in cell death, researchers try to consider the 
relationship between TNF and [Ca^^]i level. It was found that TNF increases [Ca^^]i level 
in L929 ceUs (Kong et al., 1997). However，Hasegawa and Bonavida reported that TNF-
induced ceU death was Ca^^-independent in human PBL (Hasegawa and Bonavida, 1989). 
In this project, the [Ca^^]i level was examined by different approaches. 
Two fluorescence dyes for monitoring [Ca^"]i level were appUed，fluo-3/AM and 
fura-red/AM. Fluo-3/AM is a commonly used fluorescence indicator for free Ca^^ (Merritt 
et al., 1990). Fluo-3 contains five negative charges and it cannot pass through the plasma 
membrane. Hence, the uncharged acetoxymethyl (AM) ester form of fluo-3 was employed. 
The advantage in using f luo-3/AM is that it is distributed rather homogeneously within the 
cytosol and nucleus ONicotera et al., 1994). On the other hand, the acetoxymethyl ester 
form of fura-red was employed for detecting [Ca^^]i level by chelating free Ca^^ also. The 
difference between fluo-3/AM and fura-redy'AM is that the fluorescence intensity of fluo-
3 /AM increases as [Ca】+] increases whereas the fluorescence intensity o f fura-red^AM 
decreases. Since the emission wavelengths for fluo-3/AM and fUra-redMM are different, 
they can be loaded and assayed simultaneously that wi l l not interfere with each other. 
L i this section，several techniques such as CLSM and FCM were applied to 
monitor the release of [Ca^^]i inside L929 cells. 
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3.4.2 Release of Intracellular Calcium in TNF-Treated L929 Cells 
[Ca2+]i was detected by a CLSM p^eridian). Figure 3.32 shows the confocal 
images. It was found that addition of Ca^^-free buffer did not produce Ca^^ release in a 
short time course (the time interval for each scan was 5 sec). Figure 3.33 shows the 
change of [Ca^^]i quantitatively with the replacement of normal buffer by Ca^^-free buffer 
and the addition of 40 ^ig/ml ionomycin. It is obviously that addition o f ionomycin to cells 
induced a sharp [Ca^^]i rise. The increase in [Ca^^]i by ionomycin confirmed that the Ca:+ 
system did not impair under the experimental conditions and the Ca^^ released by 
ionomycin were from intracellular stores. 
Figure 3.34 and Figure 3.35 illustrate that 50 ngAnl TNF did not cause [Ca^^]i 
increase in a short incubation time (~ 400 sec) while ionomycin produced an abrupt 
increase in Ca^^ fluorescence intensity. These imply that application o f TNF for a short 
time period did not cause the release of Ca^^ from intracellular stores. 
For a longer time period，Ca^^-free buffer did not cause an increase in [Ca^^]i while 
the addition o f ionomycin (40 ^ig/ml) induced Ca^^ release (Figure 3.36 and 3.37). 
Interestingly, addition o f 50 ng/ml TNF caused a slow rise in [Ca^^]j in Ca^^-free buffer 
(Figure 3.38). Figure 3.39 summaries the results of Figure 3.38 quantitatively. It is clear 
that the replacement o f Ca^^-containing buffer with a Ca^^-free buffer reduced the fluo-3 
fluorescence in the early phase of the experiment. After the addition of TNF (50ng/ml), 
the [Ca2+]i increased slowly. This increase was not observed in the Ca^^-free buffer in the 
absence o f T N F (Figure 3.37). These results suggest that TNF could mobiHze the Ca^^ 
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Figu re 3.32 
T h e confocal images show t h a t add i t ion of Ca^.- f ree b u f f e r d id no t cause Ca!+ 
release in L929 ceUs in a sho r t t ime course . L929 cells (2 x lOVml) were seeded on 
cover glass and incubated at 37。C and 5 % CO: for 3 days. Cells were mounted on a 
home-made holder and washed twice by Na+-HEPES buffer. Cells were loaded with 10 
^ iM f luo-3/AM for 1 hr and then washed twice by Ca^^-free buffer. Confocal scanning was 
made with a 5-second-interval at room temperature. Ca^^-free buffer and 40 p,g/ml 
ionomycin were added at the 75'*" and 475^^ sec, respectively (n = 3). 
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Figure 3.33 
Ca2+-free buffer d id not cause Ca=+ release in L929 ceUs in a short t ime course. This 
graph summaries quantitatively the results of the confocal images o f cell number 1 and 2 
from figure 3.32. Ca^^-free buffer and ionomycin (40^ig/ml) were introduced to the cells at 
the 1^ and 2"^ hairline, respectively. The y-axis, F/Fo, represented the normalized 
fluorescence intensity from cells. 
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Figure 3.34 
T h e confocal images show t h a t add i t ion of T N F did no t cause Ca�+ release in L929 
ceUs in a s h o r t t ime course. L929 cells (2 x lOVml)were seeded on cover glass and 
incubated at 37。C and 5 % CO: for 3 days. Cells were mounted on a home-made holder 
and washed twice by Na+-HEPES buffer and cells were loaded with 10 ^ iM f luo-3/AM 
for 1 hr and then washed twice by Ca^^-free buffer. Confocal scanning was made with a 5-
second-interval at room temperature. 50 ng/ml TNF in Ca^^-free buffer and 40 p,g/ml 
ionomycin were added at the 55^^  and 505'^ sec, respectively (n = 3). 
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Figure 3.35 
Addi t ion of T N F did not cause Ca:+ release in a short t ime assay. This graph 
summaries quantitatively the results o f the confocal images of cell number 1 and 2 from 
figure 3.34. TNF (50 ng/ml) in Ca^^-free buffer and ionomycin (40^ig/ml) were introduced 
to the cells at the 1欢 and 2"^ hairline, respectively. The initial decrease in fluorescence 
intensity might be due to the effect ofCa^^-free buffer. 
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Figu re 3.36 
T h e confocal images show t h a t add i t ion of Ca^^-free b u f f e r d id no t cause Ca�+ 
increase in L929 ceUs in a long t ime course . L929 cells (2 x lOVml) were seeded on 
cover glass and incubated at 37。C and 5 % CO: for 3 days. Cells were mounted on a 
home-made holder and washed twice by Na+-HEPES buffer. Cells were loaded with 10 
^ iM f luo-3/AM for 1 hr and then washed twice by Ca^^-free buffer. Confocal scanning was 
made with a 60-second-interval. Ca^^-free buffer and 40 |xg/ml ionomycin were added at 
the 600th and 6695'^ sec, respectively (n : 3). 
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Figure 3.37 
Addi t ion of Ca^^-free bu f f e r d id not cause Ca!+ release in L929 cells in a long t ime 
course. This graph summaries quantitatively the results of the confocal images of cell 
number 1 and 2 from figure 3.36. Ca^^-free buffer and ionomycin (40pig/ml) were 
introduced to the cells at the 1^ and 2^ hairline, respectively. The initial decrease in 
fluorescence intensity might be due to the effect of Ca^^-free buffer. 
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Figu re 3.38 
T h e confocal images show t h a t add i t ion of T N F p r o d u c e d a slow rise in [Ca"]^ in 
L929 ceUs in a long t ime course. L929 cells (2 x lOVml) were seeded on cover glass and 
incubated at 37 °C and 5 % COj for 3 days. Cells were mounted on a home-made holder 
and washed twice by Na+-HEPES buffer. Cells were loaded with 10 ^ iM f luo-3/AM for 1 
hr and then washed twice by Ca^^-free buffer. Confocal scanning was made with a 60-
second-interval. 50 ng/ml TNF was added at the 1200'^ (n = 5). 
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Figure 3.39 
Addi t ion of T N F p roduced t h e release of Ca=+ in a long t ime assay. This graph 
summaries quantitatively the results of the confocal images of cell number 2 and 3 from 
Figure 3.38. 50 ng/ml TNF was added at the 1200^ sec and produced a slow rise in 
[Ca2+]i. The initial decrease in fluorescence intensity might be due to the effect of Ca^^-free 
buffer. 
Chapter 3. Results Page 122 
inside the Ca^+ store. 
The release of Ca^^ in TNF-treated L929 cells was examined by FCM also. Two 
Ca2+ fluorescence dyes, f luo-3/AM and fura-red/AM were loaded into L929 cells 
simultaneously and the ratio of their fluorescence (fluo-3/fura-red) gave a more accurate 
and sensitive measurement. Figure 3.40 shows the dot plots from such experiment. The x-
axis and y-axis represent the intensity of fluo-3 and fura-red, respectively. It was found 
that incubation of cells with 50 ngy'ml TNF for 3 hr did not increase the release of Ca^^ as 
compare to control group (Figure 3.40a and b). In the control group, addition of 40 ^ig/ml 
ionomycin induced the release of Ca^^ ^Figure 3.40c，Figure 3.41c). In contrast, incubation 
of cells with 50 ng/ml TNF for 6 hr did produce a significant increase in [Ca^^]i fFigure 
3.41a and b). Addition of ionomycin induced a further release of Ca:+. Furthermore, 
addition of TNF for 10 hr produced a drastic release of Ca!+ (Figure 3.42a and b). To 
fiirther analyze these results, the cell population was divided into two groups arbitrarily, 
region 1 (R1) and region 2 (R2) as mentioned in section 2.2.4. Since the [Ca^^]i level 
increased, fluorescence of fluo-3 increased whereas fluorescence of fura-red decreased, 
the cell population shifted anti-clockwisely to the upper-left. I f the [Ca^^]i level was high in 
L929 cells, more dots should occur in R2 and vice versa in R1. Table 3.1 summarizes the 
above results, as the incubation time with TNF increased, the release of Ca^^ in L929 cells 
was increased also. It was found that in the incubation o fL929 cells wi th TNF for 3 hr did 
not cause a significant shift of dots from R1 to R2. However, in 6-hour-incubation o f T N F 
with L929 cells caused a shift of dots from R1 to R2. Furthermore, in 10-hour-inucbation, 
TNF caused a drastic shift o f cells from R1 to R2. h i another experiment, 
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Incubation of L929 cells with TNF for 3 hr did not produce a significant change in 
[Ca^^i. L929 cells (10Vml) were seeded in 6-well plate and were incubated ovemight at 
37 X, 5 % CO2. Subsequently, cells were treated with or without 50 ngAnl TNF at 37 X 
for 3 hr and then loaded with 10 p M fluo-3/AM and 10 ^iM fura-red/AM for another hr. 
Cells were then trypsinized. After washing, cells were re-suspended in the Na+-HEPES 
buffer and the fluorescence of fluo-3 and fura-red were determined by FCM with an argon 
laser. Y-axis represents the fluorescence intensity of fluo-3 whereas x-axis represents the 
fluorescence intensity o f fura-red. Dots shift to the upper-left, that is，an increase in fluo-3 
fluorescence with a decrease in fiira-red imply an increase in [Ca^^]i. (a) Control group, (b) 
L929 cells were incubated with 50 ngy^ ml TNF. Note that there was no difference in the 
pattem of dots as compared to the control group, (c) CeUs were activated by 40 p.g/ml 
ionomycin 10 min before measurement, (d) Addition o f 40 ^ig/ml ionomycin 10 min before 
measurement in the TNF-treated group. Note that a shift in the ceU population at the 
upper-left indicates there was no impairment in Ca^^ measurement system. The population 
o f cells were divided into two groups (R1 and R2) by the diagonal line arbitrarily and the 
number of cells in each region was determined. 
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Figure 3.41 
Incubat ion o f L 9 2 9 cells with TNF for 6 hr produced a significant change in [Ca^^j. 
(a) Control group, (b) L929 cells were incubated with 50 ng/ml TNF for 6 hr. Note that 
there was an increase in [Ca^^]i as compared to the control group. More dots occurred at 
the upper-left region and there was an decrease in the fluorescence intensity of fura-red. 
(c) Cells were loaded with 40 M>gAnl ionomycin 10 min before measurement, (d) Addition 
of 40 pig/ml ionomycin in the TNF-treated group caused a shift in the cell population also. 
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I n c u b a t i o n o f L 9 2 9 ceUs wi th T N F fo r 10 h r p r o d u c e d a dras t ic change in [Ca'^]i. (a) 
Control group. 0>) L929 cells were incubated with 50 ng/ml TNF for 10 hr. Note that 
there was an increase in [Ca^^]i as compared to the control group. More dots occurred at 
the upper-left region and there was an decrease in the fluorescence intensity of fura-red. 
(c) Cells were loaded with 40 n>gAnl ionomycin 10 min before measurement, (d) Addition 
o f 40 pig/ml ionomycin in the TNF-treated group caused a shift in the cell population also. 
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Table 3.1 
TNF-mediated Ca=+ release is proportional to the incubation time. 
Incubation time 3 hr 6 hr 10 hr 
T r e a t m e n t control 50 ng/ml control 50 ng/ml control 50 ng/ml 
TOF TOT TNF 
Fluo-3 intensity 74.68 8 ^ 6 s H 81.42 89.49 126.56 
(arbitrary unit) 
Fura-red 406.65 442.00 274.39 214.27 304.80 87.96 
intensity 
(arbitrary unit) 
Fluo-3 yTura-red 0.18 0.18 0.24 0.38 一 0.29 1.44 
% ofcontrol * 100 158 496 
(%) ： 
Number ofcells 9684 9686 9176 8712 9550 2803 
in R1 
Number ofcells s l 6 ~ ~ 314 824 1288 450 7197 
inR2 
Results from Figure 3.40 - Figure 3.42 were summarized and the peak fluorescences at the 
X- and y-axis were acquired. The ratio of fluo-3 to fura-red was then calculated and the % 
of control was obtained according to the following formula: 
* % ofcontrol (%) 
=[ f luo-3 / fura-red (TNF treatment)] / [fluo-3 / fura-red (control)] x 100 % 
Moreover, the number of dots in R1 and R2 were determined. 
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addition of large dose of TNF (500 ngAnl) for 3 hr produced a small increase in [Ca^^]i 
(Figure 3.43 and Table 3.2). There was a little shift of the cell population from R1 to R2 in 
3-hour-incubation of 500 ng/ml TNF with L929 ceUs. b i the ionomycin experiment, the 
distribution of dots is quite homogeneous as compared to the one with TNF treatment 
(Figure 3.40 - 3.43). When compared the responses mediated by ionomycin and TNF, it 
can be seen in Figure 3.41b and Figure 3.42b that cells responded to TNF differently. 
Basically, two populations o f cells can be visuaUzed in terms of the slope of the graph (i.e. 
the ratio of fluo-3/fura-red). In the upper left population, cells produced a relatively high 
[Ca^^]i after TNF addition, while the lower right gave a low [Ca^^]i rise.. 
3.4.3 Effect ofCalcium-Inducing Agents on TNF-Treated L929 Cells 
Thapsigargin is a sesquiterpene lactone originaUy isolated from the umbreUiferous 
plant Thapsia gargancia (Christensen and Norup, 1985). It acts as an irreversible inhibitor 
o f the Ca2+-ATPase in the endoplasmic reticulum (ER Ca^^-ATPase) (Lytton et aL, 1991; 
Thastrup et al., 1990).When the ER pump is inhibited, for example by thapsigargin, Ca^^ 
can no longer be returned from the cytosol to the ER and therefore, led to a prolonged 
rise in [Ca^^]i (Vercesi et al., 1996). However, thapsigargin is not a universal Ca?+-
releasing agent in all cell types (Vercesi et al,, 1996). 
In this experiment, the effect of thapsigargin (2 [ M ) on TNF-mediated release of 
Ca2+ was examined. Figure 3.44 shows the dot plots from FCM and it indicated that 
thapsigargin itself did not induce the release of Ca^^ after 6-hour-treatment OFigure 3 .44a 
and b). However, incubation o f ceUs with 50 ng/ml TNF together with 2 ^iM thapsigargin 
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Figure 3.43 
Incubation of L929 cells with high concentration of TNF for 3 hr caused a small 
increase in [Ca^^i. (a) Control group, (b) L929 cells were incubated with 50 ng/ml TNF 
for 3 hr. It shows that there was no significant change in [Ca^^]i as compared to control 
group, (c) Cells were incubated with 500 ng/ml TNF for 3 hr and it caused a smaU 
increase in [Ca^^]i since the fluorescence intensity of fura-red decreased. Addition of 40 
^igAnl ionomycin 10 min before measurement in the (d) control, (e)TNF-treated group, 
and (f) high concentration ofTNF-treated group caused a shift in the cell population also. 
The number o f cells in the region R1 and R2 is also determined. 
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Table 3.2 
Addition ofhigh concentration ofTNF caused a small increase in [Ca'^i. 
Incubation time 3 hr 
T r e a t m e n t control 50 ng/ml TNF 500 ng/ml TNF 
Fluo-3 intensity 78.40 93.55 78.18 
(arbitrary unit) 
Fura-red intensity 273.72 359.50 231.44 
(arbitrary unit) 
Fluo-3 yTura-red 0.28 0.26 0.34 
^ o f c o n t r o l * ( % ) / 92 121 
Number ofcells in 9 m 9713 9 ^ 
m 
Number ofcells in i ^ 287 3 ^ 
R2 
Results from Figure 3.43 were summarized and the peak fluorescences at the x- and y-axis 
were acquired. The ratio of fluo-3 to fura-red was then calculated and the % of control 
was obtained according to the following formula: 
* % ofcontrol (%) 
=[ f luo-3 / fura-red (TNF treatment)] / [fluo-3 / fura-red (control)] x 100 % 
Moreover, the number of dots in R1 and R2 were determined. 
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Figure 3.44 
Incubation of TNF with thapsigargin produced a drastic increase in [Ca^^i. (a) 
Control group, (b) L929 cells were incubated with 2 p M thapsigargin for 6 hr. I t shows 
that there was no significant change in [Ca +]i as compared to control group, (c) Cells 
were incubated with 50 ngAnl TNF for 6 hr and it produced an increase in [Ca^^i. (d) 
Addition o f 50 ng/ml TNF with 2 \xM thapsigargin produced a drastic release of Ca^^. 
Addition o f 40 pig/ml ionomycin 10 min before measurement in the (e) control and (f) 
thapsigargin-treated group caused a shift in the cell population also. The number o f cells in 
the region R1 and R2 is also determined. 
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for 6 hr produced a drastic increase in [Ca^^]i (Figure 3.44a and d) as evidenced by the 
shifting of cells from R1 to R2 as compared to TNF treatment. This may be due to the fact 
that the [Ca^^]i released by TNF could not be uptaken into Ca^^ stores as the activity of 
Ca^^-ATPases were blocked by thapsigargin. Obivously, two populations o f ceUs were 
also seen when cells were treated with TNF in the presence of thapsigargin fFigure 3.44d). 
The rise of [Ca^^i are also found in the group with ionomycin treatment in the absence 
(Figure 3.44e) and presence of thapsigargin (Figure 3.44f). These results therefore suggest 
that TG potentiated TNF-mediated release of Ca^^. 
Another Ca^^-inducing agent, thimerosal, was also used. Thimerosal, a thiol-
reactive reagent, has been shown to increase the cytosolic Ca^^ concentration in a variety 
of cells (MichelangeU et al., 1995) by sensitizing EP3 receptors (Bemdge, 1991). Figure 
3.45 shows the effect of 20 [ M thimerosal on TNF-mediated cytotoxicity. Addition of 
thimerosal increased about 10 % in TNF-mediated cytotoxicity. 
In conclusion, TNF produced a slow rise in [Ca^^]i that may involve in cell death 
since sustained Ca^^ in cytosol may cause apoptosis O^Jicotera et al., 1994). Addition of 
Ca2:inducing agent potentiated the release of Ca】+ and increased the TNF-mediated 
cytotoxicity. 
Since TNF increased the release of ROS and Ca^^ in L929 ceUs, their relationship 
was examined in the next section. 
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Figure 3.45 
Addition of thimerosal enhanced TNF-mediated cytotoxicity. L929 ceUs were seeded 
at 3 X 10^/well in complete medium in a 96-well plate and incubated for 20 hr at 37。C，5 
% CO2. 100 ^1 o fTNF of various concentrations in the presence ( • ) or absence ( • ) of 
thimerosal (20 pM) in serum-free medium was added and incubated for 20 hr at 37 °C, 5 
% CO2. Neutral red assay was then applied (n = 7). 
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3.5 Relationship between Reactive Oxygen Species and Calcium in 
Tumor Necrosis Factor-Alpha-Mediated Cytotoxicity 
3.5.1 Introduction 
In previous experiments, we have found that TNF increased the release of ROS 
and Ca2+ in L929 cells. However, their relationship is not clear and therefore we attempted 
to investigate the possible mechanisms behind by FCM. Moreover, the effect of 
mitochondrial Ca!+ (Ca^^)m was examined also. 
3.5.2 Effect ofIntracelluIar Calcium Chelator on TNF-Mediated ROS Release and 
Cytotoxicity 
BAPTA7AM is one of the commonly used Ca^^-chelators (Kong et al.’ 1996; Pahl 
and Baeuerle, 1996). In the cytotoxicity assay, appUcation of 10 ^ M BAPTA; 'AM reduced 
TNF-mediated cytotoxicity by about 5 - 10 % (Figure 3.46). Similar to the results in 
section 3.4.2，challenge of ceUs with TNF (50 ng/ml) for 3 hr did not produce any change 
in [Ca2+]i ^"igure 3.47a). However，an increase in the [Ca^^i was observed when cells 
were treated with TNF (50 ng/ml) for 6 hr OFigure 3.47b). As expected, BAPTAy^AM 
could block the rise of Ca?+ in the 6-hour-incubation group 5^igure 3.47). There was no 
significant change in the number of dots in R1 and R2 in 3-hour-incubation as compared 
to control group OFigure 3.47a) whereas addition of BAPTA>'AM in the 6-hour TNF 
treatment reduced the number of dots in R2 as compared to the one with 6-hour TNF 
treatment alone. Figure 3.48 shows the effect o f 10 j i M BAPTA7AM on the release of 
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Figure 3.46 
Addit ion of BAPTA/AM reduced TNF-mediated cytotoxicity. L929 cells (3 x 
loVweU) were seeded in a 96-well plate and incubated for 20 hr at 37 °C, 5 % CO2. In the 
treatment group, BAPTA/AM (10 pM) in serum-free medium was added to each weU and 
incubated at 37 °C for another 120 min. Subsequently, 100 ^il of TNF of various 
concentrations was added and the cells were incubated for 20 hr at 37 °C, 5 % CO2. 
Neutral red assay was then applied (n = 3, expt. = 3). 
Chapter 3. Resutis Page 135 
(a) 0)) 
control control 
(R1 = 9897’ R2 = 103) (R1 = 8891, R2 = 1109) 
S| R2~7| S| 
0 / Oi 
0 Q 
」 j 4 . : , , ^ ; . 、 . . | J j i # i P ^ ^ - & ' 
0 1023 0 1023 
+ 50 ng/ml TNF for 3 hr +50ng/mlTNFfor6hr . 
(% of control = 88 %) (% of control = 158 %) ‘ 
(R1 = 9926, R2 = 74) (R1 = 8369,R2 = 1631) S| S |~ ‘ 
o o T— T— • 
、.•:•' . 
_ . : . . . . -
^ 」肩_1.||丨::..-. i ^ 0 0 e - -
^ 0 1023 0 1023 
g + 10 fiM BAPTA/AM for 3 hr + 10 fiM BAPTA/AM for 6 hr 
« (% of control = 88 %) ( � / � o f c ntrol = 105 %) 
. s (R1 = 9915，R2 = 85) (R1 = 9122，R2 = 878) f? 
i S ?5 a o o 
E ^ ^ 
— . i — — v J J j i i a f e t e 
0 1023 0 1023 
+ 50 ng/ml TNF and + 50 ng/ml TNF and 
10 f]iM BAPTA/AM for 3 hr 10 fiM BAPTA/AM for 6 hr 
(% of control = 81 %) (% of control = 124 %) 
(R1 =• 9929, R2 = 71) (R1 - 8737, R2 - 1263) 
S | § 1 
2 2 
1 
•• . ‘ ‘ . •‘ 
. . : < . : , • 
..',；.. • •• . • V i . . . . 
.%•••/ » - . . ： 
: 塵 _ : : “ 」 J & f e ) : . . 
0 1023 0 1023 
Fura-red intensity 
Figu re 3.47 
Addi t ion of B A P T A / A M chelated T N F - m e d i a t e d Ca '^ release in t h e 6 - h o u r -
incuba t ion b u t not t he 3 - h o u r - t r e a t m e n t . (a) Neither TNF (50 ng/ml) nor BAPTA (10 
\ M ) produced any changes in [Ca^i i in L929 ceUs. (b) Addition o f 10 [ M BAPTA /AM 
for 6 hr reduced TNF-mediated Ca^^ release. 
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Figure 3.48 
Addition of BAPTAM^M reduced TNF-mediated H2O2 release. L929 cells (10Vml) 
were seeded in a 6-well plate and were incubated ovemight at 37 °C, 5 % CO2. Cells were 
treated with 10 ^iM B A P T A M M in the presence (orange line) or absence (green line) o f 
50 ngAnl TNF for 15 min (a), 3 hr (b), 6 hr (c) and 10 hr (d). Cells were then trypsinized. 
DCF (10 pM) was added and measurements were made with a FCM at the time indicated. 
The black and the purple lines represent the control and the TNF (50 ng/ml)-treated 
group, respectively. It was found that cells incubation with BAPTA/AM reduced the 
release of H2O2 in treatment with TNF. These results suggest that the release of Ca^+ 
preceded H2O2. 
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ROS in L929 cells that were incubated for 15 min, 3，6 and 10 hr. It was found that 
addition o f B A P T A / A M did reduce the release ofROS in TNF-treated cells in the 6- and 
10-hour-treatment. Therefore, it seems Ukely that the release o fROS may be mediated by 
[Ca2+]i because i f the release ofROS was independent on [Ca^"]i, it would not be inhibited. 
Figure 3.49 summaries the results from Figure 3.48 quantitatively. On the other hand, 
addition of 1 m M H2O2 did not cause the release of Ca^^ at the 3，6 or 10 hr time point 
(Figure 3.50). Figure 3.51 shows the confocal images (from CLSM, Meridian) of the early 
response of TNF on H2O2 treatment. AppUcation of 1 or 5 m M H2O2 did not cause a 
spontaneous increase in the level of [Ca^^]i (Figure 3.52) whereas addition o f ionomycin 
(40 ^ig/ml) indicates that there was no Ca^^ impairment. 
However, someone may wonder that there are two possibiHties that BAPTAy'AM 
reduced TNF-mediated release of ROS in the long time treatment (i.e. 6- or 10-hour 
incubation). First, BAPTA/AM reduced the TNP-mediated release of ROS actuaUy by 
chelating Ca!+. Second，BAPTA>^AM induced cell death, thereby reducing the release of 
ROS from dead ceUs. From the dot plots of DCF against PI, one may differentiate these 
possibilities. CeU death was examined simultaneously by applying propidium iodide (J>I). 
PI is one of the D N A chelators that can be used for detecting ceU death. PI difiuses into 
dead ceUs and chelates DNA. Therefore, dead cells give fluorescence. As the number of 
dead ceUs increased, the PI intensity increased also. Figures 3.53 - 3.56 show the dot plots 
o f incubation o f T N F for 15 min, 3，6 and 10 hr, respectively. The x-axis indicates the 
fluorescence intensity of DCF whereas the y-axis represents the PI intensity. The first 
column indicates the fluorescence o fDCF and PI in the control ceUs measured at the time 
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Figure 3.49 
Addition of BAPTA/AM caused a reduction in TNF-mediated H2O2 release. These 
graphs summarize the results from Figure 3.48 (mean 土 S.D. from 3 expt, except the one 
with 15 min TNF treatment (1 expt)). 
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Figure 3.50 
Addi t ion of H2O2 did not p r o d u c e Ca^^ release in 3，6 or 10 h r incuba t ion . Addition 
o f 1 m M H2O2 for (a) 3 hr, (b) 6 hr or (c) 10 hr did not produce Ca:+ release. 
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Figure 3.51 
T h e confocal images show t h a t add i t ion of H ^ O j d id no t p r o d u c e a s p o n t a n e o u s 
release of Ca!+ in L929 ceUs. L929 cells (2 x lOVml) were seeded on cover glass and 
incubated at 37。C and 5 % CO2 for 3 days. Cells were mounted on a home-made holder 
and washed twice by Na+-HEPES buffer. Cells were loaded with 10 ^ iM f luo-3/AM for 1 
hr and then washed twice by Ca^^-free buffer. Confocal scanning was made with a 5-
second-interval at room temperature. 1 m M and 5 m M H P 2 were added at the 100'^ and 
250出 sec, respectively. 40 ^ig/ml ionomycin was added at the 375'^ sec (n = 3). 
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Figure 3.52 
H2O2 did no t cause C a � + release in L929 cells in a shor t t ime course. This graph 
summaries the results of the confocal images of cell number 1 and 2 from figure 3.5l. 1 
m M and 5 m M H2O2 were introduced to the cells at the 1^ and 2°^ hairline, respectively. 
40 ^ig/ml ionomycin was introduced to the cells at the 3^ hairline. The y-axis, F/Fo, 
represented the noraiaUzed fluorescence intensity from ceUs. 
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Figure 3.53 
Incubat ion of L929 ceUs with T N F for 15 min did not p roduce the release of H2O2 
and cell death. L929 cells (10Vml) were treated with TNF (50 ng/ml) for 15 min at 37 
T , 5 % CO2. After washing, ceUs were labeUed with DCF (10 pM) and PI (8 jj,g/ml) and 
the fluorescences were measured with a FCM at the time indicated. X-axis and y-axis 
represent the fluorescence intensity of DCF and PI, respectively, (a) It represents the 
control group, (b) 50 ng/ml TNF was added, (c) 10 \ M BAPTAy'AM was added, (d) 50 
ng/ml TNF and 10 ^iM BAPTA/AM were added. There was no significant difference 
among groups. 
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Figure 3.54 
Incubation of L929 celIs with TNF for 3 hr did not produce the release of H2O2 and 
cell death. L929 cells (10Vml) were treated with TNF (50 ng/ml) for 3 hr at 37 °C，5 % 
CO2. After washing, cells were labelled with DCF (10 pM) and PI (8 ^ig/ml) and the 
fluorescences were measured with a FCM at the time indicated. X-axis and y-axis 
represent the fluorescence intensity o f DCF and PI, respectively, (a) I t represents the 
control group, (b) 50 ng/ml TNF was added, (c) 10 [iM BAPTA /AM was added, (d) 50 
ng/ml TNF and 10 p M BAPTA/AM were added. There was no significant difference 
among groups. 
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Figure 3.55 
Incubation of L929 ceUs with TNF for 6 hr produced the release of H2O2 and cell 
death, (a) I t represents the control group. ¢ ) 50 ng/ml TNF was added. The lower 
population moved faster to the right than that o f the control group (column 1) (c) 10 piM 
BAPTAy'AM was added. No significant difference was found when compared to the 
control group, (d) 50 ngAnl TNF and 10 [ M BAPTA/AM were added. The lower 
population moved slower to the right than that o f the TNF-treated group (column 2). It 
implied that addition o f B A P T A / A M reduced the release ofH2O2 by chelating Ca^^. 
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Figure 3.56 
Incubation of L929 cells with TNF for 10 hr produced the release of H2O2 and ceU 
dea th , (a) It represents the control group, (b) 50 ng/ml TNF was added. The lower 
population moved faster to the right than that o f the control group (colunm 1). Moreover, 
a population in the R2 region was found in the 10 hr treatment but not in the 6 hr group, 
(c) 10 n M BAPTA/AM was added, (d) 50 ngAnl TNF and 10 p M B A P T A M M were 
added. The lower population moved slower to the right than that of the TNF-treated 
group (column 2). Moreover, addition of B A P T A / A M reduced the population in R2 
region as compared to the TNF-treated group. Therefore, it implied that addition of 
BAPTA/AM reduced the release ofH2O2 and ceU death by chelating Ca^^ 
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after the addition of the fluorescent indicators. The second column represents the 
corresponding data in the TNF (50 ng/ml) treated cells. The third and the fourth columns 
correspond to the one in cells with BAPTAy'AM or BAPTA/AM plus TNF, respectively. 
For each dot plot, it could be divided into three regions, R1, R2 and R3, as 
mentioned in section 2.2.4. The lower position (R1) on the y-axis indicates the viable ceUs 
whereas the ones on the middle ¢12) and upper region (R3) of the y-axis shows the dead 
cells. Several conclusions can be obtained from these dot plots. First, a few dots were 
found in the middle region of the y-axis (i.e. only a few ceUs labeUed with PI) in the 
control and BATPA/AM-treated group (Figure 3.53 - 3.56). These indicate that 
BAPTAy^AM itself did not induce cell death. However, BAPTA/AM was able to reduce 
the release ofH2O2 by chelating Ca^+rather than induced cell death. Second, TNF induced 
an intermediate population (column 2 in Figure 3.55 and Figure 3.56) in the R2 region in 
the 6- and 10-hour TNF treatment. The appearance of this population is due to the effect 
o f T N F on the membrane lesion. This effect was more obvious in the 10-hour incubation 
(Figure 3.55 vs Figure 3.56). These results indicate that TNF induced cell death 6-hour 
after the addition o fTNF. Third, Figure 3.56 also shows that addition o fBAPTA; 'AM for 
10 hr reduced the number of TNF-induced ceU population in R2 region as compared the 
column 2 with the column 4. These observations suggest that BAPTA/AM may reduce the 
initiation ofcel l death by reducing the production ofH2O2 after 6-hour-treatment o fTNF. 
Fourth, TNF-treated cells gave a higher redox rate in terms of DCF fluorescence in the 
right-shifting population than the control ceUs in Figure 3.55 and Figure 3.56 and this 
implied that the redox rate is higher in the TNF treated group. Finally, addition of 
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BAPTA/AM reduced TNF-mediated redox rate by comparing the column 2 with column 4 
in Figure 3.55 and Figure 3.56. Figure 3.57 further shows that addition of BAPTA/AM 
reduced PI intensity. It implied that chelation of Ca^^ could reduce the ceU death mediated 
byTNF. 
Table 3.3 shows the proportion of cells in the 10-hour incubation with TNF (data 
were from the 45^-minute-plot of each treatment). Only the data from 10-hour incubation 
were analyzed since they gave a distinct response among these treatments. It was found 
that addition o f TNF induced more cell deaths since the number of cells in R2 and R3 was 
double as compared to the control group. Addition of BAPTAy'AM did not induce cell 
death since the number of cells in R2 and R3 is fewer than control group. Moreover，TNF 
with BAPTA /AM reduced the ceU number in R2. It indicates that B A P T A / A M may block 
the cell death mediated by TNF 
In the cytotoxicity assay, it was found that addition of BAPTA (10 ^iM) in the 
presence of 4-OH-TEMPO (5 mM) reduced TNF-mediated cytotoxicity to a great extent 
(Figure 3.58). These results suggest that Ca^^-chelator with antioxidant might have 
additive effect on the reduction ofTNF-mediated cytotoxicity. 
3.5.3 Effect ofMitochondrial Calcium on TNF-Mediated ROS Release and 
Cytotoxicity 
I t is still controversial that mitochondrion acts as a Ca:+ store (Somlyo et al., 
1985). The concentration o f mitochondrial free Ca?+ is found to be low (< 100 nM) in 
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Figure 3.57 
Addi t ion of B A P T A / A M reduced cell death in TNF treatment. L929 cells ( loVml) 
were seeded in a 6-well plate and were incubated overnight at 37 °C, 5 % CO2. Cells were 
treated with 10 ^iM BAPTA/AM in the presence (orange line) or absence (green line) o f 
50 ng/ml TNF 10 hr. Cells were then trypsinized. PI (8 pig/ml) was added and 
measurement was made with a FCM at the time indicated. The black and the purple lines 
represent the control and the TNF (50 ng/ml)-treated group, respectively. I t was found 
that cells incubation with BAPTA/AM reduced the cell death. 
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Table 3.3 
Addi t ion ofBAPTA>^AM reduced TNF-med ia t ed cell dea th . 
T r e a t m e n t N u m b e r of N u m b e r of N u m b e r of * % o f C e U dea th ( % ) 
ceUs in R 1 cells in R 2 cells in R 3 
— C o n t r o l 8998 91 911 — 10.02 
50 ng/ml TNF 7618 一 1161 “ 1221 23.82 
10 MM 9216 115 669 T ^ 
B A P T A M M 
50 n g M TNF ^ ^ 1 ^ 20.40 
+ 10 n M 
B A P T A M M 
Results were from the 45^-minute-plot o f each treatment in Figure 3 .56. The number of 
ceUs in R1, R2 and R3 were recorded and % of cell death was obtained according to the 
foUowing formula: 
* % ofcel l death (%) 
=pS[umber ofceUs in (R2 + R3) + Number ofceUs in (R1 + R2 + R3)] x 100 % 
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Figure 3.58 
Addition of BAPTA/AM and 4 -OH-TEMPO fur the r reduced TNF-mediated 
cytotoxicity. L929 cells (3 x 10Vwell) were seeded in a 96-weU plate and incubated for 20 
hr at 37 X, 5 % CO2 In the treatment group, BAPTAMM (10 _ in serum-free 
medium was added to each well and incubated at 37 °C for another 120 min. 
Subsequently, 100 ^il of 4-OH-TEMPO (5 mM) with TNF of various concentrations in 
serum-free medium were added and the cells were incubated for 20 hr at 37 °C, 5 % CO2. 
Neutral red assay was then applied (n = 3). * p < 0.05 and • * p < 0.005 indicate that there 
was a significant difference between 4-OH-TEMPO and BAPTA/AM with 4-OH-TEMPO 
group. 
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unstimulated cells (Miyata et al., 1991). The ER, rather than the mitochondria, is the main 
organelle regulating the [Ca^^]i (Somlyo etal., 1985). 
Three pathways for Ca^^ transport have been described in respiring mitochondria 
that maintain a high transmembrane electrical potential: (1) the Ca!+ uniporter; (2) the 
putative HVCa^+ antiporter; and (3) NaVCa^^ antiporter (review: Gunter and Pfeiffer， 
1990) that maintain the Ca^^-cycling between cytosol and mitochondria (Figure 1.6c). 
Similar to the role in cytosol, Ca^+ also acts as a second messenger in mitochondria 
(review: Denton and McCormack, 1990). I t regulates intra-mitochondrial metabolism by 
regulating different mitochondrial enzymes such as dehydrogenases (Denton et al., 1980; 
McCormack and Denton, 1980) thus affecting oxidative phosphorylation ^4oreno-
Sanchez, 1985). Moreover, the mitochondrial matrix volume is regulated by Ca^+ as well 
(Davidson and Halestrap, 1987). 
The mitochondrial Ca^^-cycling can be inhibited by some drugs such as ruthenium 
red and diltiazem. Ruthenium red，a hexavalent, inorganic dye that prevents mitochondrial 
Ca2+ uptake by inhibiting the mitochondrial Ca:+ uniporter (Chacon and Acosta, 1991; 
FauUc et al., 1995). Jn contrast, diltiazem prevents the release of Ca^^ from mitochondria 
by inhibiting Na+-dependent and H^-dependent pathways (Rizzuto et al., 1987). 
b i L929 cells, addition o f 25 [ j M ruthenium red reduced TNF-mediated 
cytotoxicity by about 5 - 10 % (Figure 3.59). Furthermore, addition o f250 \ i M diltiazem 
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Figure 3.59 
Addition of ru thenium red reduced TNF-mediated cytotoxicity. L929 cells were 
seeded at 3 x 10Vwell in complete medium in a 96-weU plate and incubated for 20 hr at 37 
°C, 5 % CO2. 100 p.1 TNF of various concentrations in the presence ( _ or absence (參）of 
ruthenium red (25 ^iM) in semm-free medium was added and incubated for 20 hr at 37 °C, 
5 % CO2. MTT assay was then appUed (n = 3, expt = 3). Similar results were obtained in 
neutral red assay (data not shown). 
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also reduced TNP-mediated cell death ( by about 5 - 10 %) (Figure 3.60). It implies that 
inhibition of Ca^^ cycling in the mitochondria inhibited the TNF-mediated cell death. 
The dot plots from FCM indicated that addition of ruthenium red (25 pJvI) or 
diltiazem (250 |oM) for 6 hr without TNF showed a small modification of the [Ca^^i level. 
As shown in Figure 3.61c, treating of cells with ruthenium red reduced the cell number in 
the lower-right corner. This may be due to the effect of ruthenium red that the Ca^^ re-
uptake into mitochondria was suppressed. For the effect of diltiazem (Figure 3.61e), more 
cells were found in the lower right comer indicating a lower [Ca^^]i in these cells. These 
may due to the action o f diltiazem that the release of Ca^^ from the mitochondria was 
blocked. However, the effect o f ruthenium red and diltiazem on the [Ca^^]i was not so 
significant. Nevertheless, pre-treatments of cells with ruthenium red and diltiazem reduced 
the TNF-mediated Ca^^ release (Figure 3.61). Furthermore, the number of ceUs did not 
increase in R2 (Figure 3.61c - f) as compared to control whereas 6-hour incubation o f 
TNF induced a shift o f cells from R1 to R2. These results imply that prevention of Ca^^ 
cycling in mitochondria inhibited the rise o f [Ca^^]i release. Our results also suggest that 
one o f the sources o f Ca^^ after TNF treatment is from the mitochondria. 
The confocal images from CLSM-MD also indicated that addition of 25 [ j M 
ruthenium red reduced both H2O2 (Figure 3.62) and Oi*" (Figure 3.64) release. The 
quantitative measurements from both experiments were summarized in Figure 3.63 and 
Figure 3.65，respectively. Furthermore, data from FCM also indicated that diltiazem could 
reduce the TNF-mediated H2O2 release O^igure 3.66). These results therefore suggested 
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Figure 3.60 
Addition of diltiazem reduced TNF-mediated cytotoxicity. L929 cells were seeded at 3 
X 10Vwell in complete medium in a 96-well plate and incubated for 20 hr at 37。C，5 % 
CO2. 100 |il TNF of various concentrations in the presence ( • ) or absence ( # ) of 
diltiazem (250 | iM) in serum-free medium was added and incubated for 20 hr at 37 °C, 5 
% CO2. MTT assay was then appUed (n = 3, expt = 3). Similar results were obtained in 
neutral red assay (data not shown). 
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Figure 3.61 
Addition ofnithenium red or diltiazem for 6 hr reduced TNF-mediated Ca�+ release, 
(a) Control group, (b) TNF increased the release of Ca^^. (c) Addition of 25 | i M 
ruthenium red did not change the release of [Ca^^]i. (d) Addition o f 50 ng/ml TNF with 25 
HM ruthenium red reduced TNF-mediated Ca^^ release as compare to TNF-treated group, 
(e) Addition o f 250 p M diltiazem did not cause the release of Ca^^. (f) AppUcation of 50 
ng/ml TNF and 250 p M diltiazem reduced TNF-mediated Ca^^ release. 
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Figu re 3.62 
T h e confocal images show t h a t r u t h e n i u m red r educed the a m o u n t of T N F -
media ted H2O2 p r o d u c t i o n in L929 ceUs. L929 cells (2 x lOVml) were seeded on a cover 
glass and incubated at 37 °C, 5 % COj for 4 days. Cells were then incubated with Na+-
HEPES buffer (a), 50 ng/ml TNF for 15 min (b), 25 j i M ruthenium red for 15 min (c), 
and 50 ng/ml TNF and 25 p-M ruthenium red for 15 min (d) at room temperature and the 
abiUty of cells to produce Hf>2 was then detected by DCF (final concentration 10 | i M ) 
with a CLSM-MD at time zero. 
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Figure 3.63 
Ruthen ium red reduced the ra te of TNF-mediated H2O2 product ion in L929 cells. 
This graph summaries the results of the confocal images from figure 3.62. The y-axis, 
F/Fiast, represented the summation of fluorescence intensity from aU ceUs at each time 
interval that was divided by the total fluorescence intensity ofthe last image. 
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Figure 3.64 
The confocal images show that ruthenium red reduced the amount of TNF-
mediated 02 . - production in L929 ceUs. L929 cells (2 x lOVml) were seeded on a cover 
glass and incubated at 3 7 � C , 5 % CO2 for 4 days. Cells were then incubated with Na+-
HEPES buffer (a), 50 ng/ml TNF for 15 min (b), 25 |iM ruthenium red for 15 min (c), 
and 50 ng/ml TNF and 25 ^iM ruthenium red for 15 min (d) at room temperature and the 
abiUty of cells to produce 62*" was then detected by HE (final concentration 10 p.M) with 
a CLSM-MD at time zero. 
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Figure 3.65 
Ruthenium red reduced the rate of TNF-mediated 02*" production in L929 cells. 
This graph summaries the results of the confocal images from figure 3.64. The y-axis, 
F/Fiast, represented the summation of fluorescence intensity from aU ceUs at each time 
interval that was divided by the total fluorescence intensity of the last image. 
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Figure 3.66 
Addition of diltiazem reduced TNF-mediated H2O2 release. L929 cells (10Vml) were 
seeded in a 6-well plate and were incubated ovemight at 37 °C, 5 % CO2. Cells were 
treated with 250 piM diltiazem in the presence (orange line) or absence (green line) of 50 
ng/ml TNF for 6 hr. Cells were then trypsinized. DCF (10 ^iM) was added and 
measurement was made with a FCM at the time indicated. The black and the purple lines 
represent the control and the TNF (50 ng/ml)-treated group, respectively. It was found 
that cells incubation with diltiazem reduced the release ofH2O2 in treatment with TNF. 
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that both ruthenium red and diltiazem may impair the formation of ROS during the TNF 
challenge because of theirs inhibitory effect on the mitochondrial Ca^^ cycling. 
In conclusion, TNF-induced cell death was inhibited by Ca!+ chelator such as 
BAPTA/AM and it implied that Ca?+ plays an important role in TNF-mediated 
cytotoxicity. Moreover，BAPTA/AM was capable of reducing the TNF-mediated H2O2 
release. This suggested that Ca^^ may be one of the mediators for the release of ROS. 
However, the site of the release of Ca^^ is unknown. Jn the experiments with the use of 
mthenium red and diltiazem, the source of Ca!+ for the TNF-effect was found to be 
mitochondria although we could not eUminate the contribution from ER. The ability of 
BAPTA/AM, ruthenium red and diltiazem in the reduction of TNF-mediated ROS release 
further suggest that [Ca^ ]^m fluxes, probably the [Ca^ ]^m cycling, may be responsible for 
the formation ofROS. 
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3.6 Effect of Tumor Necrosis Factor-Alpha on pH 
3.6.1 Introduction 
It was found that intracellular acidification may be involved in apoptosis (Barry 
and Eastman, 1992). Under the conditions where endonuclease activation occurred in HL-
60 ceUs, Barry and Eastman observed a decrease in cytosoHc pH on the order of0 .2 - 0.3 
pH units, that may lead to apoptosis. For monitoring pH inside L929 cells，the 
fluorescence indicator SNARF-l/AM was applied. An increase in the fluorescence 
intensity indicates that there is an increase in pH. 
3.6.2 Effect o f T N F on pH 
Figure 3.67 shows the confocal images (from CLSM, Meridian) that addition of 
Na+-HEPES buffer or 50 ngAnl TNF did not cause a spontaneous change in pH whereas 
application of 50 mM NH4Cl induced an increase in the fluorescence intensity. NH4Cl 
increased intraceUular pH inside the cells, therefore, it was used for the positive control. 
Figure 3.68 summaries the results form Figure 3.67. 
In conclusion, addition of TNF did not change the intracellular pH in L929 cells 
immediately after the addition of TNF. However, the long-term effect of TNF on 
intracellular pH remains to be investigated. 
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Figure 3.67 
The confocal images show that addition of Na+-HEPES and TNF did not change 
the pH in L929 ceUs. L929 cells (2 x lOVml) were seeded on cover glass and incubated at 
37 °C and 5 % CO^ for 3 days. Cells were mounted on a home-made holder and washed 
twiceby Na+-HEPES buffer. Cells were loaded with 10 ^iM SNARF-l/AM for 1 hr and 
then washed twice by Na^-HEPES buffer. Confocal scanning was made with a 5-second-
interval. Na+-HEPES buffer and 50 ng/ml TNF were added at the 150出 and 425^' sec, respectively. There was no ch ge in the fluorescenc  intensity. Addition of 50 mM NH4Clduced a significant increase in the fluoresc n  and it indicate  the incre se in the pHide L929 cells (n = 2). 
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Figure 3.68 
Na+-HEPES buffer and TNF did not change the pH in L929 ceUs. This graph 
summaries the results of the confocal images ofcell number 1 and 2 from figure 3.67. Na+-
HEPES buffer, TNF (50 ng/ml) and NH4Cl (50 mM) were introduced to the cells at the 
1功，2"d and 3'^  hairline, respectively. 
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3.7 Effect of Tumor Necrosis Factor-Alpha on Mitochondrial Membrane 
Potential 
3.7.1 Introduction 
The positively charged rhodamine analogue rhodamine 123 accumulates 
specifically in the mitochondria of living cells. The high electronegativity of the intact 
mitochondrial membrane may be responsible for the specific dye binding (Johnson et al., 
1980). The mitochondrial electron transport chain develops and maintains a potential 
across the inner mitochondrial membrane (Av|/m) of the order of -150 to -200 mV by 
expulsion of protons from the matrix. The intensity of mitochondrial staining may 
correlate with the activity of the oxidoreductive complexes responsible for the 
maintenance of the electronegativity of the mitochondrial membrane, and thus the 
rhodamine 123 may be a direct marker of the energy-supplying metabolic processes. 
Moreover, the balance of Ca^^ between the cytosol and the mitochondrial matrix ([Ca^ ]^m 
cycling) is determined by the electrochemical potential for Ca�+ across the inner 
mitochondrial membrane, and predominantly by A\|/m. Blockade of electron transport by 
mitochondrial inhibitors such as rotenone increased rhodamine 123 fluorescence ^Duchen 
and Biscoe, 1992), while fluorescence can be reduced by uncouplers such as DNP ^maus 
etal., 1986). 
3.7.2 Effect of TNF and Some Drugs on Mitochondrial Membrane Potential 
Figure 3.69 shows that addition of TNF (50 ng/ml) for 3，6 or 10 hr did not 
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Figure 3.69 
Addition of TNF for 3，6 or 10 hr did not cause any change in rhodamine 123 
intensity. L929 cells (10Vml) were seeded in a 6-well plate and were incubated overnight 
at 37 X , 5 % CO2. Cells were treated with p-RPMI (black line)，50 ng/ml TNF (purple 
line) for (a) 3 hr, (b) 6 hr and (c) 10 hr. Moreover，cells were treated with (d) 30 [iM DNP 
(green line) and (e) 50 pM rotenone (orange line). Cells were then trypsinized. After 
washing, rhodamine 123 (final concentration = 2 ^iM) was added and incubated at 37 °C 
for 15 min. Measurement was made by FCM. 
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cause any change in the Av|v. AppUcation ofDNP (30 i^M) induced a smaU decrease in the 
fluorescence intensity of rhodamine 123 since it is one of the uncouplers that may 
depolarize the Av|/m. The depolarization of A /^m reduced the binding of positively charged 
rhodamine 123. In contrast, addition of rotenone (50 pM) induced a drastic increase in the 
fluorescence intensity of rhodamine 123. It impUes that rotenone hyperpolarize the A^m. 
Table 3.4 shows the data from FCM and indicated that addition of 50 ng/ml TNF for 3, 6 
or 10 hr did not induce a significant change in the mitochondrial membrane potential. As 
expected, there was a reduction in the fluorescence intensity in the treatment of ceUs with 
DNP or ruthenium red. There was no change in the rhodamine 123 intensity in the 
treatment of TNF plus DNP or ruthenium red. However, it is interesting that addition of 
TNF reduced the rhodamine 123 intensity with treatment of rotenone and antimycin A in 
the 3 and 6 hr incubation. The mechanism of the reduction of rhodamine 123 fluorescence 
intensity in the treatment ofTNF plus rotenone or antimycin A is stiU unknown. 
In conclusion, TNF did not change the Av|/m but reduced the hyperpolarization of 
Avj/m in the treatment of ceUs with rotenone and antimycin A. 
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Table 3.4 
The effect ofTNF and other drugs on A /^m. 
Treatment Incubation time Rhodamine 123 * % of control 
Oyj intensity (arbitrary unit) ( ^ 
control 3 148.36 / 
50ngAnlTNP 3 160.71 — 108 
50 i^M rotenone 3 600.81 “ 404 
50 [ M antimycin A 3 449.73 303 
30MMDNP 3 128.43 “ 86 
25 [iM ruthenium red 3 — 139.53 — 94 
50 ngAnl TNF 3 473.20 JT8 
+ 50 fjM rotenone 
50 ng/ml TNF 3 224.23 YTl 
+ 50 |iM antimycin A 
50 ng/ml TNF 3 129.31 ^9 
+ 30 |iM DNP 
50 ngAnl TNF 3 140.25 ^ 
+ 25 |iM ruthenium red 
control 6 127.16 / 
— 5 0 ng/ml TNF 6 125.58 “ 98 
50 |iM rotenone — 6 415.23 326 
50 i^M antimycin A — 6 234.11 184 
30pMDNP 6 112.36 88 
2 5 _ r u t h e n i u m r e d 一 6 一 10164 80 — 
50 ng/ml TNF 6 316.41 ^ 
+ 50 |iM rotenone 
50 ng/ml TNF 6 156.25 m 
+ 50 i^M antimycin A 
50 ng/ml TNF 6 110.74 ^ 
+ 30 [ M DNP 
50 ng/ml TNF 6 99.91 ^ 
+ 25 i^M ruthenium red 
control 10 93.53 / 
— 5 0 ng/ml TNF 10 89.65 96 — 
% of control was obtained according to the following formula: 
* % ofcontrol (%) 
=[rhodamine 123 (TNF treatment)] + [rhodamine (control)] x 100 % 
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3.8 Comparison of Effects of Tumor Necrosis Factor-Alpha on 
Susceptible Cell Line, L929 and Resistant Cell Lines，rL929, rL929-
11E and rL929-4F 
3.8.1 Introduction 
The resistant cell lines, rL929, rL929-llE and rL929-4F were developed by Prof. 
K. P. Fung and H. K. Cheng (Department ofBiochemistry, CUHK). The resistant cell line 
was defined by their inert response to TNF cytotoxicity and was developed by Kwan as 
mentioned in section 2.1.4.2 (Kwan，1995). Kwan concluded that there was no distinctive 
morphological change in TNF-resistant cells (rL929, rL929-llE and rL929-4F) as 
compared to the parental cells (Kwan, 1995). Moreover，several conclusions are obtained 
from his study: (1) There is no difference in growth rate between L929 and rL929 cells; 
(2) Expression ofTNFRl in rL929 cells is the same as L929 (the expression ofTNFRl in 
rL929-llE and rL929-4F was not identified); (3) the resistance to TNF in rL929 ceUs is 
not due to a higher capacity of scavenging of TNF-generated free radicals. The actual 
mechanism is still unknown and may be due to a lack of the ability of rL929 cells to 
generate free radicals. 
In light of this, the differences between TNF-sensitive and resistant ceU Unes and 
the possible mechanisms account for the resistance to TNF were examined in this project. 
The effect ofTNF on the (1) cytotoxicity，(2) release ofROS, (3) release ofCa^\ and (4) 
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cell cycle were investigated and the responses to TNF in both sensitive and resistant L929 
cells were compared. 
3.8.2 Effect ofTNF on the Cytotoxicity ofResistant Cell Lines 
Figure 3.70 shows that TNF did not induce a significant cell death in rL929 cells as 
compared with the parental Une, L929 cells. Moreover, rL929-llE OFigure 3.71) and 
rL929-4F ^*igure 3.72) did not show a distinct cytotoxicity after TNF treatment. 
3.8.3 Effect ofTNF on the Release ofROS in Resistant Cell Lines 
Figure 3.73 shows that addition of 50 ng/ml TNP for 6 hr caused an increase in the 
H2O2 release in the TNP-sensitive L929 ceU line whereas there was no increase in the rate 
of production of H2O2 in resistant ceU lines. Figure 3.74 and Figure 3.75 show the dot 
plots of TNF-treated sensitive and resistant cells. It is obvious that treatment of resistant 
cells with TNF did not show any difference from the one without TNF treatment. At the 
same time, TNF increased the production of H2O2 and ceU death in sensitive ceU lines 
(Figure 3.74b). Table 3.5 shows the population of cell of TNF-sensitive and resistant cell 
lines in R1, R2 and R3 as described previously (Figure 2.4) after the TNF treatment. As 
shown in the Table 3.5, an increase in the cell number in the R2 region in the group with 
6-hour-incubation of TNF was observed. This indicates that dead ceUs were formed after 
TNF treatment in the parental cell line, L929. bi contrast, only a few number of ceUs in 
region R2 was observed in the resistant ceU lines, rL929 (Figure 3.74d), rL929-llE 
f igure 3.75b) and rL929-4F (Figure 3.75d) (Table 3.5) after 6-hour TNF treatment. 
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Figure 3.70 
TNF did not induce a significant ceU death in rL929. L929 and rL929 ceUs were 
seeded at 3 x 10Vwell in complete RPMI 1640 medium and incubated for 20 hr at 37 °C, 5 
% CO2. After incubation, spent medium was discarded and washed twice by serum-free 
medium. 100 p,l of serum-free medium with various concentrations ofTNF was added to 
each well and incubated for 20 hr at 37 X, 5 % CO2. MTT assay was appUed (n = 7). 
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Figure 3.71 
TNF did not induce a significant ceU death in rL929-llE. L929 and rL929-llE ceUs 
were seeded at 3 x 10Vwell in complete RPMI 1640 medium and incubated for 20 hr at 37 
°C, 5 % CO2. After incubation, spent medium was discarded and washed twice by serum-
free medium. 100 jj,l of serum-free medium with various concentrations ofTNF was added 
to each well and incubated for 20 hr at 37 °C, 5 % CO2. MTT assay was appHed (n = 7). 
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Figure 3.72 
TNF did not induce a significant cell death in rL929-4F. L929 and rL929-4F ceUs 
were seeded at 3 x 10Vwell in complete RPMI 1640 medium and incubated for 20 hr at 37 
°C, 5 % CO2. After incubation, spent medium was discarded and washed twice by serum-
free medium. 100 d^ of serum-free medium with various concentrations ofTNF was added 
to each well and incubated for 20 hr at 37�C，5 % CO2. MTT assay was applied (n = 7). 
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Figure 3.73 
Addition of TNF for 6 hr did not increase the release of H2O2 from resistant cell 
lines, rL929, rL929-llE and rL929-4F cells. (a) Application of 50 ng/ml TNF (purple 
line) for 6 hr in L929 cells increased the release ofH2O2. However, addition of 50 ngAnl 
TNF for 6 hr in (b) rL929, (c) rL929-llE and (d) rL929-4F did not increase the 
production of H2O2 as compared to control group (black line). The time on the left 
indicates the incubation period of cells with DCF. 
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Figure 3.74 
Incubation of L929 ceIls with TNF for 6 hr produced the release of H2O2 and cell 
death in L929 cells but not in rL929 cells, (a) It represents the L929 control group, (b) 
50 ng/ml TNF was added with L929 cells. The lower population moved faster to the right 
than that of the L929 control group (column 1) (c) It represents the rL929 control group, 
(d) 50 ng/ml TNF was added with rL929 ceUs. There was no increase in the rate ofright-
shifting of lower population in rL929 cells (column 4) as compared to rL929 control 
group (column 3). Little intermediate population was obtained in the rL929 control and 
TNF-treated rL929 group. 
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Figure 3.75 
Incubation of L929 cells with TNF for 6 hr did not produce the release of H2O2 and 
cell death in rL929-llE and rL929-4F cells, (a) It represents the rL929-llE control 
group, (b) 50 ng/ml TNF was added with rL929-llE ceUs. (c) It represents the rL9294F 
control group, (d) 50 ng/ml TNF was added with rL929-4F cells. There was no increase in 
the rate of right-shifting of lower population in rL929-llE and rL929-4F ceUs (column 2 
and column 4, respectively) as compared to rL929-llE and rL929-4F control group, 
respectively (column 1 and column 3). Little intermediate population was obtained in the 
all four columns. 
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Table 3.5 
Addition ofTNF induced cell death in L929 whereas there was no effect on resistant 
ceil line. 
Treatment Number of Number of Number of * % ofCeIl death 
cells in R1 ceUs in R2 cells in R3 r ^ 
L929 control 9 ^ ^ ^ ^ 
L 9 ^ 8 ^ ^ 443 I53I 
+ 50 ng/ml TNF 
rL929 control 9 ^ m 303 4.44 
rL929 95ls i l s ^ 4 M 
+ 50 ngAnl TNF 
rL929-llE control 9639 88 273 一 3.61 
rL929-llE 9 ^ ^ 3 ^ 456 
+ 50 ng/ml TNP 
rL929-4F control 9604 104 一 292 3.96 
rL929-4F ^ % W l ^ B 
+ 50 ng/ml TNF 
Results were from the 45^-minute-plot of each treatment in Figure 3.74 - 3.75. The 
number of cells in R1, R2 and R3 were recorded and % of cell death was obtained 
according to the foUowing formula: 
* % ofcell death (%) 
=pS[umber ofcells in (R2 + R3) + Number of ceUs in (R1 + R2 + R3)] x 100 % 
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From the assay in measuring the release of 02*", it was found that challenge of the 
L929, rL929, rL929-llE and rL929-4F ceUs for 6 hr with TNF (50 ng/ml) did not 
increase the rate of 02*" release (Figure 3.76). However, addition of 2 pig/ml AMD 
produced more 02*" release in rL929-llE and rL929-4F ceUs (Figure 3.77c and Figure 
3.77d). This might be due to the inhibition of SOD production by AMD and therefore, 
TNF could potentiate the release of Oz*". In contrast, addition of AMD did not change the 
rate of the release of 02*" in the TNF resistant Hne, rL929 cells ^"igure 3.77b). In L929 
cells, addition ofTNF with AMD induced cell death OFigure 3.78a) and therefore, there 
was no shift in the peak (Figure 3.77a). These results suggest that rL929 ceUs were the 
most resistant to TNF action even in the presence ofTNF plus AMD. Figure 3.78 shows 
the PI intensity in L929, rL929, rL929-llE and rL929-4F ceUs after the treatment with 
TNF plus AMD that eUcited an extent of cell death in L929, rL929-l lE and rL929-4F but 
not in rL929 cells. The release of 02*" in L929, rL929-llE and rL929-4F might act on 
plasma membrane and change the membrane permeabiHty. Therefore, PI diffused into the 
ceUs and the PI intensity was high in L929, rL929-llE and rL929-4F ceUs ^^igure 3.78). 
3.8.4 Effect ofTNF on the Release of Calcium in Resistant CeU Lines 
Figure 3.79 shows that addition of 50 ng/ml TNF for 10 hr produced a drastic 
increase in [Ca^^]i level in L929 ceUs while it only caused a smaU change in rL929 ceUs. It 
was found that the population of L929 cells shifted from R1 to R2 whereas no distinct 
migration of rL929 ceUs from R1 to R2. Figure 3.80 and Figure 3.81 indicate that 
appUcation of 50 ng/ml TNF for 10 hr did not produced an increase in [Ca^^]i level in 
rL929-l lE cells and it caused a Uttle increase in rL929-4F cells. Moreover，there was stiU 
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Figure 3.76 
Addition of TNF for 6 hr did not produce the release of Oz*" from L929, rL929, 
rL929-llE and rL929-4F cells. Application of 50 ngAnl TNF (purple line) for 6 hr in (a) 
L929 cells, (b) rL929, (c) rL929-l lE and (d) rL929-4F did not increase the production of 02*" as compared to control (black line). The time on the left indicates the incubation period ofcells with DCF. 
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Figure 3.77 
Addition ofTNF plus AMD for 6 hr produced the release of Oz*" from L929, rL929-
11E and rL929-4F but not in rL929 cells, (a) Application of 50 ng/ml TNF plus AMD 
(purple line) for 6 hr in L929 cells increased the production of 02*" as compared to the 
control group (AMD only, black line), (b) rL929 cells treated with TNF plus AMD did not 
produce an increase in the production of 02*". Addition of TNF plus AMD with (c) 
rL929-llE and (d) rL929-4F increased the production of 02*". The time on the left 
indicates the incubation period of cells with DCF. 
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Figure 3.78 
Addition of TNF plus AMD for 6 hr induced cell death in L929, rL929-llE and 
rL929-4F but not in rL929 cells. The results show the PI intensity in (a) L929, (b) 
rL929, (c) rL929-llE and (d) rL929-4F. It was found that addition ofTNF plus AMD 
(purple line) induced cell death in L929, rL929-llE and rL929-4F cells as compared to 
their control group (AMD only, black line) but not in rL929 ceUs. The time on the left 
indicates the incubation period of cells with DCF. 
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Figure 3.79 
Addition of TNF for 10 hr did not produce a significant change in [Ca^^i level in 
rL929. (a) It shows the control group of L929 cells, (b) L929 cells were incubated with 
50 ng/ml TNF for 10 hr. It shows that there was a drastic change in [Ca^^]i level as 
compared to control group, (c) It shows the control of rL929 ceUs. (d) rL929 cells were 
treated with 50 ng/ml TNF for 10 hr did not produce a drastic change in [Ca^^]i level, (e) 
and (f) show that addition of 40 ^ig/ml ionomycin (10 min before measurement) induce the 
release of Ca:+ in control and TNF-treated rL929 ceUs. 
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Figure 3.80 
Addition of TNF for 10 hr did not cause a significant change in [ C a = � l e v e l in 
rL929-llE. (a) It shows the control group of rL929-llE cells. ¢ ) rL929-llE ceUs were 
incubated with 50 ng/ml TNF for 10 hr. It shows that there was no change in [Ca^^]i level 
as compared to control group, (c) and (d) show that addition of 40 i^gAnl ionomycin (10 
min before measurement) induce the release of Ca^^ in control and TNF-treated rL929-
llEcells. 
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Figure 3.81 
Addition of TNF for 10 hr did not cause a significant change in [Ca^^i level in 
rL929-4F. (a) It shows the control group of rL929-4F ceUs. (b) rL929-4F cells were 
incubated with 50 ng/ml TNF for 10 hr. It shows that there a smaU change in [Ca^^i level 
as compared to control group, (c) and (d) show that addition of 40 pig/ml ionomycin (10 
min before measurement) induce the release of Ca^ ^ in the control and TNF-treated 
rL929-4F ceUs. 
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no distinct shifting ofpopulation ofrL929-l lE or rL929-4F ceUs from R1 to R2. Addition 
of 40 ^ig/ml ionomycin was used to confirm that there was no impairment in the Ca^^ 
system of the cells being investigated. 
3.8.5 Effect ofTNF on Cell Cycle in Resistant Cell Lines 
Since there was no increase in the release of ROS and Ca^ ,^ it was expected that 
there was no apoptosis in TNF-treated resistant cells and it was examined by cell cycle 
analysis. Only the ceU cycle of resistant ceU Une rL929 was shown. Figure 3.82 shows that 
addition of 50 ng/ml TNF with rL929 ceUs for 10 hr did not induce a smaU peak before the 
G0/G1 phase. This result impUed that there was no apoptotic cell after the TNF treatment. 
Actually, by the observation, there was no non-adherent cells after the 10 hr incubation 
with TNF. Furthermore, in the presence of serum, it induced more accumulation ofrL929 
cells in the S phase as compared with the serum-free condition, that was similar to the 
results in section 3.2.2. 
Li conclusion, the differences between TNF-sensitive ceU Une L929 and TNF-
resistant cell lines, rL929, rL929-llE and rL929-4F were (1) TNF increased cytotoxicity 
in sensitive ceU line but not in resistant ceU Unes; (2) TNF increased the release of ROS 
and Ca2+ in sensitive ceU Une whereas there was no response in resistant cell Unes; (3) TNF 
plus AMD produced more 02«" release and ceU death in L929, rL929-llE and rL929-4F 
but not in rL929 cells; (4) TNF induced apoptosis in L929 ceUs but not in rL929 by cell 
cycle analysis. 
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Figure 3.82 
DNA histograms of TNF-treated rL929 cells in the presence and absence of serum. 
(a) rL929 cells were treated with complete RPML (b) rL929 cells were treated with 
complete RPMI plus 50 ng/ml TNF for 10 hr. (c) t i addition, rL929 ceUs were treated 
with serum-free RPMI. (d) rL929 cells were treated with serum-free RPMI plus 50 ng/ml 
TNP for 10 hr. 
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Several biochemical pathways have been suggested for the ceU death.These include 
the activation of proteases and phospholipases (Orrenius et al., 1989)，the generation of 
ROS (Tsujimoto et al., 1986), and/or the degradation of DNA (Jones et al., 1989). 
However, the exact mechanism ofTNF cytotoxicity is still largely unknown. 
4.1 Tumor Necrosis Factor Induced Apoptosis in L929 Cells 
TNF can induce both apopotic and necrotic forms of cell lysis (Laster et al., 1988). 
Our study showed that rMuTNF-a induced DNA fragmentation in murine fibroblast cell 
line L929 (Figure 3.4). It was found that addition of TNF (50 ng/ml) for 3 hr did not 
induce cell death whereas in the 6- or 10-hr incubation, some of them become DNA 
fragmented cells. These results strongly indicate that TNF caused apoptosis in L929 cells, 
although necrosis was found in the same cell line after incubation with TNF in other 
laboratories (Vercammen et al., 1997; Grooteen et al., 1993). Our conclusion that TNF 
elicits apoptosis in L929 cells was further confirmed by the analysis of cell cycle (Figure 
3.6). It was found that in the 10-hr TNF treatment, a small peak occurred before the 
G0/G1 phase (Figure 3.6e). This hypodiploid peak was the cells with fragmented DNA. 
Moreover, these apoptotic activities arose as a rather late event after the addition of TNF 
to L929 ceUs further indicate the requirement of time to initiate the apoptotic pathway. 
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After TNF treatment, two types of cells were found, the adherent cells attached to 
the bottom of plate, and the non-adherent cells. Our results show that the non-adherent 
cells were mainly the DNA fragmented cells whereas the adherent ceUs were viable cells 
even they were treated with TNF for 10 hr. These observations can be found in the 
agarose gel electrophoresis (Figure 3.4) and the flow cytometric assay ^"igure 3.7). At 
present, we do not know the role of matrix adherence on the TNF-mediated cytotoxicity. 
However, recent reports indicate that surface adherence is an important factor to keep ceU 
survival and the disruption of extracellular matrix results in apoptosis (Chen et al,, 1998). 
4.2 Tumor Necrosis Factor Increased the Release ofReactive Oxygen 
Species in L929 Cells 
Our study showed that treatment ofL929 ceUs with TNF produced an increase in 
the level of intracellular ROS ROS is produced continuously inside the ceUs in respiring 
cells. However, about 1 - 3 % of electrons leak out from the inner mitochondrial 
membrane and react with molecular oxygen directly to form ROS O^igure 1.5). Jn the 
experiment of flow cytometry, TNF increased the release of H2O2 and was in a time 
dependent mamier (Figure 3.14). For a short time course such as 15-min or 3-hr 
incubation of L929 ceUs with TNF (50 ng/ml), the rate of H2O2 production did not 
increase as compared to control group in the flow cytometry study f igure 3.12). 
However, the incubation of L929 ceUs with TNF for a longer time (e.g. 6 or 10 hr) 
produced a significant increase in the rate of H2O2 release ^"igure 3.13). This indicates 
that TNF produced a slow rise in the H2O2 level. 
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On the other hand, addition ofTNF (50 ng/ml) for 15 min, 3 or 6 hr did not cause 
an increase in the rate of 02*" release (Figure 3.15a - c). For the 10-hr incubation, there 
was only a small increase in the rate of Oz*" release (Figure 3.15d). Addition of metaboUc 
inhibitor, AMD, with TNF for 15 min did not cause more Oz*" production in L929 cells 
(Figure 3 .16). However, incubation of TNF with AMD for 3 or 6 hr produced more 
intracellular Oz*" production fFigure 3.17). 
It is interesting to note in the experiments of CLSM that incubation of ceUs with 
TNF (50 ng/ml) for 15 min could increase the rate of intracellular H2O2 production as 
compared to control (Figure 3.9) whereas in that ofFCM, no such increase was observed 
at 15 min. However, the production ofH2O2 was found when ceUs were incubated with 
TNF for 6 and 10 hr. These discrepancies in responses may be due to the difference in the 
number of cells in the assay. Therefore, application of the same concentration ofTNF may 
exert a greater effect on the cells in CLSM. In fact, when ceUs were treated with a high 
dose ofTNF (500 ng/ml) for 3 hr, Ca?+ rise was observed ^"igure 3.43c) and no such 
effect was found when ceUs were challenged with a lower dose ofTNF (50 ng/ml) (Figure 
3.43b). Moreover, similar results were obtained in the case of detection of 62*". bi the 
assay from CLSM, incubation of TNF for 15 min could increase the rate of 02®" 
production but not in the FCM assay. 
As indicated in Figure 1.5，02*" is converted into H2O2 by MnSOD inside 
mitochondria. It was shown previously that TNF induced the production of MnSOD 
mRNA in all cell Hnes (Wong and Goeddel, 1988). Wong and Goeddel (1988) further 
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indicated that one hr of TNF treatment was sufficient to induce substantial level of 
transcript ofMnSOD that remained high for 24 hr. This explains why addition ofTNF did 
not increase the release of 02*~ in the 3- or 6- hr TNF treatment in the FCM assay. In this 
connection, AMD, a transcriptase blocker (Ostrove and Gifford, 1979) was found to block 
the expression of MnSOD mRNA (Wong and Goeddel, 1988). Therefore, addition of 
TNF with AMD should produce more 02*" release. Li fact, our results have indicated this 
point and our results thus illustrated that release of ROS is one of the mechanisms of 
TNF-mediated cytotoxicity. 
The effect of antioxidants on TNF-mediated cytotoxicity was investigated in this 
study. It was found that antioxidants such as cataIase, MnSOD, NAc and 4-OH-TEMPO 
reduced TNF-mediated cytotoxicity OFigure 3.19 - Figure 3.22). Both catalase and 
MnSOD are not cell-permeable QVCtchell et al., 1990). The reduction of cytotoxicity is 
probably due to an extracellular removal of H2O2 and 62*" by cataiase and MnSOD, 
respectively, from the culture medium that promotes the efflux ofH2O2 and 02*~ from the 
cellular cytoplasm to the external environment. When NAc was added to TNF-treated 
cells, a marked reduction in cytotoxicity was observed. Since the actions of NAc involve 
the replenishment of GSH stores, scavenging ROS and prevention of mitochondrial 
membrane depolarization (Cossarizza et al., 1995), it is very possible that NAc removes 
the ROS thereby reducing the TNF-mediated cytotoxicity. Antioxidant 4-OH-TEMPO 
also produced a lower TNF-mediated cytotoxicity. A likely sequence of reactions (1 - 4) 
shown below explains the possible protective effect of4-OH-TEMPO on the TNF elicited 
ROS (Mitchelle^a/., 1991). 
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H2O2 + Fe2+ ~> OH* + OH"+Fe^^ (1) 
Fe3+ + 02*" — Fe2+ + O2 (2) 
\ «^ \ 
02.- + z N — O H 0 2 + ^ N - O H (3) 
\ ^ \ 
^ N - O H + 02*~ ^ H2O2 + ^ N - 0 * (4) 
The first two reactions are the Haber-Weiss reaction for the iron-catalyzed production of 
OH«. 02*" acts to recycle the iron from Fe�+ to Fe^^ and it is therefore critical to the 
production of the OH* In reactions (3) and (4), 62*" is converted to H2O2 and O2 by the 
catalytic reaction with 4-OH-TEMPO. 
The first oxygen reduction product generated in mitochondria under both 
physiological and pathological conditions appears to be the 02*", which can subsequently 
be converted into H2O2 (Figure 1.5). Dismutation of 02*" and H2O2 can result in the 
production of the OH*. Conversion of 62*" and H2O2 into OH* is catalyzed by transition 
metals such as iron ions in the Haber-Weiss reaction fDawson and Dawson, 1996). 
Oxygen radicals escaping detoxifying enzymes are capable of inducing various damage. 
Attack by radicals can result in lipid peroxidation and DNA degradation. Results from our 
study indicate that ROS induced membrane lesion and therefore, the influx of PI into the 
cells was observed (Figure 3.57). 
Inhibition of mitochondrial electron transport at specific sites can differentiaUy 
interfere with TNF-mediated cytotoxicity. Inhibition of the electron transport at complex I 
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with rotenone or at complex II with TTFA significantly protected the cells against TNF 
(Figure 3.24 and Figure 3.25). On the other hand, inhibition of the electron transport at 
the site behind the ubiquinone region with antimycin A potentiated TNF cytotoxicity 
(Figure 3.26). These results suggest that oxidative events generated in mitochondria are 
crucial in TNF-mediated cytotoxicity. The enhancement of TNF cytotoxicity with 
antimycin A and the inhibition with rotenone and TTFA, strongly indicate that TNF 
activates radical production in mitochondria at the ubiquinone site. However, it remains 
unclear from our results in what way TNF affects the mitochondrial electron transport. 
Similar results were obtained from Schuke-Osthoff et al. (Schuke-Osthofif et aL, 1992). 
However, 0'Donnell et al. (1995) demonstrated in rMuTNF-treated L929 cells that 
mitochondrial-derived radicals or respiratory chain did not involve in the lytic pathway. 
They even show that significant ROS generation was not observed in TNF-treated L929 
ceUs using other assays such as DCF assay for H2O2 in a 96-weU plate measured by 
Cytofluor 2300 plate reader and cytochrome c reduction assay. On the other hand, they 
suggest a central role of Upoxygenase in the TNF-mediated ceU lysis. The differences 
between our data and theirs were that in their DCF assay, they treated the cells with 250 
pg/ml TNF and incubated for about 140 min only. The low concentration of TNF and 
short incubation time may not increase the release of H2O2 in L929 cells. On the other 
hand, they did not show the result of cytochrome c reduction assay and therefore, we 
cannot compare our results with theirs. 
Furthermore, addition of the protonophorous uncoupler DNP aUows electron 
transport in mitochondria to occur but prevents the phosphorylation of ADP to ATP and 
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therefore, the supply of energy was Umited. Depletion of intracellular ATP blocked 
apoptosis since apoptosis is ATP-dependent (review: Nicotera and Leist, 1997). 
Therefore, addition of uncoupler DNP may block apoptosis and reduced TNF-mediated 
cytotoxicity O i^gure 3.31). However, Schulze-OsthofF et al. (1992) found that DNP did 
not exert effect on TNF-eUcited cytotoxicity. Moreover, they demonstrated that 
oUgomycin, which directly blocks the ATP synthesis by inhibiting the Fi-ATPase subunit, 
did not influence the activity ofTNF on L929 ceUs. These imply that ATP did not involve 
in the TNF-mediated cell death. 
4.3 Tumor Necrosis Factor Increased the Release of Calcium in L929 
Cells 
In this study, we also found that TNF caused a slow rise in [Ca^ ]^i. In the 
experiment of FCM, it was found that application of TNF (50 ngAnl) for 3 hr did not 
change [Ca^ ]^i in L929 ceUs ^"igure 3.40). Contrary to these observations, data from 
CLSM shows a faster (30 min after TNF application) release of [Ca^ ]^i ^"igure 3.38). 
Again, the number of cells in the assay may account for this discrepancy. In fact, 
application ofhigher dose ofTNF (500 ng/ml) for 3 hr in the assay from FCM did produce 
a smaU increase in the level of [Ca^ ]^i ^Figure 3.43). However, in the 6- or 10-hr 
incubation of L929 cells with TNF, a significant increase in the [Ca^^i was visuaUzed 
(Figure 3.41 and Figure 3.42). Therefore, TNP caused a slow release of Ca^ .^ Similar 
conclusion was obtained in BT-20 ceUs (BeUomo et al., 1992) and gUal ceUs (KoUer et al., 
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1996) after TNF treatment. In contrast，TNF causes a rapid release of [Ca^ ]^i in human 
neutrophils (Schumann et al.’ 1993). 
It seems that in L929 cells, the release of Ca^ + is not due to the IP3 system. Stored 
Ca2+ within intraceUular pools is released to the cytotsol when rP3 binds to its receptor. 
When embedded in a Upid membrane, the JP3 receptor responds Uke a conventional 
channel, displaying an increase in open frequency in response to IP3. The mean open time 
was less than 10 msec (review: Berridge, 1993). Since TNF caused a slow rise in Ca^ ,^ we 
concluded that the release of Ca?+ in TNF-treated L929 ceUs was not due to the transient 
activation 0fn*3 system. 
Since Ca:+ cannot be generated or degraded, the level of Ca:+ is tightly regulated 
OFigure 1.6). However, the site of TNF-mediated Ca�+ release is stiU poorly understood. 
The data from the study with Ca^^-free buffer suggests that the source of Ca^ ^ released by 
TNF should be intracellular. Our results further indicate that the Ca^^ may come from 
mitochondria since addition of ruthenium red or diltiazem reduced the TNF-mediated Ca?+ 
release ffigure 3.61) and at the same time, cells were viable. As mitochondrial Ca^ -^
cyclings can be inhibited by ruthenium red and diltiazem, it is possible that ruthenium red 
prevents mitochondrial Ca!+ uptake by inhibiting mitochondrial Ca:+ uniporter (Chacon 
and Acosta, 1991; Faulk et al., 1995) and diltiazem prevents the release of Ca^ ^ from 
mitochondria by inhibiting Na+-dependent and H%dependent pathways (Rizzuto et al., 
1987). It impUes that prevention of Ca!+ cycling in mitochondria inhibited the rise of 
[Ca2+]i and therefore reduced TNF-mediated cytotoxicity (Figure 3.59 and Figure 3.60). 
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Another Une of evidence shows that addition of Ca^^-inducing agent such as 
thimerosal produced a higher TNF-mediated cell death ^"igure 3.45). Thimerosal has been 
shown to increase the cytosolic [Ca�+] (Michelangeli et al., 1995) by sensitizing H^ 
receptors. On the other hand, application of Ca^^-chelator BAPTA/AM reduced the TNF-
mediated cytotoxicity (Figure 3.46). 
These results suggest that an elevation of [Ca^ ]^i level, that may come from 
mitochondria or ER, may induce TNF-mediated cell death. It has long been demonstrated 
that sustained increase in the [Ca^ ]^i induces the activation of Ca^^-dependent proteases, 
phospholipases and endonucleases (review: Orrenius et al.’ 1989). All these enzymes 
induce ceU death. The major target for proteases are the cytoskeletal proteins such as a -
actinin and actin-binding protein. A stimulation of intracellular proteolysis and the 
appearance of plasma membrane blebs ON i^cotera et al., 1986) is one of the characteristics 
of apoptosis. PLA2 catalyzes the hydrolysis of membrane phospholipids that requires Ca?+ 
for activation，which could cause cell damage (Chien et al, 1979). Ca?+ activates 
endonucleases that cleaves cell chromatin into oUgonucleosomal fragments. Accumulation 
of [Ca2+] induced DNA fragmentation in rat liver nuclei (Jones et al, 1989). Since there 
were some DNA fragments observed in L929 cells 6 or 10 hr after the addition of TNF 
and the [Ca^ ]^i was very high at that time, it is very possible that Ca^^ played a role in the 
TNF-mediated cytotoxicity. With the use of BAPTA/AM, a Ca:+ chelator, the TNF-
meidated cytotoxicity was reaUy reduced. 
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Apart from the release of Ca^^ from intracellular store，Ca^^ may entry from the 
extraceUular environment. Ca^^ entry into cells can be regulated by a number of 
mechanisms, for example through channels operated by voltage or by receptors (review: 
Berridge, 1993). In L929 cells, TNF was able to open Ca^ ^ channels on the cell surface 
(Kong et al., 1997). Our results also indicate that in the absence of external Ca^ ,^ the 
release of intracellular Ca^ ^ still occurred in TNF-treated L929 ceUs. 
4.4 Calcium Induced Reactive Oxygen Species Release in TNF-Treated 
L929 Cells 
A sustained level of ROS and/or Ca^ ^ can induce ceU death. Our study indicates 
that TNF increased both ROS and Ca^^ release in L929 ceUs but their relationship is still 
unknown. It was found that H2O2 did not induce Ca:+ release ^"igure 3.50 and Figure 
3.51). On the other hand, in the assay from FCM, appUcation of Ca^^-chelator 
BAPTA/AM reduced the rate ofTNF-mediated H2O2 release fFigure 3.48). A reduction in 
cell death in the 10-hr incubation with TNF was also observed (Figure 3.57). Moreover, 
addition of diltiazem, that prevents the release of Ca^^ from mitochondria, reduced the rate 
ofH2O2 release in TNF-treated ceUs O^igure 3.66). t i the assay from CLSM, appUcation 
of ruthenium red reduced the rate of both H2O2 and 02*" release too ^Figure 3.62 and 
Figure 3.64). Therefore, TNF-mediated ROS production requires mitochondrial Ca^ + 
cyding because they are suppressed by the omission of Ca^ ^ in the presence of ruthenium 
red and diltiazem. These observations imply that TNF may cause the release of Ca^ ^ from 
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mitochondria firstly and then somehow induces the release ofROS. Our findings provide 
evidence for the correlation between the elevation of [Ca^ ]^i and the formation ofROS in 
response to TNF. Both elevation of[Ca^^]i and ROS have been shown to be messengers in 
the initiation of process such as apoptosis. Several findings indicate that disruption in Ca?+ 
homeostasis may be involved in the release ofROS (Goldman et a/.，1998，Chacon and 
Acosta, 1991; Malis and Bonventre, 1986). Chacon and Acosta (1991) suggested that in 
doxorubicin-treated myocardial cells, Ca^ ^ fluxes through the mitochondrial membrane 
may be linked to the formation of ROS which results in the permeabiUzation of the 
membrane ofa Ca^^-induced permeabilization which then aUows the release ofOz*" to the 
cytosolic side of the membrane. In contrast，Richter (1993) suggested that pro-oxidants 
induce Ca^ + release from mitochondria, which may be foUowed by Ca^ ^ cycling, coUapse 
of A^m, and ATP depletion. Under these conditions the ceUular Ca:+ homeostasis cannot 
be maintained, the cytosolic Ca^ ^ level rises, and cells go into apoptosis. Moreover, recent 
study found that TNF-mediated ROS release may relate to ceramide (Garcia-Ruiz et al., 
1997). The enzyme PC-PLC appears to be involved in the activation of acidic SMase 
through 1,2-DAG. This enzyme generates a functional distinct pool of ceramide, that acts 
on mitochondria, enhancing the production of ROS (review: Femandez-Checa et al., 
1997) and therefore, induces apoptosis ^Hartfield etal., 1997). 
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4.5 Tumor Necrosis Factor Did Not Change the pH and 
Mitochondrial Membrane Potential in TNF-Treated L929 Cells 
A decrease in cytosolic pH on the order of0.2 - 0.3 pH unit may lead to apoptosis 
by endonuclease activation (Barry and Eastman, 1992). In this study, it was found that 
TNF did not change the pH in L929 cells immediately after the addition of TNF to ceUs 
(figure 3.67). In addition, collapse of A^m induces Ca^ ^ release from mitochondria 
(review: Vercesi, 1993). However, our study shows that TNF did not change the A?min 
the 6- and 10-hr assay (Table 3.4). This implies that in L929 cells； TNF-mediated Ca^ ^ 
release from mitochondria is independent on the coUapse ofATm. However, recent finding 
indicates that L929 cells treated with TNP and AMD resulted in the loss of 80 % of 
rhodamine 123 fluorescence within 6 hr (Pastorino et aL, 1996). As mentioned before, 
AMD inhibits the expression ofMnSOD and therefore, increases the release of 62*", that 
may cause damage on mitochondrial membrane in TNF-treated ceUs. hi our experiments, 
L929 cells were treated with TNF alone. Therefore, the discrepancy between our result 
and theirs may be due to the additive effect of AMD on the TNF-induced change of zVFm. 
Another finding in human hepatoma-derived HuH-7 ceUs indicates that geranylgeranoic 
acid induced a rapid loss ofthe mitochondrial inner membrane potential that finaUy led to 
apoptosis (Shidoji et aL, 1997). It seems that dysfunction of A^^ is one of the most Ukely 
candidates to induce apoptosis. Moreover, using the UpophiHc dye JC-1 to determine 
A^^n，Polla et al. (1996) showed that TNF induces time-dependent alterations in A^m in 
L929 cells. 
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Figure 4.1 shows the proposed mechanism of TNF-mediated cytotoxicity in L929 
ceUs. At first, TNP binds to TNFR1 and stimulates the unknown messenger(s) in the 
cytosol. The unknown messenger(s) then stimulates the Ca^ ^ release from mitochondria, ln 
consequence, the level of [Ca^ ]^i increases. The increase in the [Ca^"]i level induces more 
ROS release from mitochondria and the site of action may be on the ubiquinone site 
(complex ni). It is still unknown how the cytoplasmic or mitochondrial Ca:+ acts on 
electron transport chain. The release of ROS can be prevented by the application of 
BAPTA/AM, ruthenium red, diltiazem, MnSOD, catalase, NAc or 4-OH-TEMPO. hi 
contrast, appUcaction of AMD enhances the release of 02*" by inhibiting the MnSOD 
expression. This causes an increase in the level of intraceUular ROS. A sustained increase 
in [Ca2+]i level induces the activation of proteases, phosphoUpases or endonucleases that 
leads to cell death. On the other hand, an increase in intraceUlular ROS leads to Upid 
peroxidation and base damage on DNA or RNA (Park et al., 1998; Wiseman and 
HaUiweU, 1996)，that results in ceU death also. This model is based on the findings from 
this project. Of course, TNF may utilize some other signal molecules to execute its 
cytotoxicity in L929 cells. In fact, the use of blockers, or inhibitors to block the Ca^ ^ 
andy'or ROS activity could not totally eUminate the killing effect of TNF. These suggest 
that some other biochemical pathways may involve in the TNF-mediated cytotoxicity. 
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Figure 4.1 
A proposed model for TNF-mediated cell death in L929 cells. Note that TNF 
increased the release ofboth Ca^^ and ROS that eventually lead to cell death. 
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4.6 Tumor Necrosis Factor Did Not Increase the Release of Reactive 
Oxygen Species or Calcium in Resistant Cell Lines 
TNP resistant ceU Unes such as rL929, rL929-llE and rL929-4F gave an inert 
response to TNF cytotoxicity. To produce resistant L929 cells, parental L929 cells were 
subcultured in the presence of TNF (20 units/ml). The cells were maintained in this 
medium for two weeks with a change of fresh medium every 3 days. Dead cells were 
washed away and living cells were aUowed to grow to confluence again. TNF 
concentration was then increased to 50, 100，200，1000，and 2000 units/ml in a stepwise 
manner. Finally, three cell clones, rL929, rL929-l lE and rL929-4F, were isolated. 
Someone may wonder that the absence of TNFR1 in resistant cell lines may make 
them resistant to TNF action. Although the expression of TNFR1 in rL929-llE and 
rL929-4F was not identified，Kwan found that the expression of TNFR1 in rL929 cells is 
the same as parental ceU line (Kwan, 1995). Therefore, the characteristic of resistant to 
TNF is not due to the absence ofTNFRl. Moreover, Kwan found that TNF resistant of 
rL929 ceUs is not due to a higher capacity of the ceU to scavenge ROS generated by TNF 
since there was no difference between the expression of rescue genes (such as glutathione 
reductase) in L929 and rL929 cells. The actual mechanism is currently unknown and may 
be due to a lack of the ability of rL929 cells to generate ROS. 
Cell cycle analysis indicates that there was no DNA fragmentation in the 10-hr 
TNF treatment in rL929 ceU (Figure 3 .82). Moreover, the 6 hr treatment ofaU resistant 
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cell Unes with TNF (50 ng/ml) did not cause a higher rate in the release of H2O2 as 
compared to the parental cell line ^"igure 3.73b - d). However, when rL929-llE and 
rL929-4F were treated with TNF with AMD, more 62*" release was observed whereas no 
response was found in rL929 cells (Figure 3.77b - d). These results suggest that rL929 
cells were the most resistant line to TNF action. Moreover, addition ofTNF for 10 hr did 
not cause the release of Ca^ ^ in rL929 and rL929-llE cells, whereas there was a smaU 
increase in rL929-4F cells ^"igure 3.80 and Figure 3.81). Since there was no sustained 
increase in [Ca^ ]^i and ROS in the resistant cell Unes, TNF did not produce cytotoxicity in 
these cell lines (Tigure 3.70 - Figure 3.72). According to our proposed model, TNT" should 
not increase the release ofROS without the rise of [Ca^ ]^i. To our surprise, TNF, together 
with AMD, produced more 02*~ release in rL929-llE and rL929-4F but not accompanied 
with a significant increase in [Ca^ ]^i. These imply that the rise of [Ca^ ]^i is not the only 
inducer to produce ROS. Therefore, the cytotoxic mechanism mediated by TNF in 
resistent L929 cells remains to be elucidated. 
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Chapter 5. Future Perspective 
This study found that TNF increased the release of Ca^^ and ROS from 
mitochondria thus induced cell death. However, the connection among TNF-TNFR1 
complex, mitochondria and [Ca^ ]^i is still unknown. Further information about their 
relationship should be investigated. Moreover, the mechanism of resistant ceU Unes on 
TNP is still unknown. To decode this unknown mechanism of resistant cell lines may be 
one of the best ways to understand why some tumor ceU Unes are resistant to TNF. 
Actually, to study the mechanisms ofTNF-mediated cell death is virtually unlimited and is 
under exploration by several groups of research. 
5.1 The Relationship Between Tumor Necrosis Factor and Cytochrome c 
Recently, it was found that the migration of cytochrome c from mitochondria to 
cytosol may involve in cell apoptosis (Yang et aL, 1997; Kluck et al., 1997). Cytochrome 
c is localized on the outer surface of the inner mitochondrial membrane (review: 
Skulachev, 1998). Cells undergoing apoptosis were found to have an elevation of 
cytochrome c in the cytosol and a corresponding decrease in the mitochondria. It is 
interesting to investigate whether there is a relationship among TNF, cytochrome c and 
apoptosis. By the application of the antibody technique, the localization of cytochrome c 
can be traced after the application ofTNF on sensitive cell line such as L929. 
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5.2 The Relationship Between Tumor Necrosis Factor and Mitochondrial 
DNA Damage 
The mitochondrial respiratory system is the major intraceUular source ofthe ROS. 
The mitochondrial DNA (mtDNA), while not protected by histones or DNA-binding 
proteins，is continually exposed to a high steady state level of ROS in the matrix of the 
mitochondria (Wei, 1998). The oxidative modification and mutation of mtDNA occur with 
great ease. The respiratory enzymes containing the defective mtDNA-encoded protein 
subunits exhibit impaired electron transport function and thereby increase the electron leak 
and ROS production, which in tum elevate the oxidative stress and oxidative damage to 
mitochondria. Therefore, the effect of TNF on mtDNA damage should be investigated, to 
see whether there is another mechanism on TNF-mediated ROS release from 
mitochondria. 
5.3 Clinical studies with Tumor Necrosis Factor 
The in vivo antitumor effects of TNF may be related to direct cytotoxicity, 
immunomodulatory effects or endothelial effects on tumor vasculature (Spriggs et al., 
1987). The clinical trials of rHuTNF are under way in Japan and the USA as early as 1992 
(Taguchi et aL, 1992; Spriggs and Yates，1992). rHuTNF is directly cytotoxic to some but 
not all human tumor cell lines (Old, 1985). This cytotoxicity is dose-dependent. Moreover, 
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TNF is much less toxic to normal ceUs, suggesting that this agent could have a high 
therapeutic index. 
Since there is about 79 % homology between rHuTNF and rMuTNF, application 
of rMuTNF is possible for clinical studies. At first, the effect of rMuTNF on human cell 
line such as human breast carcinoma MCF-7 should be investigated. It was found that 
MCF-7 is sensitive to rHuTNF (Sugarman et al., 1985) and therefore, rMuTNF is 
expected to give similar effect on MCF-7 (Kramer et al., 1988). 
On the other hand, the effect of rHuTNF on human cell lines can also be studied by 
similar methods that are mentioned in this study. The investigation of the release of Ca^ + 
and ROS should be examined. Combination studies have been initiated utilizing rHuTNF 
with y-interferon, in an attempt to exploit the synergy seen in the pre-cUnical tumor studies 
(Williamson et al., 1983). Combination studies with established antitumor agents such as 
metabolic inhibitor (AMD), Ca^^-inducing agent (thapsigargin or thimerosal) can also be 
expected. 
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